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ABSTRACT

Investigations of Synthetic Models of Mononuclear
Nonheme Iron Dioxygenases
Michael M Bittner, B.S.
Marquette University, 2014

Ring cleaving dioxygenases, such as o-aminophenol dioxygenase (APDO) and
extradiol catechol dioxygenases (CatD), play an important role in human metabolism and
the degradation of aromatic pollutants, yet questions still remain concerning the enzymatic
mechanisms. One area of the catalytic cycle that remains controversial is the geometric
and electronic structure of the intermediate formed after O 2 binding to the Fe(II) centers.
Synthetic model systems can be useful for studying enzyme active sites, as they are easier
to modify and characterize than the enzymes themselves. However, synthetic models of
APDOs have been relatively rare thus far.
We prepared several monoiron(II) complexes that faithfully model the enzymesubstrate intermediates of o-aminophenol dioxygenases (APDO) and catechol
dioxygenases. The complexes use either the Ph2Tp (Ph2Tp = hydrotris(3,5-diphenylpyrazol1-yl)borate) or Ph2TIP (Ph2TIP = tris(4,5-diphenyl-1-methylimidazole)phosphine)
supporting ligands and one of three bidentate, redox-active ligands: 4-tertbutylcatecholate,
4,6-di-tert-butyl-2-aminophenolate,
or
4-tert-butyl-1,2phenylenediamine.
These complexes have been extensively characterized with
crystallographic, spectroscopic, and electrochemical techniques, in conjunction with
computational methods (e.g, density functional theory). Each complex is reactive towards
O2, and the geometric and electronic structures of the resulting species were examined with
various methods to determine whether the oxidation is iron-based, ligand-based, or a
combination of both.
Treatment of the Ph2Tp / Ph2TIP monoiron(II) aminophenolate complex with a
phenoxyl radical results in formation of a complex containing an iron(II) center
coordinated to an iminobenzosemiquinonate radical, that to the best of our knowledge has
no synthetic precedence. Further oxidation leads to a complex best described as a ferric
center bound to the iminiobenzosemiquinate radical. The electronic structures of these
complexes were determined with the aid of spectroscopic and computational methods.
Several monoiron(II) complexes were also prepared to model the active-site
structure of -diketone dioxygenase (Dke1). For this purpose, we employed the Ph2Tp
supporting ligand and acacX substrate ligands, where acacX represents the anion of dialkyl
malonate. Upon exposure to O2 in toluene it was found that the complexes exhibited
reactivity similar to Dke1, although at a much slower rate than the native enzyme.

i

ACKNOWLEDGEMENTS

Michael M Bittner, B.S.

I would like to thank Dr. Adam Fiedler for all his guidance, understanding, and patience.
He has always been there for his students and provided help when they needed. My lab
mates Jake Baus, Amanda Baum, Denan Wang, Xixi Hong, and Dr. Heaweon Park for
their thoughtful discussions and assistance during my time at Marquettee. Most of all,
my Mother, Father, and family for all their support during my graduate career.

ii

TABLE OF CONTENTS
ACKNOWLEDGEMENTS..................................................................................................i
LIST OF TABLES...............................................................................................................v
LIST OF FIGURES...........................................................................................................vii
LIST OF COMPLEXES....................................................................................................xii
CHAPTER
I. INTRODUCTION: STRUCTURE AND FUNCTION OF NONHEME IRON
DIOXYGENASES...................................................................................................1
A. Nonheme Iron Dioxygenases.................................................................2
B. Catalytic Mechanism of the Nonheme Iron Dioxygenases....................5
C. A New Class of Nonheme Iron Dioxygenases.....................................10
D. Biomimetic Studies of Nonheme Iron Dioxygenases..........................15
E. Importance of Non-Innocent Ligands..................................................17
F. Specific Aims of This Project..............................................................18
II. SYNTHESIS AND STRUCTURAL CHARACTERIZATION OF IRON(II)
COMPLEXES WITH TRIS(IMIDAZOLYL)PHOSPHANE LIGANDS:
A PLATFORM FOR MODELING THE 3 HISTIDINE FACIAL TRIAD OF
NONHEME IRON DIOXYGENASES.................................................................20
A. Introduction..........................................................................................21
B. Results and Discussion........................................................................24
C. Conclusions..........................................................................................34
D. Experimental........................................................................................35

iii

III. SYNTHETIC MODELS OF THE PUTATIVE Fe(II)IMINOBENZOSEMIQUINONATE INTERMEDIATE
IN THE CATALYTIC CYCLE OF O-AMINOPHENOL
DIOXYGENASES.................................................................................................39
A. Introduction..........................................................................................40
B. Results and Discussion........................................................................42
C. Conclusions..........................................................................................53
D. Experimental........................................................................................53
IV. SPECTROSCOPIC AND COMPUTATIONAL STUDIES OF Fe
COMPLEXES WITH O-AMINOPHENOLATE AND
IMINOBENZOSEMIQUINONE
LIGANDS..............................................................................................................60
A. Introduction..........................................................................................61
B. Synthesis of Complexes [7b]+-[9b]2+ and 10a.....................................64
C. Electrochemistry of Complexes 4a -[6a]+...........................................75
D. Geometric and Electronic Structures of DFT-Optimized Models.......78
E. Mӧssbauer Spectroscopy.....................................................................84
F. Electronic Absorption and MCD Spectroscopy...................................88
G. Resonance Raman Spectroscopy.........................................................95
H. Discussion............................................................................................99
I. Conclusions........................................................................................101
J. Experimental......................................................................................102

iv

V. DIOXYGEN REACTIVITY OF BIOMIMETIC Fe(II) COMPLEXES WITH
NONINNOCENT CATECHOLATE, O-AMINOPHENOLATE, AND
O-PHENYLENEDIAMINE LIGANDS..............................................................108
A. Introduction........................................................................................109
B. Synthesis, Solid State Structures, and Spectroscopic Features..........113
C. Reaction With Dioxygen....................................................................122
D. Spectroscopic and Computational Studies of 12ox.............................131
E. Kinetic Analysis of O2 Reactivity......................................................138
F. Computational Studies of O2 Reactivity............................................147
G. Discussion..........................................................................................152
H. Conclusions........................................................................................158
I. Experimental......................................................................................159

VI.

O2 REACTIVITY OF Fe(II) COMPLEXES THAT MIMIC THE
ACTIVE-SITE STRUCTURE OF ACETYLACETONE
DIOXYGENASE.....................................................................................167
A. Introduction........................................................................................168
B. Synthesis, Solid State Structures, and Spectroscopic Features..........170
C. Oxygenation of Fe(II) Complexes.....................................................172
D. Conclusions........................................................................................176
E. Experimental......................................................................................176

BIBLIOGRAPHY................................................................................................180

v

LIST OF TABLES

Table 2.1: Selected metric parameters for [Fe2+(LN3)(MeCN)3]2+ complexes................ 25
Table 2.2: Selected metric parameters for ferrous carboxylate complex
[2]OTf·4MeOH..........................................................................................29
Table 2.3: Summary of 1H NMR spectroscopic parameters for [2]OTf and [3]OTf in
CD2Cl2.......................................................................................................33
Table 2.4: Summary of the X-ray Crystallographic Data Collection and Structure
Refinement.................................................................................................38
Table 3.1: Selected Bond Distances (Å) for Complexes 4a-[6a]+.....................................43
Table 3.2: Selected bond distances (Å) and bond angles (deg) for 4a and 5a obtained
from X-ray diffraction (XRD) experiments, along with values
computed by density functional theory (DFT) for models 5a1 and 5a2.....49
Table 3.3: Selected bond distances (Å) and bond angles (deg) for [6a]+ obtained from
X-ray diffraction (XRD) experiments, along with values
computed by density functional theory (DFT)...........................................50
Table 3.4: Summary of X-ray Crystallographic Data Collection and Structure
Refinement.................................................................................................59
Table 4.1: Selected bond lengths (Å) and angles (deg) for complexes 4a, [7b]BPh4, and
10a..............................................................................................................68
Table 4.2: Selected bond lengths (Å) from the X-ray structures of [6a]SbF6●0.5 DCE and
[9b](OTf)2●1.5 CH2Cl2..............................................................................72
Table 4.3: Experimental and DFT-computed properties of selected complexes...............74
Table 4.4: Selected Bond Distances (Å) and Angles (deg) for Complexes 5a and [8b]+
Obtained by XRD and DFT.......................................................................79
Table 4.5: Experimental and computed bond distances (Å) and bond angles (deg) for
complexes [6a]+ and [9b]2+ Obtained by XRD and DFT..........................82
Table 4.6: Experimental Mӧssbauer Parameters...............................................................85
Table 4.7: Comparison of Computed (TD-DFT) and Experimental Energies for Selected
Electronic Transitions of Complexes 5a and [6a]SbF6..............................91
Table 4.8: Summary of X-ray Crystallographic Data Collection and Structure
Refinement...............................................................................................107

vi

Table 5.1: Selected Bond Distances (Å) and Bond Angles (deg) for [11]+, [12]2+, and
[13]+ Measured with X-ray Diffraction...................................................117
Table 5.2: Experimental Mӧssbauer Parameters.............................................................124
Table 5.3: Selected Bond Distances (Å) and Angles (deg) for Complex [7]+ and the
Corresponding [Fe/O2]+ Species (Stot = 3,2, and 1) Obtained by DFT
Calculations..............................................................................................149
Table 5.4: Selected Bond Distances (Å) and Angles (deg) for Complex [11]+ and the
Corresponding [Fe/O2]+ Species (Stot = 3,2, and 1) Obtained by DFT
Calculations..............................................................................................149
Table 5.5: Selected Bond Distances (Å) and Angles (deg) for Complex [12]2+ and the
Corresponding [Fe/O2]+ Species (Stot = 2, and 1) Obtained by DFT
Calculations..............................................................................................150
Table 5.6: Energetics of O2 Binding to Complexes [7]+, [11]+, [12]2+, and Comparison of
O─O Bond Distances and Stretching Frequencies in the Resulting Fe/O2
Adducts....................................................................................................151
Table 5.7: Summary of X-ray Crystallographic Data Collection and Structure
Refinement...............................................................................................166
Table 6.1: Selected Bond Distances (Å) and Bond Angles (deg) for 2-acacOMe • 1.5
CH2Cl2, and 2-acacPhmal • MeCN............................................................172
Table 6.2: Summary of X-ray Crystallographic Data Collection and Structure
Refinement...............................................................................................179

vii

LIST OF FIGURES

Figure 1.1: Biodegradation pathway of naphthalene...........................................................2
Figure 1.2: Various aromatic substrates cleaved by nonheme Fe dioxygenases.................4
Figure 1.3: Common active-site structure of nonheme Fe dioxygenases, featuring the 2His-1-carboxylate facial triad of protein residues.......................................4
Figure 1.4: Selected reactions in the kynurenine pathway..................................................5
Figure 1.5: Proposed mechanism for extradiol catechol dioxygenases and o-aminophenol
dioxygenases................................................................................................7
Figure 1.6: Proposed mechanism for HAD..........................................................................9
Figure 1.7: Reactions catalyzed by nonheme Fe dioxygenases with the 3His triad..........11
Figure 1.8: Crystallographically-derived structures of the 2-His-1-carboxylate facial triad,
and the 3His facial triad in Dke1 active site..............................................12
Figure 1.9: Proposed mechanism for Dke1........................................................................14
Figure 1.10: Oxidation states accessible by catechols.......................................................17
Figure 1.11: Schematic illustrating of the various methods employed in our modeling
studies of nonheme Fe dioxygenases.........................................................19
Figure 2.1: Cleavage of several different examples nonheme iron dioxygenase
substrates...................................................................................................22
Figure 2.2: Phosphine ligand used as supporting ligand in various Fe(II)
complexes synthesized...............................................................................23
Figure 2.3: Synthesis of Fe(II) complexes with the Ph2TIP ligand.....................................24
Figure 2.4: Thermal ellipsoid plot (50% probability) of [1](OTf)2•0.5Et2O.....................26
Figure 2.5: 19F NMR spectra of [1](OTf)2 in CD3CN and CD2Cl2
collected at room temperature....................................................................27
Figure 2.6: Thermal ellipsoid plot (50% probability) derived from [2]OTf·4MeOH.......28
Figure 2.7: Thermal ellipsoid plot (50% probability) derived from [3]OTf·2CH2Cl2......31

viii

Figure 2.8: Electronic absorption spectra of the complexes [Fe(4-TIPPh)(acacPhF3)]OTf
and [3]OTf measured at room temperature in MeCN................................31
Figure 3.1: Reaction Catalyzed by HAA Dioxygenase (HAD).........................................41
Figure 3.2: Catalytic Cycle of Ring-Cleaving Dioxygenases............................................41
Figure 3.3: Synthesis and thermal ellipsoid diagram of complex 4...................................42
Figure 3.4: Electronic absorption spectra of 4 (─ - -), 5 (─), and [6]SbF6 (- - -) measured
in CH2Cl2 at RT.........................................................................................43
Figure 3.5: Thermal ellipsoid plot (50% probability) of 5•2CH2Cl2.................................44
Figure 3.6: X-band EPR spectrum of 5 at 20 K.................................................................46
Figure 3.7: Interconversion of 5 and [6]+ by one-electron reactions.................................48
Figure 3.8: Thermal ellipsoid plot (50% probability) of [6]SbF6•0.5DCE.......................52
Figure 3.9: Isosurface plots of selected MOs computed for [6]+ by DFT.........................52
Figure 4.1: Proposed catalytic cycle of ECDO and APDO...............................................63
Figure 4.2: Complexes prepared and examined in this chapter.........................................64
Figure 4.3: Thermal ellipsoid plot of [7b]BPh4 and 10a...................................................66
Figure 4.4: 1H NMR spectra of 4a and [7b]OTf in CD2Cl2...............................................67
Figure 4.5: UV-vis spectra of complexes 4a-[6a]+, [7b]+-[9b]+, and 10a.........................68
Figure 4.6: X-band EPR spectra of 5a (top) and [8b]OTf collected at 20 and 10 K,
respectively................................................................................................70
Figure 4.7: X-band EPR spectra of [9b](OTf)2 collected at 10 K in perpendicular mode
and parallel mode.......................................................................................71
Figure 4.8 Thermal ellipsoid plot (50% probability) derived from the X-ray structure of
[9b](OTf)2●1.5 CH2Cl2...............................................................................72
Figure 4.9: CV diagram of complexes 4a, 5a, and 10a. All potentials have been
referenced to the ferrocene/ferrocenium couple........................................76
Figure 4.10: Diagram of the redox reactions/disproportionation of complexes 4a-6a......76

ix

Figure 4.11: Cyclic voltammograms of ligands tBuAPH2 and DMAPH in CH2Cl2 with 100
mM (NBu4)PF6 as the supporting electrolyte............................................78
Figure 4.12: Qualitative molecular orbital diagrams for 5a and [6a]+ obtained from
broken-symmetry DFT calculations..........................................................80
Figure 4.13: Mӧssbauer spectra of complexes 4a, 5a, and [6a]SbF6 recorded at 6 K in an
applied field of 0.04 T................................................................................84
Figure 4.14: Mӧssbauer spectra of complexes [7b]OTf, [8b]OTf, and [9b](OTf)2,
recorded at 6 K, in an applied field of 0.04 T............................................85
Figure 4.15: Experimental and TD-DFT computed absorption spectra for 5a and
[6a]+...........................................................................................................89
Figure 4.16: Experimental and TD-DFT computed absorption spectra for 5a and electron
density difference maps (EDDMs) for computed transitions....................90
Figure 4.17: Experimental and TD-DFT computed absorption spectra for [6a]+ and
electron density difference maps (EDDMs) for computed transitions......92
Figure 4.18: Variable-temperature solid-state MCD and VTVH-MCD spectra of
[9b](OTf)2..................................................................................................94
Figure 4.19: Resonance Raman spectra obtained with 488.0 nm excitation (45 mW) of
frozen CD2Cl2 solutions of natural abundance [6a]SbF6
with incorporation of 15N isotope in the LO,N ligand..................................96
Figure 4.20: Normal modes, experimental and DFT-calculated frequencies, and computed
isotope shifts for 15N- and 18O-labeled ligand............................................97
Figure 4.21: Resonance Raman spectra obtained with 488.0 nm excitation (45 mW) of
frozen CD2Cl2 solutions of 4a and [6a]SbF6.............................................98
Figure 5.1: Redox active o-Phenylene ligands and their varying electron
configurations..........................................................................................109
Figure 5.2: Complexes discussed in this chapter.............................................................111
Figure 5.3: Thermal ellipsoid plot (50% probability) derived from the X-ray structure of
[11]OTf•2DCE.........................................................................................114
Figure 5.4: 1H NMR spectra of [11]OTf and [12](OTf)2 in CD2Cl2...............................115
Figure 5.5: Thermal ellipsoid plots (50% probability) derived from
[12](OTf)(BPh4)•DCE•C5H12 and [12(MeCN)](OTf)•MeCN•Et2O........116

x

Figure 5.6: Thermal ellipsoid plot (50% probability) derived from the X-ray structure of
[13]OTf•1.5CH2Cl2..................................................................................118
Figure 5.7: Cyclic voltammograms for [11]OTf, [13]OTf, and [12](OTf)2 collected in
CH2Cl2 with 0.1 M (NBu4)PF6 as the supporting electrolyte and
scan rate of 100 mV/s..............................................................................121
Figure 5.8: Time-resolved absorption spectra for the reaction of [11]OTf, [7]OTf, and
[12](OTf)2 with O2...................................................................................123
Figure 5.9: Experimental X-band EPR spectrum of 11ox in CH2Cl2 collected at 10 K and
simulated spectrum generated with the program EasySpin4...................124
Figure 5.10: Mössbauer spectra of complexes 11 and 11ox recorded at 5 K and 77 K,
respectively, in an applied field of 0.04 T...............................................125
Figure 5.11: Possible decomposition pathways of Fe(III)-catecholates..........................126
Figure 5.12: GC-MS data of the solution obtained from the reaction of [11]OTf with 16O2
and 18O2....................................................................................................127
Figure 5.13: 1H NMR spectra of [13]OTf in CD2Cl2.......................................................128
Figure 5.14: Absorption spectrum of [13]OTf measured in anaerobic CH2Cl2 and a plot of
absorption intensity at 610 nm as a function of time for the reaction of
[13]OTf with O2.......................................................................................129
Figure 5.15: Mӧssbauer spectra collected before and after exposure of [12](OTf)2 to
O2.............................................................................................................132
Figure 5.16: Bond distances (in Å) of the [Fe(DIBQ)] 2+ unit in the 12ox-DFT model and
isosurface plot of the spin-down (β) HOMO of 12ox-DFT.....................134
Figure 5.17: Experimental and TD-DFT computed absorption spectra for 12ox and
electron density difference maps (EDDMs) for computed transitions...135
Figure 5.18: Resonance Raman spectra of 12ox in frozen CD2Cl2 solutions collected with
647.1 nm and 488.0 nm laser excitation..................................................136
Figure 5.19: Normal mode compositions, experimental and DFT-calculated frequencies,
and computed isotope shifts for the 15N-substituted ligand.....................137
Figure 5.20: Plots of initial rates versus Fe concentration for the reactions of [11]OTf,
[7]OTf, and [12](OTf)2 with O2...............................................................139
Figure 5.21: Plots of initial rates versus O2 concentration for the reactions of [11]OTf,
[7]OTf, and [12](OTf)2 with O2...............................................................140

xi

Figure 5.22: Plots of absorption intensity as a function of time for the reactions of
[11]OTf, [7]OTf, and [12](OTf)2 with O2...............................................142
Figure 5.23: Eyring plot for the reaction of [7]OTf with O2 in O2-saturated CH2Cl2 over a
temperature range of 22 °C to -30 °C......................................................143
Figure 5.24: Absorption spectra obtained by treating [11]OTf with TEMPO• or O2 in
CH2Cl2 at room temperature....................................................................145
Figure 5.25: Absorption spectra of [12](OTf)2 and 12ox compared to the one obtained by
treating [12](OTf)2 with two equivalents of TTBP•................................146
Figure 5.26: DFT-calculated structures of the Fe/O2 adducts.........................................148
Figure 5.27: Summary of diverse O2 reactivity displayed by our complexes.................154
Figure 5.28: Proposed mechanism for the formation of a ferric-alkylperoxo intermediate
leading to ring-cleavage products and the condensed mechanism
utilized by ring-cleaving dioxygenases....................................................157
Figure 6.1: Naming scheme of compounds in this chapter..............................................170
Figure 6.2: Thermal ellipsoid plots (50% probability) derived from 14•1.5 CH2Cl2, and
15•MeCN.................................................................................................171
Figure 6.3: Time-dependent absorption spectra of the reaction of 15 (0.36 mM) with O2 at
room temperature in toluene....................................................................174
Figure 6.4: Proposed mechanistic path for the oxidative cleavage of acac X ligands utilized
by our synthetic models...........................................................................174

xii

LIST OF COMPLEXES

[Fe2+(Ph2TIP)(MeCN)3](OTf)2................................................................................[1](OTf)2
[Fe2+(Ph2TIP)(OBz)(MeOH)]OTf...............................................................................[2]OTf
[Fe2+(Ph2TIP)(acacPhF3)]OTf........................................................................................[3]OTf
[Fe2+(Ph2Tp)(tBu2APH)]......................................................................................................[4]
[Fe2+(Ph2Tp)(tBu2ISQ)]........................................................................................................[5]
[Fe3+(Ph2Tp)(tBu2ISQ)]SbF6................................................................................................[6]
[Fe2+(Ph2TIP)(tBu2APH)]OTf.......................................................................................[7]OTf
[Fe2+(Ph2TIP)(tBu2ISQ)]OTf.........................................................................................[8]OTf
[Fe3+(Ph2TIP)(tBu2ISQ)]OTf2....................................................................................[9](OTf)2
[Fe2+(Ph2Tp)(DMAP)]......................................................................................................[10]
[Fe2+(Ph2TIP)(tBuCatH)]OTf......................................................................................[11]OTf
[Fe2+(Ph2TIP)(tBuPDA)]OTf2.................................................................................[12](OTf)2
[Fe2+(Ph2TIP)(Me2MP)]OTf.......................................................................................[13]OTf
[Fe2+(Ph2Tp)(acacOMe)].....................................................................................................[14]
[Fe2+(Ph2Tp)(acacPhmal)]...................................................................................................[15]

1

Chapter 1

Introduction: Structure and Function of Nonheme Iron
Dioxygenases

Vetting, M. W.; D'Argenio, D. A.; Ornston, L. N.; Ohlendorf, D. H. Biochemistry 2000, 39, 7943.

Abstract: Mononuclear nonheme iron dioxygenases play a central role in the
biodegradation of various aromatic and aliphatic compounds. Despite their prevalence in
Nature, certain aspects of the enzymatic mechanisms remain poorly understood. In the
ring-cleaving dioxygenases, the catalytic cycle is thought to involve formation of
substrate-based radical after binding of O2 to the Fe(II) center, although the identity of
this intermediate is controversial. We have explored fundamental questions regarding the
reactivity of iron-containing dioxygenases using a biomimetic approach that combines
coordination chemistry, spectroscopy, electrochemistry, and reactivity studies.
Portions of this chapter have appeared in the paper: Bittner, M. M.; Kraus, D.; Lindeman,
S. V.; Popescu, C. V.; Fiedler, A. T. Chem. Eur. J. 2013, 9686-9698.
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1.A. Nonheme Iron Dioxygenases
A number of important metalloenzymes are found in metabolic pathways evolved
by bacteria to breakdown and assimilate recalcitrant pollutants – a process referred to as
bioremediation.1,2 Single and multi-ring hydrocarbons are a major class of pollutants
amenable to bioremediation. The aerobic degradation of these compounds is largely
mediated by nonheme iron-containing dioxygenases (enzymes capable of incorporating
both atoms of O2 into substrate).3 For example, the first step in the catabolism of
naphthalene is its oxidation to the corresponding cis-1,2-diol (Figure 1.1) – a reaction
catalyzed by naphthalene 1,2-dioxygenase (NDO).4 After aromatization of the diol to the
corresponding catechol, the aromatic ring is oxidatively opened by either an intradiol- or
extradiol-cleaving catechol dioxygenase (CatD).5 The resulting products are then further
degraded to yield intermediates that can feed into the Krebs cycle, thereby allowing the
organisms to utilize the pollutant as a source of energy. 1

Figure 1.1. Biodegradation pathway of naphthalene.

3

Nonheme Fe dioxygenases have been shown to oxidatively cleave a wide variety of
aromatic substrates, including catechol, protocatechuates, 6 hydroquinones7-9, oaminophenols10,11, and salicylates12-14 (Figure 1.2). With the exception of the intradiol
catechol dioxygenases, these ring-cleaving dioxygenases generally share a common
active-site structure: the high-spin monoiron(II) center is bound to one aspartate (or
glutamate) and two histidine residues in a facial array, along with two or three H 2O
ligands (Figure 1.3)4,5,15-18. This “2-His-1-carboxylate (2H1C) facial triad” is the
dominant coordination motif found among nonheme monoiron enzymes involved in O 2
activation – other examples include the -ketoglutarate- and pterin-dependent
oxygenases and isopenicillin N-synthase (IPNS)19-21. The 2H1C structure facilitates
catalysis by permitting the Fe center to bind both substrate and O 2. In the extradiol
CatDs, substrate coordinates to Fe in a bidentate, monoanionic fashion with concomitant
dissociation of all H2O ligands18,22,23. The resulting five-coordinate Fe2+ center then
binds O2 in the vacant site adjacent to the bound substrate.18,24

4

Figure 1.2. Various aromatic substrates cleaved by nonheme Fe dioxygenases.

Figure 1.3. Common active-site structure of nonheme Fe dioxygenases, featuring the 2His-1-carboxylate facial triad of protein residues.5

5

While the vast majority of nonheme iron dioxygenases are found in bacteria, a few
significant examples occur in mammals (including humans). For instance, a key step in
tryptophan degradation involves the O2-mediated ring-cleavage of 3-hydroxyanthranilate
(HAA) by HAA-3,4-dioxygenase (HAD; Figure 1.4)25. This reaction occurs as the final
step in the kynurenine pathway that coverts excess tryptophan to quinolinic acid, which is
then used to produce the NADH cofactor.26 X-ray crystallographic studies revealed a
nonheme Fe center coordinated by the canonical 2H1C facial triad.

Figure 1.4. Selected reactions in the kynurenine pathway.

1.B. Catalytic Mechanism of the Nonheme Iron Dioxygenases
The catalytic mechanism of the extradiol CatDs has been studies extensively with
experimental and computational methods. The first step involves bidentate coordination
of substrate to Fe with loss of a proton, accompanied by displacement of the H2O
ligands5,18,23. The resulting five-coordinate Fe(II) center then binds O2 in the vacant site

6

adjacent to the bound substrate18,24. Formation of a short-lived ferric-superoxo
intermediate is thought to trigger the transfer of one electron from the substrate ligand to
iron, resulting in a bound o-semiquinone radical18. The existence of this putative
intermediate would likely require deprotonation of the distal –OH group by a secondsphere residue, although it is not clear whether these three events (O2 coordination,
electron transfer, and proton transfer) occur in a stepwise or concerted manner. The
degree of semiquinone character on the substrate ligand in the O2-bound form of the
enzyme is also uncertain (vide infra); however, it is well-established that the next step of
the catalytic cycle involves generation of an Fe(II)-alkylperoxo species, which undergoes
a Criegee rearrangement and hydrolysis to eventually yield the ring-opened product.
Interestingly, the general catalytic strategy employed by the ring-cleaving dioxygenases
differs substantially from the O2-activation mechanism employed by cytochrome P450s27,
methane monooxygenase28, and α-ketoglutarate dependent dioxygenases29. In these
enzymes, O2 is used to generate an iron(IV)-oxo intermediate that performs the
demanding hydroxylation of an aliphatic substrate. In contrast, structural, mutagenic, and
radical trap experiments and also computational studies have revealed that the ringcleaving dioxygenase mechanism does not involve high-valent Fe intermediates (Figure
1.5).23,30-32
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Figure 1.5. Proposed mechanism for extradiol catechol dioxygenases and o-aminophenol
dioxygenases.

While there is broad agreement concerning the generic mechanism shown in Figure
1.5, the electronic structure of the critical Fe/O2/substrate intermediate remains disputed.
While Fe/O2 adducts are normally described as ferric-superoxo species (such as
intermediate I in Figure 1.5), early studies by Lipscomb33 and Bugg34 lead to the proposal
that ring-cleaving dioxygenases proceed instead via a superoxo-Fe(II)(imino)semiquinone species (II). The radical character of the substrate was presumed to
facilitate reaction with the superoxo ligand, thereby overcoming the large kinetic barrier
to formation of the peroxy intermediate. This hypothesis was partly inspired by model
studies that had demonstrated the “non-innocent” nature of metal-bound
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catecholates35-37 and iminophenolates38. Subsequent experiments with a substrate
analogue featuring a cyclopropyl moiety as a radical probe indicated formation of
semiquinonate (SQ) radical during the catalytic cycle of MhpC, a well-studied ECDO.39
Density functional theory (DFT) analysis by Siegbahn further supported this electronic
structure description40-42. In addition, Emerson et al. demonstrated that a pair of ECDOs,
Fe-HPCD and Mn-MndD, are equally active with either Fe or Mn in their active sites,
despite the intrinsically different redox potential of the two metal ions.43 This result lead
to the conclusion that the Fe (or Mn) oxidation state does not change during the catalytic
cycle; instead, the metal ion only serves to conduct an electron from the bound substrate
ligand to O2, thus yielding intermediate II directly.
Despite this large body of evidence, recent studies have challenged the prevailing
notion that a substrate-based radical is generated in the catalytic cycles of ECDOs (and,
by extension, other ring-cleaving dioxygenases). Firstly, Lipscomb and coworkers
succeeded in isolating the Fe/O2 adduct of a HPCD mutant (H200N) bound to the
“unactivated” substrate 4-nitrocatechol. Interrogation with EPR and Mössbauer
spectroscopies revealed that this species contains an Fe3+O2 • unit with S = 2 –
inconsistent with the presence of a SQ ligand. 44 A follow-up study of H200N HPCD
with the native substrate resulted in the isolation and spectroscopic characterization of
novel intermediate best described as a hydroperoxo-Fe(III)-semiquinone species (III in
Figure 1.5).45 However, a recent computational study by Ye and Neese suggested that
this intermediate is not catalytically viable. 46 Their calculations of the ECDO mechanism
found no evidence that a SQ-containing intermediate (either II or III) is required for
catalysis. Instead, they favor a mechanism in which the ferric-superoxo adduct (I)
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converts directly to a hydroperoxo-bridged species (Figure 1.5). The kinetic barrier for
this step is lowered by concomitant transfer of a proton from the second-sphere histidine
residue to the nascent peroxo group.
Compared to the extensive literature that exists for the extradiol CatDs, there have
been few mechanistic studies of nonheme Fe dioxygenases that oxidize non-catechol
substrates, such as o-aminophenols and hydroquinones.5 Proposed catalytic cycles for
these dioxygenases largely follow the ordered mechanism described above for the
extradiol CatDs. For instance, based on X-ray crystallographic studies, Zhang et al.
suggested the catalytic cycle shown in Figure 1.6 for HAD. 30 As in the extradiol CatDs
mechanism, the electronic structure of the key Fe/O2/HAA adduct is uncertain.

.
Figure 1.6. Proposed mechanism for HAD.47
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1.C. A New Class of Nonheme Iron Dioxygenases
Despite the prevalence of the 2H1C facial triad, a new class of mononuclear nonheme
Fe dioxygenases has recently emerged that employ the 3-histidine (3His) facial triad
instead.48,49 As with NDO and the extradiol CatDs, these enzymes are largely found in
bacteria where they serve to degrade xenobiotic compounds (the lone exception is
cysteine dioxygenase (CDO), an enzyme found in mammalian cells that initiates the
catabolism of L-cysteine; see Figure 1.7).50,51 Members of this “3His family” catalyze
novel transformations that have expanded the known boundaries of Fe dioxygenase
chemistry. For example, the enzyme -diketone dioxygenase (Dke1) is one of the few
dioxygenases capable of oxidatively cleaving aliphatic C-C bonds.52,53 Dke1 converts
acetylacetone – a toxic and prevalent pollutant – to acetic acid and 2-oxopropanal (Figure
1.7). It was first isolated from a bacterial strain (Acinetobacter johnsonii) that is capable
of growing on acetylacetone and other -diketones as its sole carbon source.50 X-ray
diffraction (XRD) studies confirmed that the metal center in Dke1 is facially coordinated
by three His residues and presumably 2-3 H2O molecules, although these were not
resolved in the structure (Figure 1.8).54,55 While the active site can bind several first-row
transition metal ions, only Fe(II) results in catalytic activity.52 Spectroscopic studies
suggest that substrate coordinates to Fe as the deprotonated -keto-enolate in a bidentate
manner.56
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Figure 1.7. Reactions catalyzed by nonheme Fe dioxygenases with the 3His triad.
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Figure 1.8. Crystallographically-derived structures of (A) the 2-His-1-carboxylate facial
triad,14 and (B) the 3His facial triad in Dke1 active site.

Other Fe dioxygenases with the 3His triad include gentisate 1,2-dioxygenase (GDO)57
and salicylate 1,2-dioxygenase (SDO),12,13,58 both of which oxidatively cleave aromatic
C-C bonds (Figure 1.7). Sequence analysis also suggests that 1-hydroxy-2-naphthoate
dioxygenase (HNDO) belongs to the 3His family of Fe dioxygenases, 13,59 although
crystallographic data are currently lacking. Each of these microbial enzymes participates
in the degradation pathways of polycyclic aromatic hydrocarbons.13,57,60 The reaction
catalyzed by GDO is very similar to those catalyzed by the extradiol CatDs and likely
follows a similar mechanism.57 However, the reactions of SDO and HNDO are
fundamentally different due to the lack of a second hydroxyl group.10,13,61 Only a handful
of enzymes are capable of cleaving monohydroxylated aromatic compounds, and most of
these examples involve aminophenol substrates in which the amino moiety assumes the
role of the second hydroxyl group. SDO and HNDO are therefore unique in performing
the oxidative cleavage of aromatic rings with only one electron-donating group.
Finally, the enzyme quercetin dioxygenase (QDO), which catalyzes the aerobic
breakdown of plant flavonols by fungi and some bacteria (Figure 1.7), employs a
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variation of the 3His motif.62,63 An X-ray structure of bacterial QDO from Bacillus
subtilis revealed two monoiron active sites per subunit. 64 Both Fe(II) centers are
pentacoordinate with four protein ligands (one Glu and three facial His) and one H 2O
ligand. However, in the site closest to the C-terminus, the Glu ligand is only weakly
bound with an Fe-OGlu distance of 2.44 Å.64 Thus, QDO can be considered a member of
the 3His family with an extra Glu residue at the interface of the first- and secondcoordination spheres. While QDO from B. subtilis was isolated with Fe2+, the enzyme
exhibits equal or greater activity with other transition-metal ions.64 Indeed, nearly all
QDOs can function in vitro with multiple divalent metal ions, including Mn2+, Fe2+, Co2+,
Ni2+, and Cu2+.64-66
Given the prevalence and effectiveness of monoiron enzymes with the “canonical”
2H1C triad, the emergence of the 3His family of Fe dioxygenases raises an interesting
question: what is the significance of this change in Fe coordination environment for
catalysis? Interestingly, a mutant of Dke1 in which the His104 ligand was replaced with
Glu was able to partially bind Fe2+ (~30% of wild type) yet exhibited no catalytic
activity.67 Similarly, a mutant of IPNS in which the Asp ligand was replaced with His
was inactive although it contained approximately the same amount of Fe as the wild type
enzyme.68 Thus, the 2H1C and 3His motifs are not functionally interchangeable, yet it
remains unclear exactly how these ligand-sets tune the catalytic properties of their
respective enzymes.
Another open question concerns the mechanism of oxidative C-C bond cleavage in
the 3His dioxygenases. Based on kinetic data for Dke1, Straganz has proposed that the
reaction proceeds via direct addition of O2 to the bound substrate to give an

14

alkylperoxidate intermediate.69 The nucleophilic peroxidate then attacks the carbonyl
group to yield a dioxetane species, which subsequently collapses to the products via
concerted C-C and O-O bond cleavage (Figure 1.9A). This mechanism resembles the
one proposed for the intradiol CatDs in which the role of the Fe center is to activate
substrate, not O2.70,71 A more conventional O2-activation mechanism has also been
proposed for Dke1 that involves initial formation of an Fe-superoxo intermediate,
followed by reaction with bound substrate (Figure 1.9B).72 The mechanisms of SDO and
HNDO are also unsettled. The lack of a second electron-donating group on the
substrates, noted above, makes it unlikely that these enzymes follow the same catalytic
cycle as the extradiol CatDs, which involves a Criegee rearrangement to form a lactone
intermediate.5,23 This step requires ketonization of the second –OH group to transfer
electron-density onto the ring – an impossibility for the SDO and HNDO substrates.
Thus, these 3His Fe dioxygenases require an alternative strategy for oxidative ring
scission that has yet to be determined.

Figure 1.9. Proposed mechanism for Dke1.
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1.D. Biomimetic Studies of Nonheme Iron Dioxygenases
Our knowledge of metalloenzymes has greatly benefited from the development of
small-molecule analogs that replicate important structural, spectroscopic, and/or
functional properties of the enzyme active sites. 73 The intra- and extradiol CatDs have
been the target of numerous synthetic modeling studies, which have been extensively
reviewed by Que and Gebbink.20,74-77 By comparison, few efforts have been made to
produce models of ring-cleaving dioxygenases with non-catechol substrates, such as the
o-aminophenol or hydroquinone dioxygenases. 78,79
To date, synthetic models of Fe dioxygenases have yielded little insight into the
electronic structure of the critical Fe/O2/substrate intermediates, which are thought (by
some) to possess a coordinated substrate radical. 78,80-83 Notably, all relevant models of
the extradiol CatDs feature unambiguous [Fe3+catecholate]+ units. Similarly, the
Fe(III)iminosemiquinone complexes generated by Wieghardt and coworkers exclusively
undergo ligand-based reductions to give the corresponding Fe(III)imidophenolate(2-)
species.78,81,83 Thus, previous modeling studies have provided no evidence to support the
existence an Fe(II)/substrate radical species in the catalytic cycles of ring-cleaving
dioxygenases.
Biomimetic studies of the 3His family of Fe dioxygenases have also been lacking. A
notable exception is Limberg’s structural and functional model of Dke1. In 2008,
Limberg et al. reported that the reaction of [Fe(MeTp)(Phmal)] (where Phmal = the anion
of diethyl phenylmalonate; MeTp = tris(3,5-dimethylpyrazolyl)borate) with O2 at room
temperature in MeCN results in dioxygenolytic ring cleavage of the bound ligand; yet no
attempt was made to trap reactive intermediates. 72 The unique reactions performed by
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the 3His family of Fe dioxygenases, as well as their relevance to bioremediation
processes, make them worthy targets for biomimetic studies. Thus, one theme of our
research efforts has been the design of metal complexes that serve as structural and
functional models of dioxygenases with the 3His facial triad (Dke1, SDO, GDO, HNDO,
and QDO).
A key advantage of the biomimetic approach is that the properties of the dioxygenase
models can be modified in a straightforward and systematic manner, thereby allowing
one to isolate those factors that play crucial roles in modulating electronic structure and
catalytic activity. While similar changes can be made to protein active sites via
mutagenesis, such modifications often cause widespread and ill-defined changes in
structure that result in loss of activity. For instance, in the 2H1C and 3His families, many
variants arising from point mutations of coordinating residues fail to bind Fe(II), and
most are catalytically inactive, limiting the information that can be derived from
mutagenesis studies.49,84 In contrast, the flexible synthetic approach described here will
provide a series of Fe complexes with a broad range of geometric and electronic
properties. By exploring the reactivities of these various complexes with O 2, we have
been able to formulate structure-reactivity correlations that are transferrable to the
biological systems. In addition, the biomimetic approach is ideally suited for the
isolation and characterization of catalytic intermediates that are difficult to observe in
studies of the metalloenzymes, since it permits a great deal of control over ligand
properties and reaction conditions.
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1.E. Importance of Non-innocent Ligands
As shown above, redox active ligands play an important role in the mechanism of
nonheme iron dioxygenases; specifically, the possible formation of a Fe 2+-(substrate
radical) intermediate. While redox noninnocence of the substrate ligand is vital from a
mechanistic standpoint; the electronic structure of compounds containing these types of
ligands are often difficult to characterize, since multiple assignments of metal and ligand
oxidation states are possible. This necessitates careful examination of these complexes
with a variety of spectroscopic and computational methods in order to obtain an accurate
description of their electronic structure. 85-89

Figure 1.10. Oxidation states accessible by catechols.

Figure 1.10 shows the possible oxidation states of catechols, the prototypical
example of a noninnocent redox active ligand. It is important to note that while it is
possible to for these ligands to undergo electron-transfer, an area that has been studied
extensively, they can also transfer two protons. This gives these ligands the ability to
facilitate proton-coupled electron transfers (PCET)- a scenario that has received less
attention. By synthesizing Fe2+ compounds with noninnocent ligands like aminophenols,

18

catechols, and phenylenediamines we hope to gain a better understanding of the possible
intermediates and the role of PCET in the catalytic cycle of nonheme iron dioxygenases.

1.F. Specific Aims of this Project
Our research involves a combination of synthetic inorganic chemistry, physical
characterization (crystallography, electrochemistry, and spectroscopy), computational
methods, and examination of reactivities (Figure 1.11). With this integrated approach,
we have addressed fundamental questions regarding the catalytic activity of nonheme Fe
dioxygenases. Specifically, we have:
1. Synthesized several monoiron(II) complexes with tris(imidazolyl)phosphane (TIP)
ligands in an effort to model the 3His facial triad of some Fe dioxygenases.
[Chapter 2]
2. Prepared synthetic models of putative catalytic intermediates in the mechanism of
aminophenol dioxygenases. Significantly, we succeed in generating the first synthetic
example of an Fe(II) center coordinated a biologically-relevant iminosemiquinonate
ligand. A combination of crystallographic, spectroscopic, and computational methods
were used to probe the electronic structure of this unique complex. The
corresponding Fe(III)-iminosemiquinone complex was also prepared and examined
with similar techniques. [Chapters 3 and 4]
3. To explore the role of redox-active ligands in O2 activation, we synthesized and
structurally-characterized iron(II)-Ph2TIP-based complexes with ligands derived from
catechol and o-phenylenediamine. These complexes, in conjunction with the
aminophenolate complex described in Chapter 4, constitute a unique series of high-
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spin Fe(II) complexes with redox-active ligands. Each complex is oxidized in the
presence of O2, and the geometric and electronic structures of the resulting species
were examined with spectroscopic and computational methods. The kinetics of the
O2 reactions and the identities of ring-cleavage products (if any) were also examined.
[Chapter 5]
4. Examined the reactivity of Dke1 models with O2. Building upon earlier studies
performed by Drs. Heaweon Park and Jake Baus, three novel Ph2Tp-based complexes
with dialkyl-malonate anions were prepared. We demonstrated that these complexes
exhibit dioxygenase activity and thus serve as functional Dke1 models. [Chapter 6]

Figure 1.11. Schematic illustrating of the various methods employed in our modeling
studies of nonheme Fe dioxygenases.
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Chapter 2

Synthesis and Structural Characterization of Iron(II)
Complexes with Tris(imidazolyl)phosphane Ligands: A
Platform for Modeling the 3 Histidine Facial Triad of
Nonheme Iron Dioxygenases

Abstract: Two monoiron(II) complexes containing the ligand tris(4,5-diphenyl-1methylimidazole)phosphine (Ph2TIP) have been prepared and structurally characterized
using X-ray crystallography and NMR spectroscopy. The key feature of each of complex
is the [Fe(κ3-TIP)]2+ unit in which the remaining coordination sites are occupied by easily
displaced ligands. The viability of these complexes was demonstrated through the synthesis
of Ph2TIP-based complexes with a β-diketonate ligand that represents a faithful model of βdiketone dioxygenase (Dke1).
Portions of the following chapter have appeared in the following paper: Bittner, M. M.;
Baus, J. S.; Lindeman, S. V.; Fiedler, A. T. Eur. J. Inorg. Chem. 2012, 2012, 1848.
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2.A. Introduction
Mononuclear nonheme iron dioxygenases play a central role in the oxidative
catabolism of a wide range of biomolecules and pollutants. 90,91,3 Members of this enzyme
family include the extradiol catechol dioxygenases,21,92,93 Rieske dioxygenases4,17,
homogentisate dioxygenase,94,5 and (chloro)hydroquinone dioxygenases95-98. These
enzymes feature a common active-site motif in which the ferrous center is facially ligated
by one aspartate (or glutamate) and two histidine residues [the so-called 2-His-1carboxylate (2H1C) facial triad].19, 42 However, recent structural studies have shown that
the Asp/Glu ligand in some monoiron dioxygenases is replaced with His, resulting in the
3His facial triad.48 For example, cysteine dioxygenase (CDO) 99,50 – the first 3His enzyme
to be structurally characterized – catalyzes the initial step in l-cysteine catabolism by
converting the thiol into a sulfinic acid (Figure 2.1). Other 3His Fe dioxygenases include
gentisate 1,2-dioxygenase (GDO)57,100 and salicylate 1,2-dioxygenase (SDO),58,101,102
both of which oxidatively cleave aromatic C–C bonds (Figure 2.1). Each of these
microbial enzymes participates in the degradation pathways of polycyclic aromatic
hydrocarbons. While the reaction catalyzed by GDO is very similar to those catalyzed by
the extradiol catechol dioxygenases and likely follows a similar mechanism, SDO is
unique in performing the oxidative cleavage of an aromatic ring with only one electrondonating group.
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Figure 2.1. Cleavage of several different examples nonheme iron dioxygenase
substrates.

In synthetic models, the 2H1C triad is typically modeled with anionic, tridentate
supporting ligands such as tris(pyrazol-1-yl)borates (Tp),103-107 bis(pyrazolyl)acetates,108110

and bis(1-alkylimidazol-2-yl)propionates.111 The last two ligand sets replicate the

mixed N2O donor set of the 2H1C triad by the inclusion of carboxylate arms. Given the
unique and significant reactions catalyzed by the 3His family of Fe dioxygenases, it is
important to develop supporting ligands with specific relevance to the 3His facial triad.
To this end, we have sought to exploit the tris(imidazol-2-yl)phosphane (R2TIP)
framework shown in Figure 2.2, which accurately mimic the charge and donor strength of
the 3 His coordination environment. These ligands were initially generated to model the
3His ligand sets found in the active sites of carbonic anhydrase (Zn2+) and cytochrome c

23

oxidase (Cu2+).112-118 To date, the application of the TIP framework to Fe systems has
been limited to homoleptic [Fe(TIP)2]2+/3+ complexes119-121 and carboxylatebridged
diiron(III) species.121,73,74

Figure 2.2. Phosphine ligand used as supporting ligand in various Fe(II) complexes
synthesized.

A key advantage of the R2TIP ligand is that their steric properties can be easily
modified by altering the R substituent(s). Thus far, we have primarily employed the
Ph2

TIP and, as the steric bulk of the phenyl rings discourages both dimerization and

formation of the homoleptic [Fe(TIP) 2]2+ complexes. The “one-pot” approach, however,
is not always successful for various combinations of supporting and “substrate” ligands.
Thus, as described in this chapter, we have generated several Fe2+ complexes with Κ3TIP ligands that also contain displaceable ligands (such as solvent, triflate, and benzoate)
bound to the opposite face of the octahedron. These complexes resemble the resting states
of 3 His Fe dioxygenases, which feature two or three cis-labile H2O molecules.55,54 In
addition, it is shown that these TIP-based complexes serve as excellent precursors for the
formation of monoiron complexes with three facial imidazole donors and various bound
substrates, including β-diketonates and salicylates (mimics of Dke1 and SDO,
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respectively). Thus, the chemistry described here establishes a valuable platform for
future synthetic modeling studies of nonheme Fe dioxygenases with the 3His facial triad.

2.B. Results and Discussion
The novel Ph2TIP ligand was synthesized by means of lithiation of 4,5-diphenyl-1methylimidazole at the 2-position at –78 °C, followed by addition of PCl3 (0.33 equiv.).
Reaction of Ph2TIP with Fe(OTf)2 in MeCN provided the complex [1](OTf)2 in 60% yield
(Figure 2.3). Crystals suitable for X-ray diffraction (XRD) analysis were obtained by
layering a concentrated MeCN solution with diethyl ether.

Figure 2.3. Synthesis of Fe(II) complexes with the Ph2TIP ligand.
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Table 2.1. Selected metric parameters for [Fe2+(LN3)(MeCN)3]2+ complexes. Bond
lengths in Å and angles in degrees.
[1](OTf)2·0.5Et2O[a]

[Fe(trisoxtBu)(MeCN)3]2+

[Fe(tpmPh2)(MeCN)3]2+

(ref.122)[b]

(ref.123)[c]

Fe1-N2

2.186(1)

2.257(2)

2.199(2)

Fe1-N4

2.177(1)

2.205(2)

2.196(2)

Fe1-N6

2.182(1)

2.215(2)

2.205(3)

Fe1-N7

2.196(1)

2.163(2)

2.131(3)

Fe1-N8

2.179(1)

2.131(2)

2.166(2)

Fe1-N9

2.205(1)

2.171(3)

2.156(3)

Fe-NTIP (av.)

2.181

2.226

2.200

Fe-Nsolv (av.)

2.193

2.155

2.151

N2-Fe1-N4

88.87(5)

84.62(6)

84.40(9)

N2-Fe1-N6

91.43(5)

82.12(6)

85.84(9)

N4-Fe1-N6

88.32(5)

86.89(7)

83.27(9)

N7-Fe1-N8

85.48(5)

90.25(8)

87.6(1)

N7-Fe1-N9

82.06(5)

91.33(8)

86.4(1)

N8-Fe1-N9

83.23(5)

86.00(8)

90.3(1)
+

[a] Average values for the two independent, but chemically equivalent [1] cations. [b] trisoxtBu = 1,1,1tris(4-tert-butyloxazolin-2-yl)-ethane. [c] tpmPh2 = tris(3,5-diphenylpyrazol-1-yl)methane.

The structure features two symmetrically independent [1]2+ units with nearly
identical metric parameters (Table 2.1; details concerning the data collection and analysis
of all X-ray structures are summarized in Table 2.4). As shown in Figure 2.4, the sixcoordinate (6C) Fe2+ center is ligated by Ph2TIP and three MeCN ligands in a distorted
octahedral geometry. As expected, the Ph2TIP ligand coordinates in a facial manner. The
average Fe–N distance of 2.19 Å is indicative of a high-spin Fe2+ center (S = 2),
consistent with the measured magnetic moment of 5.2 μB. The triflate counteranions are
not bound to the metal centers, and the asymmetric unit also contains one equivalent of
noncoordinated Et2O.
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Figure 2.4. Thermal ellipsoid plot (50% probability) of [1](OTf)2•0.5Et2O. Only one of
the symmetrically inequivalent [1](OTf)2 units is shown. Hydrogen atoms, counteranions,
and noncoordinating solvent molecules have been omitted for clarity.

Two related high-spin Fe2+ structures with [Fe(LN3)-(MeCN)3]2+ compositions
have been reported in the literature, and their metric parameters are also provided in
Table 2.1. The average Fe–NTIP distance of 2.18 Å in [1]2+ is significantly shorter than
the distances observed for the analogous tris(3,5-diphenylpyrazol-1-yl)methane (tpmPh2)76
and 1,1,1-tris(4-tert-butyloxazolin-2-yl)ethane (trisoxtBu)77 complexes, which display
average Fe–N distances of 2.20 and 2.23 Å, respectively. Conversely, the average Fe–
NMeCN distance in [1]2+ is approximately 0.04 Å longer than those reported for the tpmPh2
and trisoxtBu complexes. Both facts suggest that Ph2TIP is a somewhat stronger donor than
other neutral N3 ligands that have appeared in the literature. Elemental analysis
performed with ground and dried crystals of [1](OTf)2 indicate that at least two MeCN
ligands are removed under vacuum. In addition, evidence for Fe–OTf bonding in noncoordinating solvents was obtained by using 19F NMR spectroscopy (see Figure 2.5).
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Figure 2.5. 19F NMR spectra of [1](OTf)2 in CD3 CN (black line) and CD2Cl2 (grey line)
collected at room temperature.

For [1](OTf)2 in CD3CN, the triflate counteranion gives rise to a sharp peak at δ =
–79.2 ppm, which is identical to the chemical shift observed for [NBu 4]OTf under the
same conditions. The lengthy longitudinal relaxation time (T 1 value) of 128 ms measured
for this feature suggests that the triflate counteranion is only weakly associated with the
[Fe(Ph2TIP)]2+ unit in MeCN. In contrast, the 19F NMR spectrum of [1](OTf)2 in CD2Cl2
exhibits a broad feature at δ = –60.9 ppm with a short T1 value of 14 ms which indicates
that the triflate ion is directly bound to the Fe center.
Reaction of equimolar amounts of Fe(OTf)2, Ph2TIP, and sodium benzoate
(NaOBz) in MeOH provided the colorless complex [Fe( Ph2TIP)(OBz)(MeOH)]OTf
([2]OTf), as shown in Figure 2.6. X-ray-quality crystals were obtained from a solution of
[2]OTf in MeOH layered with pentane. The resulting structure reveals a pentacoordinate
(5C) iron(II) center with a Κ3-Ph2TIP ligand, monodentate benzoate ligand, and bound
solvent (Figure 2.6). In addition to the second-sphere triflate anion, the asymmetric unit
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also contains four MeOH molecules that do not directly interact with the [2]+ cation. The
complex adopts a distorted square-pyramidal geometry (τ = 0.25)124 with an O2N2
pseudobasal plane. Two phenyl rings of the Ph2TIP ligand lie across the vacant
coordination site (i.e., parallel to the plane of the benzoate ligand), which prevents further
solvent binding. The Fe–NTIP and Fe–O distances are typical for high-spin Fe2+ centers
(Table 2.1). The H atom of the coordinated MeOH molecule was found objectively and
refined. The resulting O2···O3 distance of 2.610(2) Å and H3···O2 distance of 1.81(1) Å
are indicative of an intramolecular hydrogen bond that closes a six-membered ring.

Figure 2.6. Thermal ellipsoid plot (50% probability) derived from [2]OTf·4MeOH. Noncoordinating solvent molecules, counter anions, and most H atoms have been omitted for
clarity. The dotted line indicates the hydrogen-bonding interaction between H3 of the
MeOH ligand and O2 of the benzoate anion.
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Table 2.2 Selected metric parameters for ferrous carboxylate complex [2]OTf·4MeOH.
[2]OTf·4MeOH
Fe1-N2

2.124(2)

Fe1-N4

2.127(2)

Fe1-N6

2.226(2)

Fe-NLN3 (av.)

2.158

Fe1-O1

2.011(1)

Fe1-O3

2.105(1)

O1-Ccarboxyl

1.273(2)

O2-Ccarboxyl

1.254(2)

N2-Fe1-N4

93.94(6)

N2-Fe1-N6

85.36(6)

N4-Fe1-N6

91.69(6)

O1-Fe1-N2

153.44(6)

O1-Fe1-N4

112.06(6)

O1-Fe1-N6

88.38(6)

O1-Fe1-O3

87.64(6)

N2-Fe1-O3

93.34(6)

N4-Fe1-O3

100.01(6)

N6-Fe1-O3

168.29(6)

τ value

0.25

Complex [2]+ resembles the structure of [Fe(Ph,MeTp)-(OBz)(Ph,Mepyz)] (in which
Ph,Me

pyz = 3-phenyl-5-methylpyrazole) published by Fujisawa and co-workers.125 Both

complexes feature a distorted square-pyramidal geometry with a monodentate benzoate
ion linked to a neutral ligand by means of an intramolecular hydrogen bond. This result is
consistent with our study of [Fe2+(LN3)(β-diketonato)]+/0 complexes that found only slight
differences (on average) between Fe–NTIP and Fe–NTp bond lengths in 5C species,
despite the different charges of the supporting ligands. 126
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Starting from either of these two Fe( Ph2TIP) precursors – [1](OTf)2 or [2]OTf –
we were able to generate the complex [Fe(Ph2TIP)(acacPhF3)]OTf ([3]OTf; Figure 2.7; in
which acacPhF3 = anion of 4,4,4-trifluoro-1-phenyl-1,3-butanedione). The acacPhF3 ligand
was selected for two reasons: (i) it is a viable Dke1 substrate, 53,56 53,56 57,60 52,53 and (ii)
previous studies in our laboratory found that [Fe(LN3)(acacPhF3)]+/0 complexes exhibit
intense Fe2+-acacPhF3 MLCT bands that serve as useful spectroscopic markers. 126 For both
Fe(Ph2TIP) precursors, reaction with Na(acac PhF3) provides a deep purple solution that
displays an absorption manifold centered at 502 nm (ε = 700 m–1cm–1;) (Figure 2.8). Not
surprisingly, the [3]OTf spectrum closely resembles the one published for [Fe(4TIPPh)(acacPhF3)]OTf, although the absorption features are blueshifted in the former by
approximately 400 cm–1.126 Crystals of [3]OTf were obtained from the reaction of
[1](OTf)2 and Na(acacPhF3) in CH2Cl2, followed by crystallization in CH2Cl2/pentane.
The asymmetric unit contains two independent units with virtually identical structures.
As shown in Figure 2.7, the 5C Fe2+ center is coordinated to the Ph2TIP and acacPhF3
ligands in a distorted trigonal-bipyramidal geometry (τ = 0.51) with the O atom proximal
to the CF3 group (O1) in the axial position. The metric parameters of [3]OTf are not
significantly different from those reported for [Fe2+(Ph2Tp)(acacPhF3)] and [Fe2+(4TIPPh)(acacPhF3)]OTf.126
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Figure 2.7. Thermal ellipsoid plot (50% probability) derived from [3]OTf·2CH2Cl2.
Non-coordinating solvent molecules, counteranions, and most H atoms have been omitted
for clarity. Only one of the two independent [3]+ units is shown. Selected bond lengths
[Å] and angles [deg] for this unit: Fe1–O1 2.089(3), Fe1–O2 1.973(3), Fe1–N2 2.118(4),
Fe1–N4 2.190(4), Fe1–N6 2.118(4); O1–Fe1–O2 87.2(1), O1–Fe1–N2 91.0(2), O1–Fe1–
N4 176.4(2), O1–Fe1–N6 89.5(2), O2–Fe1–N2 120.4(2), O2–Fe1–N4 96.5(2), O2–Fe1–
N6 146.3(2).

Figure 2.8. Electronic absorption spectra of the complexes [Fe(4-TIPPh)(acacPhF3)]OTf
(solid line) and [3]OTf (dashed line) measured at room temperature in MeCN.
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The solution structures of [2]OTf and [3]OTf in CD2Cl2 were probed using 1H
NMR spectroscopy, and the observed chemical shifts, peak integrations, and T 1 values
are summarized in Table 2.3. The three imidazole ligands are spectroscopically
equivalent in solution due to dynamic averaging of the ligand positions on the NMR
spectroscopic timescale. The Ph2TIP derived resonances were assigned with the help of
peak integrations and by making two assumptions: (i) T 1 values follow the order orthometa-para for each phenyl ring,105,126 and (ii) T1 values of the 4-Ph protons are shorter
than the corresponding protons on the 5-Ph ring. Thus, the fast-relaxing peaks (T1 ≈ 1
ms) near –20 ppm were attributed to the ortho protons of the 4-phenyl Ph2TIP
substituents, which are positioned near the Fe2+ center. The peaks with the largest
integration at (21.9) ppm were assigned to the 1-N-Me protons. The remaining
resonances were then identified as the benzoate and acacPhF3 groups of [2]OTf and
[3]OTf, respectively, by using the relative T 1 values to assign the phenyl resonances of
both ligands.
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Table 2.3. Summary of 1H NMR spectroscopic parameters for [2]OTf and [3]OTf in
CD2Cl2.
[2]OTf

[3]OTf

Resonance

δ[ppm]

T1[ms]

Resonance

δ[ppm]

T1[ms]

o-4-Ph

-21.0

1.1

o-4-Ph

-16.0

0.4

m-4-Ph

6.7

12.0

m-4-Ph

5.2

4.7

p-4-Ph

9.0

31.6

p-4-Ph

9.3

13.3

o-5-Ph

2.6

31.5

o-5-Ph

2.4

13.7

m-5-Ph

6.3

159

m-5-Ph

6.1

88.2

p-5-Ph

5.2

238

p-5-Ph

5.0

120

N-1-Me

21.9

15.7

N-1-Me

20.2

5.9

o-OBz

34.8

3.2

acac-o-Ph

22.6

1.7

m-OBz

19.0

37.0

acac-m-Ph

9.5

20.0

p-OBz

10.6

67.6

acac-p-Ph

17.3

45.5

Acac H

39.4

0.8

This chapter has described the synthesis and X-ray structural characterization of
iron(II) complexes supported by tris(imidazolyl)phosphane ligands Ph2TIP. The
complexes – [1](OTf)2, [2]OTf, and – feature easily displaced ligands, such as solvent
molecules and/or carboxylates, in the coordination sites trans to the TIP chelate. Like the
resting states of the enzymatic active sites, these “precursor” complexes are intended to
serve as scaffolds that permit various substrate ligands to coordinate to the iron(II) center.
The versatility of this approach was demonstrated by the formation of the Dke1 model
[3]OTf from the reaction of Na(acacPhF3) with the Ph2TIP-based complexes [1](OTf)2 and
[2]OTf.
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2.C. Conclusions
In this chapter we have described the synthesis and X-ray structural
characterization of iron(II) complexes supported the tris(imidazolyl)phosphine ligand
(Ph2TIP). Two of the complexes – [1](OTf)2, and [2]OTf feature easily displaced ligands,
such as solvent molecules and/or carboxylates, in the coordination sites trans to the TIP
chelate. These complexes exhibit variability in their coordination numbers (5C or 6C).
Intra- and intermolecular hydrogen-bonding interactions between the ligands and solvent
are evident in the solid-state structures of each complex {with the exception of
[1(OTf)2]}.
Like the resting states of the enzymatic active sites, these “precursor” complexes
are intended to serve as scaffolds that permit various substrate ligands to coordinate to the
iron(II) center. The versatility of this approach was demonstrated by the formation of the
Dke1 model [3]OTf from the reaction of Na(acacPhF3) with the Ph2TIP-based complexes
[1](OTf)2 and [2]OTf. The facile formation of [3]OTf indicates that the TIP ligands are
resistant to displacement by strong, anionic ligands. This is significant because halfsandwich ferrous complexes with neutral LN3 ligands, such as trispyrazolymethanes, have
been shown to suffer from high lability and a tendency to decompose to the more stable
bisligand species.127 The relatively short Fe-NTIP bond lengths found in our series of
complexes suggest that the TIP ligands bind tightly to the iron centers. Thus, the
precursor complexes described here provide a robust platform for the development of
synthetic models of dioxygenases with the 3His facial triad.
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2.D. Experimental
All reagents and solvents were purchased from commercial sources and used as
received unless otherwise noted. MeCN and CH2Cl2 were purified and dried using a
Vacuum Atmospheres solvent purification system. 4,5-diphenyl-1-methylimidazole127
was prepared according to literature procedures. The synthesis and handling of airsensitive materials were carried out under an inert atmosphere using a Vacuum
Atmospheres Omni-Lab glovebox equipped with a freezer set to –30 °C. Elemental
analyses were performed at Midwest Microlab, LLC in Indianapolis, IN. Infrared (IR)
spectra of solid samples were measured with a Thermo Scientific Nicolet iS5 FTIR
spectrometer equipped with the iD3 attenuated total reflectance accessory. UV/Vis
spectra were obtained with an Agilent 8453 diode array spectrometer. NMR spectra were
recorded on a Varian 400 MHz spectrometer. 19F NMR spectra were referenced using the
benzotrifluoride peak at –63.7 ppm. 31P NMR spectra were referenced to external H3PO4
(δ = 0 ppm). Magnetic susceptibility measurements were carried out using the Evans
NMR method.
Ph2

TIP: 4,5-Diphenyl-1-methylimidazole (6.81 g, 29.1 mmol) was dissolved in

THF (175 mL) and the solution was purged with argon for 25 min. The flask was cooled
to –78 °C and nBuLi (32.0 mmol) was added dropwise. The solution was stirred for 30
min at –78 °C and then for 30 min at room temperature. The reaction was cooled again to
–78 °C and PCl3 (0.850 mL, 9.74 mmol) was added slowly. The mixture was allowed to
slowly warm to room temp. over the course of several hours, and then 30% NH4OH (75
mL) was added and stirred for 1 h. The layers were separated and the aqueous layer was
extracted with THF (2-35 mL). The combined THF layers were washed with H2O and
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brine (50 mL each), dried with MgSO4, and the solvent was removed under vacuum. The
orange residue was triturated with pentane and washed with methanol, thereby providing
a fine white powder (1.66 g); yield 24%. C48H39N6P (730.8): calcd. C 78.88, H 5.38, N
11.50; found C 78.05, H 5.83, N 11.03. The disagreement indicates that small amounts of
impurities are present. 1H NMR (400 MHz, CDCl3 ): δ = 7.48 (m, 12 H, Ar– H), 7.40 (m,
6 H, Ar–H), 7.17 (m, 12 H, Ar–H), 3.64 (s, 9 H, CH3) ppm. 13C NMR (100 MHz,
CDCl3): δ = 140.5, 140.0, 139.9, 134.8, 133.6, 131.1, 131.0, 129.2, 129.0, 128.2, 126.9,
126.5, 33.4 ppm. 31P NMR (162 MHz, CDCl3): δ = –56.6 ppm. IR (neat cm-1): ν = 3053,
2940, 2863, 1601, 1503, 1442, 1363, 1071, 1024, 961 cm–1.
[Fe(Ph2TIP)(MeCN)3](OTf)2 ([1]OTf): Ph2TIP (1.32 g, 1.81 mmol) and Fe(OTf)2
(670 mg, 1.90 mmol) were mixed in CH3CN (20 mL) and stirred until the solution had
become clear (about 3h). The solution was filtered and layered with excess Et 2O; X-rayquality crystals formed after one day. The white crystals were collected and dried under
vacuum to provide 1.31 g of material; yield 60%. Elemental analysis showed that at least
two of the coordinated CH3CN ligands are removed upon drying.
C50H39F6FeN6O6PS2·CH3CN (1125.9): calcd. C 55.47, H 3.76, N 8.71; found C 55.02, H
3.90, N 8.68. IR (neat, cm-1): ν = 3048, 2932, 2283 [ν(C-N)], 1466, 1444, 1257, 1222,
1145, 1028, 983 cm–1.
[Fe(Ph2TIP)(OBz)(MeOH)]OTf ([2]OTf): Ph2TIP (779 mg, 1.07 mmol), NaOBz
(155 mg, 1.07 mmol), and Fe(OTf)2 (378 mg, 1.07 mmol) were combined in MeOH (12
mL). After stirring for several hours the precipitate was removed by filtration and the
filtrate was reduced to about 5 mL in volume. Layering with pentane afforded the desired
product as a white crystalline material (116 mg); yield 11%. X-ray diffraction analysis
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revealed four uncoordinated MeOH molecules in the resulting structure, and elemental
analysis indicated that two solvent molecules remain after drying under vacuum.
C57H47F3FeN6O6PS·2CH3OH (1152.0): calcd. C 61.51, H 4.81, N 7.30; found C 61.35, H
4.48, N 7.07. IR (neat, cm-1): ν = 3043, 2953, 1598, 1551, 1443, 1370, 1258, 1153, 1029,
981 cm–1.
[Fe(Ph2TIP)(acacPhF3)]OTf ([3]OTf): A solution of 4,4,4-trifluoro-1-phenyl-1,3butanedione (126 mg, 0.584 mmol) and NaOCH3 (32 mg, 0.59 mmol) in THF was stirred
for 30 min, after which the solvent was removed under vacuum to give white
Na(acacPhF3). Na(acacPhF3) was then dissolved in CH3CN (5 mL) and slowly added to a
solution of [1](OTf)2 (704 mg, 0.583 mmol) in CH 2Cl2 (5 mL). The purple solution was
stirred overnight and the solvent was removed under vacuum. The residue was dissolved
in CH2Cl2 (5 mL), filtered, and layered with pentane to yield deep red crystals suitable
for X-ray crystallography (457 mg); yield 68%. The X-ray structure revealed
uncoordinated CH2Cl2 molecules in the asymmetric units, and elemental analysis
suggests that a small amount of solvent (≈0.7 equiv.) remains after vacuum drying.
C59H45F6FeN6O5PS·0.7CH2Cl2 (1210.36): calcd. C 59.24, H 3.86, N 6.94; found C 59.25,
H 3.99, N 6.75. UV/Vis (MeCN): λmax (ε,m–1cm–1) = 519 (720), 494 (730) nm. IR (neat,
cm-1): ν = 3058, 2955, 1602 [ν(C=O)], 1572, 1462, 1443, 1253, 1141, 1029, 981 cm–1.
19

F NMR (376 MHz, CD2Cl2): δ = –44.9 (acacPhF3), –77.7 (OTf) ppm.
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Table 2.4. Summary of the X-ray crystallographic data collection and structure refinement.
[1](OTf)2·0.5Et2O

[2]OTf·4MeOH

[3]OTf·2CH2Cl2[a]

Emperical formula

C58H53F6FeN9O6.5PS2

C61H64F3FeN6O10PS

C61H49Cl4F6FeN6O5PS

Formula weight

1245.03

1217.06

1320.77

Crystal System

triclinic

triclinic

monoclinic

Space Group

P1¯

P1¯

Pc

a [Å]

13.3432(3)

14.9470(5)

16.0689(5)

b [Å]

15.8007(3)

15.1921(5)

20.6668(5)

c [Å]

27.8621(6)

16.4349(6)

19.6239(4)

α [°]

76.994(2)

90.642(3)

90

β [°]

88.757(2)

113.784(3)

90.088(2)

γ [°]

87.690(2)

115.873(4)

90

V [Å3]

5718.4(2)

2992.3(3)

6516.9

Z

4

2

4

Dcalcd. [g/cm3]

1.446

1.351

1.325

λ [Å]

1.5418

1.5418

0.7107

μ [mm ]

3.749

3.205

0.489

θ range [°]

7 to 149

7 to 148

7 to 59

Reflections collected

64740

39217

56565

Independent reflections

22662

11891

28249

(Rint = 0.0315)

(Rint = 0.0299)

(Rint = 0.0339)

Data/restraints/parameters

22662/19/1591

11891/2/784

28249/12/1550

GOF (on F2)

1.025

1.028

1.061

R1/wR2 [I > 2σ(I)][b]

0.0332/0.0855

0.0413/0.1094

0.0608/0.1541

R1/wR2 (all data)

0.0374/0.0886

0.0449/0.1128

0.0666/0.1613

–1

[a] One of the solvates in [4]OTf·2CH2Cl2 is partially occupied by a pentane molecule.
[b] R1 = Σ ||Fo| – |Fc||/Σ|Fo|; wR2 = [Σw(Fo2 – Fc2 )2/Σw(Fo2)2]1/2.
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Chapter 3

Synthetic Models of the Putative Fe(II)Iminobenzosemiquinonate Intermediate in the Catalytic Cycle
of o-Aminophenol Dioxygenases

Abstract: The oxidative ring cleavage of aromatic substrates by nonheme dioxygenases
is thought to involve formation of a ferrous-(substrate radical) intermediate. Here we
describe the synthesis of the trigonal bipyramidal complex Fe( Ph2Tp)(ISQtBu) (5), the first
synthetic example of an iron(II) center bound to an iminobenzosemiquinonate (ISQ)
radical. The unique electronic structure of this S = 3/2 complex and its one-electron
oxidized derivative ([6]+) have been established on the basis of crystallographic,
spectroscopic and computational analyses. These findings further demonstrate the
viability of Fe2+-ISQ intermediates in the catalytic cycles of o-aminophenol
dioxygenases.
Portions of this chapter have appeared in the paper: Bittner, M. M.; Lindeman, S. V.;
Fiedler, A. T. J. Am. Chem. Soc. 2012, 134, 5460.
All DFT calculations were performed by Dr. Adam Fiedler.
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3.A. Introduction
In biochemical pathways, the oxidative ring cleavage of substituted aromatic
compounds, such as catechols and o-aminophenols, is generally performed by
mononuclear nonheme iron dioxygenases. 5,23,90 While these enyzmes are usually found
in bacteria, some play important roles in human metabolism: for instance, a key step in
tryptonphan degradation involves the O2-mediated ring cleavage of 3hydroxyanthranilate (HAA) by HAA-3,4-dioxygenase (HAD; Figure 3.1).11,30 With the
exception of the intradiol catechol dioxygenases, the ring-cleaving dioxygenases share a
common O2-activation mechanism, illustrated in Figure 3.2. 5,23,90 A notable feature of
this proposed mechanism is the superoxo-Fe2+-(iminobenzo)-semiquinonate intermediate
(B) that is thought to form after O2 binding to the enzyme-substrate complex (A). The
development of radical character on the substrate ligand presumably facilitates reaction
with the bound superoxide yielding the key Fe2+-alkylperoxo intermediate (C).41,42
Although the electronic structure of B remains somewhat controversial,128 evidence in
favor of substrate radical character has been provided by radical-trap experiments39 and
DFT calculations,41,42 as well as a remarkable X-ray structure of the Fe/O2 adduct of an
extradiol dioxygenase in which the radical character of the bound substrate was inferred
from its nonplanar geometry.18
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Figure 3.1 Reaction Catalyzed by HAA Dioxygenase (HAD).

Figure 3.2 Catalytic Cycle of Ring-Cleaving Dioxygenases.

Despite these biological precedents, synthetic analogues of intermediate B in
which a ferrous center is coordinated to an (iminobenzo)semiquinone radical, (I)SQ, have
been lacking in the literature, even though numerous ferric complexes with such ligands
exist.35,36,38,78,80-83,129-131 Herein, we report the synthesis and detailed characterization of
an Fe2+-ISQ complex, 2a, that represents the first synthetic model of this important type
of enzyme intermediate. We also examine the geometric and electronic structures of the
species [3a]+ generated via one-electron oxidation of 2a.
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3.B. Results and Discussion
In our efforts to generate synthetic models of HAD, we have used the
tris(pyrazolyl)borate ligand, Ph2Tp, (where Ph2Tp = hydrotris(3,5-diphenylpyrazol-1yl)borate(1-)) to mimic the facial His2Glu coordination environment of the enzyme active
site. The reaction of [(Ph2Tp)Fe2+(OBz)]105 (OBz = benzoate) with 2-amino-4,6-di-tertbutylphenol (tBuAPH2) in the presence of base provided the light yellow complex
[(Ph2Tp)Fe2+(tBuAPH)] (4) in 71% yield. The X-ray crystal structure of 4 reveals a fivecoordinate (5C) Fe2+ center in which the tBuAPH─ ligand binds in a bidentate fashion
(Figure 3.3). The average Fe1-NTp bond length of 2.15 Å is typical of high-spin Fe2+
complexes with Tp ligands105,126, while the short Fe1-O1 distance of 1.931(1) Å is
consistent with coordination by an aminophenolate anion (Table 3.1) The complex
adopts a distorted trigonal-bipyramidal geometry (τ = 0.61) with the amino group of
tBu

APH- in an axial position trans to N5. To the best of our knowledge, 4 represents the

first synthetic model of an aminophenol dioxygenase.

Figure 3.3. Synthesis and thermal ellipsoid diagram of complex 4. For the sake of
simplicity, the 5-Ph substituents of the Ph2Tp ligand have been omitted and only the amino
hydrogens are shown. Selected bond lengths are provided in Table 3.1
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Table 3.1. Selected Bond Distances (Å) for Complexes 4-[6]+

4

5

[6]SbF6a

Fe1-N1

2.101(1)

2.108(2)

2.071(7)

Fe1-N3

2.127(1)

2.087(2)

2.038(7)

Fe1-N5

2.223(1)

2.216(2)

2.134(6)

Fe1-O1

1.931(1)

2.095(2)

2.082(6)

Fe1-N7

2.214(1)

1.982(2)

2.017(8)

O1-C1

1.345(2)

1.285(3)

1.26(1)

N7-C2

1.451(2)

1.328(4)

1.33(1)

C1-C2

1.398(2)

1.469(5)

1.47(1)

C2-C3

1.388(2)

1.413(4)

1.42(1)

C3-C4

1.388(2)

1.363(4)

1.35(2)

C4-C5

1.403(2)

1.427(4)

1.43(2)

C5-C6

1.394(2)

1.375(4)

1.37(2)

C1-C6

1.420(2)

1.440(4)

1.44(1)

a

The bond distances listed here represent the average distance in the two independent
units of [6]+, while the uncertainty is taken to be the larger of the two σ-values.

Figure 3.4. Electronic absorption spectra of 4 (─ - -), 5 (─), and [6]SbF6 (- - -) measured
in CH2Cl2 at RT.
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Reaction of 4 with 1 equiv of 2,4,6-tri-tert-butylphenoxy radical (TTBP•) at RT in
CH2Cl2 gives rise to a distinct chromophore, 5, with a broad absorption manifold
centered at 715 nm (εmax = 0.76 mM-1 cm-1 ; see Figure 3.4). Addition of MeCN,
followed by cooling to -30 °C, provides pale green crystals of 5 suitable for
crystallographic analysis. As with 4, the X-ray structure of 5 features a neutral 5C Fe
complex with a distorted trigonal-bipyramidal geometry (τ = 0.58), although O1 now
occupies an axial position instead of N7 (Figure 3.5). The N7 atom in 5 is
monoprotonated, confirming that 5 is generated via abstraction of an H-atom from the –
NH2 group of 4.

Figure 3.5. Thermal ellipsoid plot (50% probability) of 5•2CH2Cl2. Noncoordinating
solvent molecules and most hydrogen atoms have been omitted for clarity. The tBuISQ
ligand is disordered in a 7:1 ratio; only the high-occupancy (major) species is shown
here.
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Interestingly, the average Fe1-NTp bond distance observed for 5 (2.136 Å) is
nearly identical to the value found for 4 (2.150 Å), suggesting minimal change in Fe
charge. Metric parameters for the O,N-coordinated ligand, however, are dramatically
different in the two structures. In the structure of 4, the six C-C bonds of the tBuAPH─
ring are approximately equidistant (1.40 ± 0.02 Å), reflecting its closed-shell, aromatic
nature. In contrast, the corresponding C-C bond distances in 5 exhibit the “four long/two
short” distortion commonly observed for quinoid moieties (Table 3.1). 35,36,38,78,80-83,129-131
The short O1-C1 and N7-C2 distance of 1.285(3) and 1.328(4) Å, respectively, are also
characteristic of ISQ─ ligands, as amply demonstrated by Wieghardt 78,80-83,130,131 and
others.38 Thus, the X-ray crystallographic data strongly support the formulation of 5 as
[(Ph2Tp)Fe2+(tBuISQ)]. This assignment rationalizes the absorption spectrum of 5, which
closely resembles those reported for Co2+ and Ni2+ complexes with a lone ISQ─ ligand.131
The X-band EPR spectrum of 5 displays an intense peak at g = 6.5, along with a
broad derivative-shaped feature centered near g = 1.8 (Figure 3.6). Such spectra are
typical of S = 3/2 systems with large and rhombic zero-field splitting parameters.130-132
The simulated spectrum in Figure 3.6 assumed a negative D-value (with |D| ≫ hν), an
E/D-ratio of 0.24, and g-values of 2.36, 2.30, and 2.17. Significant E/D strain was
incorporated to adequately account for the broadness of the higher-field features. The
combined experimental results therefore indicate that 5 contains a high-spin Fe2+ center
(S = 2) antiferromagnetically coupled to a tBuISQ radical anion.
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Figure 3.6. X-band EPR spectrum of 5 at 20 K. The derivative-shaped feature at g = 4.3
(▼) arises from a minor ferric impurity, while the feature at g = 2.0 (*) is due to residual
TTBP radical. Parameters used to generate the simulated spectrum are provided in the
text.

Further evidence in favor of a ligand-based radical was obtained from density
functional theory (DFT) calculations. Two geometry-optimized models of 5 with S = 3/2
were computed that differ with respect to their electronic configurations. Analysis of the
geometric and electronic structure of the first model (51) indicates that it contains an
intermediate-spin Fe3+ center coordinated to a closed-shell imidophenolate ligand,
tBu

AP2-. The optimized structure of 51 features a square-pyramidal geometry (τ = 0.18)

with very short Fe-O1 and Fe-N7 distances of ~1.87 Å, in poor agreement with the
experimental structure (Table 3.2). Furthermore, the computed bond distances for the
tBu

AP2- ligand deviate sharply from the distances found experimentally for 5 with nearly

all such differences being significantly greater than the estimated error (3σ) in the
crystallographic data. The second model (52) was generated via a broken-symmetry
calculation in order to obtain the [(Ph2Tp)Fe2+(tBuISQ)] electronic configuration described
above. The resulting structure accurately reproduces the overall trigonal-bipyramidal
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geometry of 5 and provides reasonably consistent Fe-ligand distances. Most importantly,
the computed and experimental tBuISQ─ bond distances exhibit remarkable agreement,
with an rms deviation of merely 0.007 Å. (Table 3.2) Model 52 is also 9 kcal/mol more
stable than 51, indicating an energetic preference for the Fe2+-tBuISQ form.
To the best of our knowledge, the electronic structure of 5 has no precedent
among synthetic complexes. While Fe2+-SQ intermediates are often invoked in the
mechanisms of catechol dioxygenases, all relevant models to date feature unambiguous
[Fe3+-catecholate]+ units.133-135 Similarly, the Fe3+-ISQ complexes generated by
Wieghardt and co-workers exclusively undergo ligand-based reductions to give the
corresponding Fe3+-AP species.81,130,131 The unique Fe2+-ISQ configuration of 5 is likely
due to the presence of a high-spin, 5C Fe ion, whereas related complexes prepared by
Wieghardt (such as [(L)Fe3+(RISQ)]+, where L = cis cyclam and R = H or tBu) generally
feature lowspin, 6C Fe centers.81 Thus, changes in spin state and coordination geometry
are capable of shifting the delicate balance between the Fe2+-ISQ and Fe3+-AP valence
tautomers.
Reaction of 5 with 1 equiv of an acetylferrocenium salt in CH2Cl2 provides a dark
green species, [6]+, with intense absorption features at 770 and 430 nm (Figure 3.4).
Treatment of [6]+ with 1 equivalent of reductant (such as Fe(Cp*)2) fully regenerates 5,
indicating that the two species are related by a reversible one-electron process (Figure
3.7). EPR experiments with frozen solutions of [6]+ failed to detect a signal in either
perpendicular or parallel mode, indicative of an integer-spin system. Indeed, the
magnetic moment of [6]+ was found to be 5.0(1) µB at RT, close to the spin-only value for
an S = 2 paramagnet.
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Figure 3.7. Interconversion of 5 and [6]+ by one-electron reactions. Top: Spectrum A =
0.55 mM solution of 5 at RT in CH2Cl2. Spectrum B = Formation of [6]+ after addition of
0.9 equivalents of the oxidant acetylferrocenium tetrafluoroborate to the initial solution
(A). Middle: Spectrum C = Spectrum measured after addition of 0.95 equiv. of the
reductant Fe(Cp*)2 to the B solution. The gray dotted line is the spectrum of 0.42 mM
[Fe(Cp*)2]BF4. Bottom: Spectrum C (adjusted) = Spectrum C minus the contributions from
the [Fe(Cp*)2]+ features. The adjusted spectrum is nearly identical to spectrum A,
indicating full regeneration of 5.
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Table 3.2. Selected bond distances (Å) and bond angles (deg) for 4 and 5 obtained from
X-ray diffraction (XRD) experiments, along with values computed by density functional
theory (DFT) for models 51 and 52.

a

Bond distances

4 (XRD)

5-maj (XRD)a

5-min (XRD)a

51 (DFT)

52 (DFT)

Fe1-N1

2.101(1)

2.108(2)

2.108(2)

2.057

2.129

Fe1-N3

2.127(1)

2.087(2)

2.087(2)

2.278

2.136

Fe1-N5

2.223(1)

2.216(2)

2.043

2.299

Fe1-O1

1.931(1)

2.095(2)

2.216(2)
2.13(1)

1.887

2.130

Fe1-N7

2.214(1)

1.982(2)

2.00(2)

1.887

2.029

O1-C1

1.345(2)

1.285(3)

1.284(14)

1.322

1.276

N7-C2

1.451(2)

1.328(4)

1.326(16)

1.359

1.335

C1-C2

1.398(2)

1.469(5)

1.473(18)

1.418

1.461

C2-C3

1.388(2)

1.413(4)

1.432(16)

1.404

1.420

C3-C4

1.388(2)

1.363(4)

1.356(16)

1.386

1.372

C4-C5

1.403(2)

1.427(4)

1.433(16)

1.408

1.427

C5-C6

1.394(2)

1.375(4)

1.396(14)

1.390

1.372

C1-C6

1.420(2)

1.440(4)

1.444(14)

1.405

1.432

Bond angles

4 (XRD)

5-maj (XRD)a

5-min (XRD)a

51 (DFT)

52 (DFT)

N1-Fe1-N3

92.82(5)

93.44(7)

93.44(7)

89.8

94.6

N1-Fe1-N5

83.309(5)

82.76(7)

82.76(7)

87.2

83.3

N3-Fe1-N5

86.11(5)

89.80(7)

89.80(7)

89.6

86.1

O1-Fe1-N3

136.61(5)

94.16(7)

93.9(3)

91.6

97.2

O1-Fe1-N5

129.47(5)

95.62(7)

90.4(3)

97.4

97.6

N7-Fe1-N1

105.94(4)

173.93(8)

170.0(3)

173.0

176.2

N7-Fe1-N3

92.60(5)

138.99(9)

136.0(4)

163.5

138.5

N7-Fe1-N5

88.68(5)

127.37(9)

132.8(4)

106.4

126.8

N7-Fe1-N7

173.20(5)

99.36(8)

101.1(4)

95.8

98.6

O1-Fe1-N7

80.76(4)

79.52(8)

78.2(5)

83.2

78.5

Τ-value

0.61

0.58

0.57

0.16

0.63

In the crystal structures of 5•2CH2Cl2, the tBuISQ ligand is disordered in a 7:1 ratio. The
metric parameters provided in Table 3.1 refer to the high-occupancy (major) species. Here
we also provide parameters for the low-occupancy (minor) species.
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Table 3.3. Selected bond distances (Å) and bond angles (deg) for [6]+ obtained from X-ray
diffraction (XRD) experiments, along with values computed by density functional theory
(DFT).
Bond distances
Fe1-N1
Fe1-N3
Fe1-N5
Fe1-O1
Fe1-N7
O1-C1
N7-C2
C1-C2
C2-C3
C3-C4
C4-C5
C5-C6
C1-C6
Bond angles
N1-Fe1-N3
N1-Fe1-N5
N3-Fe1-N5
O1-Fe1-N3
O1-Fe1-N5
N7-Fe1-N1
N7-Fe1-N3
N7-Fe1-N5
N7-Fe1-N7
O1-Fe1-N7
Τ-value

[61]+ (XRD)a
2.084(6)
2.037(7)
2.132(7)
2.088(6)
2.009(8)
1.277(11)
1.358(11)
1.474(11)
1.400(12)
1.377(13)
1.417(13)
1.363(13)
1.429(11)
[61]+ (XRD)a
94.5(3)
84.6(3)
92.4(3)
86.6(2)
93.8(3)
169.6(3)
144.6(3)
117.6(3)
106.9(3)
77.4(3)
0.42

[62]+ (XRD)a
2.058(7)
2.039(6)
2.135(6)
2.076(6)
2.025(7)
1.250(11)
1.308(11)
1.472(13)
1.446(12)
1.313(16)
1.449(18)
1.386(15)
1.449(12)
[62]+ (XRD)a
93.9(3)
84.7(3)
91.6(2)
95.4(3)
96.2(2)
172.2(2)
149.3(3)
149.3(3)
99.0(3)
76.9(3)
0.38

[6DFT]+ (DFT)
2.078
2.077
2.137
2.078
2.047
1.256
1.311
1.482
1.425
1.364
1.451
1.361
1.442
[6DFT]+ (DFT)
95.4
88.5
90.3
93.3
93.3
175.9
137.3
126.0
100.0
76.2
0.64

a

The crystal structure of [6]SbF6•0.5DCE contains two symmetrically-independent units,
here labeled [61]+ and [62]+.

X-ray quality crystals of [6]SbF6 were prepared by vapor diffusion of pentane into
a concentrated dichloroethane solution. The resulting structure (Figure 3.8) contains two
symmetrically independent Fe units, each featuring a distorted square-pyramidal
geometry (τ = 0.42 and 0.38). Despite the difference in charge, complexes [6]+ and 5
have identical atomic compositions. Yet the average Fe−NTp bond distance shortens from
2.132 to 2.081 Å upon conversion of 5 to [6]+, suggesting an increase in Fe-based charge.
While the structural parameters of the bidentate O,N-donor ligand of [6]+ are consistent
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with a tBuISQ-radical, it was not possible to rule out a neutral iminobenzoquinonate
ligand (tBuIBQ) due to sizable uncertainties in the bond distances.
We therefore turned to DFT calculations to further explore the electronic structure
of [6]+. The resulting geometryoptimized model, [6DFT]+, exhibits good agreement with
the crystallographic data, although the DFT structure is more distorted toward the
trigonal-bipyramidal limit (τ = 0.64; Table 3.3). The computed Fe-ligand bond distances
nicely match the experimental values (rms deviation = 0.022 Å), indicating that the
calculation converges to the correct S = 2 electronic configuration. Comparison of [6DFT]+
and 52 reveals more pronounced “quinoid” character in the O,N-donor ligand of the
former. Using the experimentally derived correlations of bond distances and ligand
oxidation states recently published by Brown, the O,N-donor ligand of [6DFT]+ has an
oxidation state of −0.35(5) (i.e., partway between ISQ1− and IBQ0).136 Moreover, the
highest-occupied spin-down MO (β-HOMO) of [6]+ contains roughly equal Fe and ligand
character (47 and 42%, respectively), and the β-LUMO is evenly delocalized over the
two units (Figure 3.9). Thus, the DFT results suggest that the electronic structure of [6]+
lies between the Fe3+-tBuISQ and Fe2+-tBuIBQ limits. Detailed spectroscopic studies of
[6]+ will be discussed in the next chapter.
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Figure 3.8. Thermal ellipsoid plot (50% probability) of [6]SbF6•0.5DCE. Counteranions,
noncoordinating solvent molecules, and most hydrogen atoms have been omitted for
clarity. Only one of the two independent [6]+ units is shown.

Figure 3.9. Isosurface plots of selected MOs computed for [6]+ by DFT.
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3.C. Conclusions
Complexes synthesized in this chapter model the enzyme active site structure of
APDOs and are the first to do so. Complex 4 can be converted to a novel complex upon
reaction with 1 equivalent of phenoxyl radical (6). While the structure of 6 can be
described as a having an iminobenzosemiquinonate radical ligand, this is not definitive
due to large uncertainties in the crystal structure bond distances. Further studies
described in the following chapter will provide more evidence for the electronic structure
of 5 and [6]SbF6.
Complexes 4−6 replicate key structural and electronic aspects of the proposed oaminophenol dioxygenase mechanism. In particular, the conversion of 4→5 mimics the
transformation of the enzyme−substrate complex (A) into a ferrous−ISQ species (B) via
coupled proton and electron transfers. Our results therefore provide a synthetic precedent
for the existence of Fe2+-ISQ intermediates in enzymatic catalysis. Of course, complex 5
is an imperfect model of intermediate B, since it lacks the coordinated superoxo ligand.

3.D. Experimental
All reagents and solvents were purchased from commercial sources and used as
received unless otherwise noted. Acetonitrile and dichloromethane were purified and
dried using a Vacuum Atmospheres solvent purification system. The compounds
K(Ph2Tp),137 tBuAPH2,138 and TTBP•139 were prepared according to literature procedures.
The synthesis and handling of airsensitive materials was carried out under an inert
atmosphere using a Vacuum Atmospheres Omni-Lab glovebox equipped with a freezer
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set to -30 °C. Elemental analyses were performed at Midwest Microlab, LLC in
Indianapolis, IN. Infrared (IR) spectra of solid samples were measured with a Thermo
Scientific Nicolet iS5 FTIR spectrometer equipped with the iD3 attenuated total
reflectance accessory. UV-vis spectra were obtained with an Agilent 8453 diode array
spectrometer. Magnetic susceptibility measurements were carried out using the Evans
NMR method.
EPR experiments were performed using a Bruker ELEXSYS E600 equipped with
an ER4415DM cavity resonating at 9.63 GHz., an Oxford Instruments ITC503
temperature controller and ESR-900 He flow cryostat. The spectrum shown in Figure 3.6
was obtained under the following conditions: [5] = 2.3 mM in CH2Cl2 ; frequency = 9.63
GHz.; power = 10.0 mW; modulation = 1 G; temperature = 20 K. The program
EasySpin140 was used to simulate the experimental spectra.
Density functional theory (DFT) calculations of complexes 5 and [6]+ were
performed using the ORCA 2.7 software package developed by Dr. F. Neese.141 In each
case, the corresponding X-ray structure provided the starting point for geometry
optimizations. In the computational models, the 5-Ph groups of the Ph2Tp ligand were
replaced by -CH3 groups, and the tBu moieties at the 4- and 6-positions of the tBuISQ
ligand were also replaced with methyl groups. All calculations employed Becke’s threeparameter hybrid functional for exchange along with the Lee-Yang-Parr correlation
functional (B3LYP).142,143 All atoms were equipped with Ahlrichs’ valence triple-ζ basis
set (TZV), in conjunction with the TZV/J auxiliary basis set.144,145 Polarization functions
were also included on all atoms. Finally, the gOpenMol program developed by
Laaksonen146 was used to generate isosurface plots of molecular orbitals.
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[Fe2+(Ph2Tp)(tBuAPH)] (4). (Ph2Tp)Fe2+(OBz) was prepared following a published
procedure. (Ph2Tp)Fe2+(OBz) (723 mg, 0.85 mmol) and 4,6-di-t-butyl-aminophenol (190
mg, 0.86 mmol) were dissolved in 12 mL of CH2Cl2. Following addition of 0.13 mL of
NEt3 (0.95mmol), the resulting solution was stirred for 16 hours. The solution was
filtered and the solvent removed under vacuum to give a light yellow solid. The product
was then dissolved in 5 mL of CH2Cl2, layered with excess MeCN, and placed overnight
in a -30 °C freezer. The resulting crystals were dried to provide complex 4 in 71% yield
(569 mg). X-ray quality crystals were obtained by vapor diffusion of MeCN into a
concentrated 1,2-dichloroethane (DCE) solution of 4. Elemental analysis calcd for
C59H56FeBN7O: C, 74.93; H, 5.97; N, 10.37%; found: C, 74.20; H, 5.86; N, 10.04%. The
disagreement in the %C-value is due to the presence of small amounts of solvent
impurities. UV-vis [λmax, nm (ε, M-1 cm-1) in CH2Cl2]: 371 (1620). IR (neat, cm-1,
selected bands): 3332 (NH2), 3284 (NH2), 2613 (BH).
[Fe2+ (Ph2Tp)(tBuISQ)] (5). Complex 4 (301 mg, 0.32 mmol) and TTBP• (84
mg,0.32 mmol) were dissolved in 10 mL of CH2Cl2, and the resulting dark green solution
was stirred for 45 min. The solvent was reduced to 5 mL and layered with excess
CH3CN. Thin green needles developed after standing overnight at -30 °C. The solvent
was decanted and the product collected and dried to give a green powder (121 mg, 40%
yield). Elemental analysis calcd. for C59H55FeBN7O: C, 75.01; H, 5.87; N 10.38%; found:
C, 74.77; H, 6.01; N 10.01%. UV-vis [λmax, nm (ε, M-1 cm-1) in CH2Cl2]: 335 (6950), 715
(750). IR (neat, cm-1, selected bands): 3334 (NH), 2614 (BH).
[Fe3+(Ph2Tp)(tBuISQ)]SbF6 ([6]SbF6). Two distinct methods were used to
generate complex [3a]SbF6. Method A: Complex 1a (284 mg, 0.30 mmol) and two
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equivalents of AgSbF6 (212 mg, 0.62 mmol) were mixed in 10 mL of CH2Cl2 and stirred
for one hour. The solution was filtered through Celite twice and the solvent removed
under vacuum. The resulting solid was washed with diethyl ether (2 x 15 mL) and dried
to give 218 mg of dark green powder (62% yield).
Method B: Complex 5 (116 mg, 0.12 mmol) and one equivalent of AgSbF6 (42
mg, 0.12 mmol) were mixed in 6 mL of CH2Cl2 and stirred for one hour. The resulting
dark green solution was filtered twice through Celite and vacuumed to dryness to yield a
dark green solid (75 mg, 52% yield). X-ray quality crystals of [6]SbF6 were obtained by
vapor diffusion of pentane into a concentrated 1,2-dichloroethane solution. UV-vis [λmax,
nm (ε, M-1 cm-1) in CH2Cl2]: 430 (5320), 767 (4670). IR (neat, cm-1, selected bands):
3266 (NH), 2646 (BH).
The sample of [6]SbF6 sent for elemental analysis was prepared using Method B.
The results indicate that [6]SbF6 was only generated in 84% yield, due to incomplete
oxidation of the starting material 5. Elemental analysis calcd for C59H55FeBF6N7OSb: C,
60.03; H, 4.70; N, 8.31; F, 9.66%. Calculated values assuming 84% conversion of 5 to
[6]SbF6: C, 62.00; H, 4.85; N, 8.58; F, 8.38%. Found: C, 61.93; H, 5.25; N, 8.18; F,
8.17%.
X-ray diffraction (XRD) data were collected at 100 K with an Oxford Diffraction
SuperNova Kappa-diffractometer (Agilent Technologies) equipped with dual microfocus
Cu/Mo X-ray sources, X-ray mirror optics, Atlas CCD dectector, and low-temperature
Cryojet device. Crystallographic data for particular compounds are shown in Table 3.4.
The data were processed with CrysAlis Pro program package (Agilent Technologies,
2011) typically using a numerical Gaussian absorption correction (based on the real shape
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of the crystal), followed by an empirical multi-scan correction using SCALE3
ABSPACK routine. The structures were solved using SHELXS program and refined
with SHELXL program147 within Olex2 crystallographic package.148 B- and C-bonded
hydrogen atoms were positioned geometrically and refined using appropriate geometric
restrictions on the corresponding bond lengths and bond angles within a riding/rotating
model (torsion angles of methyl hydrogens were optimized to better fit the residual
electron density).
The structure of complex 4 contains additional MeCN and DCE (1,2dichloroethane) solvent molecules; the latter is positioned on a crystallographic inversion
center. The hydrogen atoms of the –NH2 group were localized ina difference Fourier
synthesis and refined isotropically.
For complex 4 the structure contains a non-stoichiometric amount of heavily
disordered solvent (CH2Cl2) molecules. In addition, the tBuISQ ligand is partially (13%)
disordered over an internal (non-crystallographic mirror plane formed by the tripodal
Ph2

TP supporting ligand. The NH hydrogen atom of the minor component of the disorder

was localized objectively in a difference Fourier synthesis and then refined isotropically.
The corresponding –NH hydrogen of the minor component was treated geometrically.
Complex [6]SbF6 has a crystal structure that represents a regular twin (with a
48:52 component ratio) grown with a 180° rotation around reciprocal x axis. It was
treated using HKLF 5 refinement option (Sheldrick, 2008). The structure contains two
symmetrically-independent complex ionic units along with one equivalent of DCE
solvent. Because of the twinning, Fourier maps were substantially compromised and
objective localization of the H atom of –NH group was not feasible.
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Its presence was established by FTIR spectroscopy. Therefore, this H atom was
positioned geometrically and refined using a riding model with appropriate geometric
restraints.
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Table 3.4. Summary of X-ray Crystallographic Data Collection and Structure
Refinementa
4•MeCN•0.5DCE

5•2CH2Cl2 c

[6]SbF6•0.5DCE

empirical formula

C62H61BClFeN8O

C61H59BCl4FeN7O

C60H57BClF6FeN7OSb

formula weight

1036.30

1114.64

1229.99

crystal system

monoclinic

monoclinic

monoclinic

space group

P21/n

P21/c

P21/c

a, Å

10.0304(2)

14.9365(6)

39.237(1)

b, Å

32.0673(6)

9.9321(5)

13.8346(4)

c, Å

17.1467(3)

37.6317(14)

20.7143(5)

α, deg

90

90

90

β, deg

97.680(2)

92.617(4)

97.218(3)

, deg

90

90

90

V, Å3

5465.76(19)

5576.9(4)

11155.2(5)

Z

4

4

8

Dcalc, g/cm3

1.259

1.253

1.465

, Å

0.7107

1.5418

1.5418

µ, mm-1

0.374

3.583

6.936

-range, deg

7 to 59

7 to 148

7 to 148

30976

27278

13966

11016

27278

[Rint = 0.0377]

[Rint = 0.0467]

[Rint = 0.0]

data/restraints/parameters

13966/0/682

11016/100/882

27278/0/1418

GOF (on F2)

1.035

1.029

1.026

R1/wR2 (I>2σ(I))b

0.413 / 0.0989

0.0512 / 0.1279

0.0831 / 0.2089

R1/wR2 (all data)

0.0519 / 0.1068

0.0643 / 0.1382

0.1115/0.2331

reflections collected
independent reflections

60411

a DCE = 1,2-dichloroethane b R1 = ∑║F0│-│Fc║ / ∑│F0│; wR2 = [∑w(F02 – Fc2)2 /
∑w(F02)2]1/2 c The solvate molecules in 5•2CH2Cl2 are only partially populated.
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Chapter 4

Spectroscopic and Computational Studies of Fe Complexes
with o-Aminophenolate and Iminobenzosemiquinone Ligands

Abstract: The complexes reported in chapter 3 are examined with various spectroscopic
methods, including UV-vis absorption, magnetic circular dichroism (MCD), electron
paramagnetic resonance (EPR), and Mӧssbauer spectroscopies. In addition, an analogous
series of complexes featuring the Ph2TIP supporting ligand are synthesized and
characterized. The spectroscopic data are interpreted with the help of density functional
theory (DFT) calculations, resulting in detailed electronic structure descriptions.
Portions of this chapter have appeared in the paper: Bittner, M. M.; Kraus, D.; Lindeman,
S. V.; Popescu, C. V.; Fiedler, A. T. Chem. Eur. J. 2013, 9686-9698.
All DFT calculations and resonance Raman experiments were performed by Dr. Adam
Fiedler.
Mӧssbauer experiments were conducted by Codrina V. Popescu of Ursinus College.
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4.A. Introduction
A critical step in the microbial degradation of numerous aromatic compounds
involves oxidative ring scission by a mononuclear nonheme Fe dioxygenase. 90,91 Ringcleaving dioxygenases have been shown to oxidize and impressive array of substrates,
including catechols, protocatechuates,31,149 o-aminophenols,10,11 hydroquinones,79,94,96,150,151

and salicylates.58,101,102 The general catalytic strategy employed by these

dioxygenase differs substantially from the “textbook” O2-activation mechanism
exemplified by the cytochrome P450s, 152 methane monooxygenase,28 and αketoglutarate-dependent dioxygenases.29 In this set of enzymes, O2 is used to generate an
iron(IV)-oxo (ferryl) intermediate that performs the demanding hydroxylation of an
aliphatic substrate. By contrast, extensive experimental and computational studies have
revealed that the ring-cleaving dioxygenase mechanism does not involve high-valent Fe
intermediates, as illustrated for the extradiol catechol dioxygenases (ECDOs) and oaminophenol dioxygenases (APDOs) in Figure 4.123,31,32,47 In both cases, the bidentate
substrate coordinates to the Fe2+ center as a monoanionic ligand. Displacement of the
bound H2O molecules facilitates formation of an Fe/O2 adduct capable of reacting
directly with the bound substrate. The resulting peroxy-bridged intermediate undergoes a
Criegee rearrangement to generate a lactone, which is hydrolyzed by the Fe─OH unit to
provide the ring-opened product. Several of these intermediates were observed
crystallographically in different subunits of the enzyme homoprotocatechuate 2,3dioxygenase (HPCD).18
Despite significant progress in elucidating the catalytic cycles of ring-cleaving
dioxygenases, the electronic structure of the critical Fe/O 2/substrate intermediate in
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Figure 4.1 remains disputed (as described in Chapter 1). The development of suitable
synthetic models can help resolve the ambiguous electronic structures of enzymatic
intermediates. In the last chapter, we described the synthesis and X-ray structure of a
five-coordinate Fe(II)-aminophenolate complex (4) (Figure 4.2). This complex was used
to generate 5 – the first synthetic example of an Fe2+ center coordinated to a biologically
relevant (imino)semiquinonate ligand (ISQ). The supporting ligand is hydrotris(3,5-diphenylpyrazol-1-yl)borate (Ph2Tp), which adequately models the facial coordination
geometry and monoanionic charge of the 2-His-1-carboxylate coordination motif of most
ring-cleaving dioxygenases.19,153 A combination of crystallographic, spectroscopic
(absorption, EPR), and computational methods were used to confirm the existence of the
tBu

ISQ ligand in 5. The overall spin of 3/2 arises from antiferromagnetic (AF) coupling

between the high-spin Fe3+ center (S = 5/2) and ISQ radical. Using similar techniques,
we also examined the complex [6]SbF6 that arises from one-electron oxidation of 5. The
X-ray structural data for [6]+ are consistent with the presence of an Fe3+─tBuIBQ character
(where tBuIBQ is the neutral iminobenzoquinone with tert-butyl substituents at the 4- and
6-positions.
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Figure 4.1. Proposed catalytic cycle of ECDO and APDO.

In this chapter, we seek to develop detailed electronic-structure descriptions of 5
and [6]+ using an assortment of spectroscopic methods, including UV/Vis/NIR
absorption, Mӧssbauer, magnetic circular dichroism (MCD), and resonance Raman (rR)
spectroscopy. In addition, we have prepared a parallel series of complexes ([1b]+, [2b]+,
and [3b]2+) containing the facial N3-donor ligand tris(4,5-di-phenyl-1-methylimidazol-2yl)phosphine (Ph2TIP; Figure 4.2). X-ray structures of complexes [1b]BPh4 and
[3b](OTf)2 are presented to complement those already shown for 1a, 2a, and [3a]SbF6.
By employing this neutral supporting ligand, we are able to evaluate the role of the
coordination environment in modulating the oxidation states of the Fe center and ISQ
ligand. In all cases, the spectroscopic data were analyzed with the aid of DFT
calculations. By elucidating the spectroscopic signatures of these synthetic complexes,
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we anticipate that our results will assist in the interpretation of comparable data from the
biological systems, thereby allowing researchers to determine whether Fe─(I)SQ species
are viable intermediates in the catalytic cycles of ring-cleaving dioxygenases.

Figure 4.2. Complexes prepared and examined in this chapter.

4.B. Synthesis of Complexes [7b]+-[9b]2+ and 10a
The synthesis and X-ray structure of [Fe2+(Ph2Tp)(tBuAPH)] (4a) was reported in
the previous chapter. The analogous complex [7b]+ based on the neutral Ph2TIP ligand
was generated by mixing [Fe2+(Ph2TIP)(OTf)2]154 and 2-amino-4,6-di-tert-butylphenol
(tBuAPH2) with one equivalent of triethylamine in CH2Cl2 ; recrystallization from
toluene/pentane provided [7b]OTf as a yellow solid. Following counteranion metathesis
with NaBPh4, X-ray quality crystals of [7b]BPh4 were obtained by layering a
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concentrated 1,2-dichloroethane (DCE) solution with MeOH. The resulting structure
(Figure 4.3) contains two symmetrically independent [7b]+ units with nearly identical
geometries. Relevant structural parameters for 4a, [7b]BPh4, and 10a are provided in
Table 4.1. Similar to 4a, complex [7b]+ features a five-coordinate monoiron(II) center in
a distorted trigonal-bipyramidal coordination environment ( = 0.60155). The amino and
phenolate donors of the bidentate tBuAPH ligand are found in axial and equatorial
positions, respectively (Figure 4.1). The average Fe-NTIP bond distance of 2.19 Å in
[7b]+ is ~0.04 Å longer than the average Fe-NTp distance in 4a, reflecting the weaker
donating ability of neutral Ph2TIP relative to anionic Ph2Tp. In both 4a and [7b]+, the FeN/O bond lengths are indicative of high-spin Fe(II) centers, consistent with the presence
of paramagnetically-shifted peaks in their corresponding 1H NMR spectra (Figure 4.4).
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Figure 4.3. Thermal ellipsoid plot of [7b]BPh4 and 10a. Counteranions, noncoordinating
solvent molecules, and most hydrogen atoms have been omitted for clarity.
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Figure 4.4. 1H NMR spectra of 4a (top) and [7b]OTf (bottom) in CD2Cl2. Note that peak
intensities for the outer portions of the spectra were enlarged (x 2) for the sake of clarity.
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Table 4.1. Selected bond lengths (Å) and angles (deg) for complexes 4a, [7b]BPh4, and
10a
Fe1-N1
Fe1-N3
Fe1-N5
Fe1-O1
Fe1-N7

4a•MeCN•0.5DCE
2.101(1)
2.127(1)
2.223(1)
1.931(1)
2.214(1)

7b[BPh4] •1.5DCE
2.175(2)
2.175(2)
2.222(2)
1.929(2)
2.229(2)

10a•4CH2Cl2
2.121(2)
2.158(2)
2.236(2)
1.920(2)
2.335(2)

N1-Fe1-N3
N1-Fe1-N5
N3-Fe1-N5
O1-Fe1-N1
O1-Fe1-N3
O1-Fe1-N5
O1-Fe1-N7
N1 -Fe-N7
N3 -Fe-N7
N5 -Fe-N7
τ-value

92.82(5)
83.30(5)
86.11(5)
136.61(5)
129.47(5)
105.94(4)
80.76(4)
92.60(5)
88.68(5)
173.20(5)
0.61

92.50(7)
85.88(7)
84.43(6)
134.21(7)
130.73(7)
109.45(6)
80.24(6)
88.33(7)
87.90(7)
170.17(7)
0.60

100.11(9)
80.90(9)
81.79(9)
131.71(9)
127.63(9)
109.69(9)
78.07(8)
100.11(9)
98.07(9)
170.40(9)
0.65

The Ph2Tp-based complex 10a contains the DMAPH ligand – the N,Ndimethylated version of tBuAPH.

Figure 4.5. UV-vis spectra of complexes 4a-[6a]+, [7b]+-[9b]+, and 10a.
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This complex is intended serve as a “control”, since methylation of the –NH2
group hinders conversion to the ISQ state. The overall structure of 10a, as revealed by
X-ray crystallography (Figure 4.3), is quite similar to 4a. The most prominent difference
is the 0.12 Å elongation of the Fe1-N7 bond in 10a relative to 4a (Table 4.1), presumably
due to steric repulsion between the -NMe2 group and 3-Ph substituents of the Ph2Tp
ligand. Additionally, the plane of the DMAPH ligand is bent away from the O1-Fe-N7
chelate ring by 26o, whereas the two planes are nearly colinear in 4a and [7b]+.
Treatment of [7b]OTf with TTBP• in CH2Cl2 produces a light green chromophore
[8b]+ with an absorption spectrum similar to the one collected for 5a (Figure 4.5). In
addition, the EPR spectra of [8b]+ and 5a are nearly identical; both exhibit a sharp peak
at g ≈ 6.5 and broad derivative feature centered at g ˂ 1.8 (Figure 4.6). Such spectra are
characteristic of S = 3/2 systems with large, negative D values and moderate rhombicities
(E/D = 0.24 and 0.18 for 5a and [8b]+, respectively). Unfortunately, despite repeated
attempts, it was not possible to obtain X-ray quality crystals of [8b]+. However, the
strong resemblance between the spectroscopic features of 5a and [8b]+ suggests similar
Fe2+ISQ electronic configurations─an assumption verified by analysis with Mӧssbauer
spectroscopy (vide infra).
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Figure 4.6. X-band EPR spectra of 5a (top) and [8b]OTf collected at 20 and 10 K,
respectively. The experimental spectra (solid lines) were simulated (dashed line) assuming
a S = 3/2 ground state. Simulation parameters for 5a: D = -10 cm-1 ; E/D = 0.24; g = 2.36,
2.30, 2.17. Simulation parameters for [8b]OTf: D = -12 cm-1 ; E/D = 0.18; g = 2.45, 2.35,
2.01. The program EasySpin4 was used to simulate the experimental spectra (S. Stoll and
A. Schweiger, Journal of Magnetic Resonance, 2006, 178, 42-55).

Oxidation of 4a and [7b]OTf with two equivalents of AgX (X = SbF6 or OTf) in
CH2Cl2 gives rise to complexes [6a]SbF6 and [9b](OTf)2, respectively, that each display a
distinctive absorption band near 780 nm (12800 cm-1 ; Figure 4.5). The magnetic
moments of these complexes are near 5.0 µB, typical for S = 2 paramagnets, and the EPR
spectrum of [9b]2+ exhibits a 4S signal at g = 8.7 (Figure 4.7).
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Figure 4.7. X-band EPR spectra of [9b](OTf)2 collected at 10 K in perpendicular mode
(black) and parallel mode (red).

The structural data for [6a]SbF6 reported in the previous chapter suffers from
large uncertainties in bond lengths (3σ ≈ 0.035 Å in C─distances), which hindered
evaluation of the ligand oxidation state based on geometric parameters. As noted in the
introduction, DFT calculations suggested an electronic structure intermediate between
Fe3+─tBuISQ and Fe2+─tBuIBQ.
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Figure 4.8. Thermal ellipsoid plot (50% probability) derived from the X-ray structure of
[9b](OTf)2●1.5 CH2Cl2. Non-coordinating solvent molecules, counteranions and most
hydrogen atoms have been omitted for clarity. Key metric parameters are provided in
Table 4.2.

Table 4.2. Selected bond lengths [Å] from the X-ray structures of [6a]SbF6●0.5 DCE and
[9b](OTf)2●1.5 CH2Cl2.
[6a]SbF6

[9b](OTf)2

[6a]SbF6

[9b](OTf)2

Fe1-N1

2.071(7)

2.077(3)

O1-C1

1.264(11)

1.287(5)

Fe1-N3

2.038(7)

2.089(4)

N7-C2

1.333(11)

1.314(6)

Fe1-N5

2.134(6)

2.093(4)

C1-C2

1.473(12)

1.483(6)

Fe1-O1

2.082(6)

2.037(3)

C2-C3

1.423(12)

1.429(6)

Fe1-N7

2.017(8)

2.013(4)

C3-C4

1.345(15)

1.340(7)

Crystals of [9b](OTf)2 were obtained by layering a CH2Cl2 solution with pentane;
the resulting X-ray structure is shown in Figure 4.8, and relevant metric parameters for
[6a]SbF6 and [9b](OTf)2 are compared in Table 4.2. The -values for the [9b](OTf)2
bond distances are significantly smaller than those in the [6a]SbF6 structure. Like [6a]+,
complex [9b]2+ features a distorted trigonal-bipyramidal coordination geometry ( =
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0.57) with O1 occupying an axial position. The O1-C1, N7-C2, and C-C bond distances
of the O,N-donor ligand are fully consistent with ligand-based oxidation. Recently,
Brown developed a helpful procedure for assessing the oxidation state of oaminophenolate ligands based on their metric parameters. 136 Using this method, the
ligands in [6a]+ and [9b]2+ have estimated charges of ─0.54(8) and ─0.48(10),
approximately halfway between the ISQ─ and IBQ0 limits (Table 4.3). Further insights
into the Fe and ligand oxidation state of [6a]+ and [9b]2+ are provided by spectroscopic
and computational studies described below.
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Table 4.3. Experimental and DFT-computed properties of selected complexes.
metric parameters

4a

[7b]+

5a

exptl

2.150

2.191

2.137

DFT

2.215

2.240

2.188

exptl

1.345

1.340

1.285

DFT

1.330

1.338

1.276

exptl

1.451

1.455

1.328

DFT

1.454

1.460

1.335

exptl

-

-

─0.69

DFT

-

-

─0.72

Fe

DFT

+3.78

+3.76

O,N─ligand

DFT

+0.14

δ [mms-1]

exptl

Fe-NTp/TIP ave [Å]
O1─C1 [Å]
N7─C2 [Å]
ligand charge

Mulliken spins

Mӧssbauer

ΔEQ [mms-1]

[8b]+

[6a]+[a]

[9b]2+[a]

2.081

2.086

2.077

2.122

1.264

1.287

1.278

1.273

1.336

1.314

1.329

1.326

─0.54

─0.48

─0.73

─0.62

─0.54

+3.77

+3.76

+3.94

+3.93

+0.18

─0.86

─0.82

─0.30

─0.15

1.06

1.06/1.14

0.97

0.95/0.99

0.73

0.64

DFT

0.96

0.95

0.86

0.91

0.57

0.62

exptl

2.52

2.08/2.93

3.5

1.95[b]/2.5

2.33

1.94

DFT

2.00

1.86

2.93

2.09

0.71

1.34

2.233
1.277
1.337

[a] DFT calculation employed the BP functional. [b] Average ΔEQ value for the dominant species in the [8b]+ MB
spectrum.
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4.C. Electrochemistry of Complexes 4a-[6a]+
Our original intent in performing chemical oxidations of 4a and [7b]OTf was to
generate the corresponding ferric complexes [Fe3+(Ph2Tp)(tBuAPH)]+ (4aox) and
[Fe3+(Ph2TIP)(tBuAPH)]2+ (7box). However, treatment of 4a and [7b]OTf with a single
equivalent of one-electron oxidants (such as acetylferrocenium, [N(C6H4Br-4)3]+, or Ag+)
instead produced 0.5 equivalent of [6a]+ and [9b]2+, respectively. Indeed, titrations of 4a
and [7b]OTf with acetylferrocenium revealed a linear increase in the intensity of the
[6a]+/[9b]2+ absorption features up to two equivalents of oxidant, indicating that the
Fe(II) precursors exclusively undergo two-electron oxidations. This situation generally
occurs when the product of the initial one-electron transfer undergoes a chemical change
to yield a species that is more reducing than the starting complex.
To better understand this phenomenon, cyclic voltammetric studies of the Ph2Tp series
were conducted in CH2Cl2 with 100 mM [NBu4]PF6 as the supporting electrolyte. All
redox potentials are referenced to the ferrocenium/ferrocene couple (Fc+/Fc). As shown
in Figure 4.9, 4a undergoes an irreversible oxidation at -15 mV, followed by a cathodic
wave at -490 mV with half the current intensity of the anodic wave.
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Figure 4.9. CV diagram of complexes 4a, 5a, and 10a. All potentials have been
referenced to the ferrocene/ferrocenium couple.

Figure 4.10. Diagram of the redox reactions/disproportionation of complexes 4a-6a.

We therefore concluded that the oxidation at -15 mV corresponds to the two-electron
process 4a  [6a]+ + H+, while the subsequent reduction corresponds to one-electron
reduction of [6a]+ to 5a. This conclusion was confirmed by the CV of 5a (Figure 4.9),
which shows a quasi-reversible [6a]+/5a couple with E1/2 = -380 mV (ΔE = 140 mV).
Thus, 5a is indeed more reducing than 4a, accounting for the behavior described above.
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Figure 4.10 summarizes the electrochemical properties of these complexes. One-electron
oxidation of 4a presumably yields the ferric complex 4aox, although this transient species
is never observed.
Instead, 4aox quickly sheds a proton to the surrounding medium to give 5a, since the
change in Fe oxidation state dramatically lowers the pKa of the coordinated –NH2 donor.
The fact that E1/2(4aox/4a) > E1/2([6a]+/5a) ensures that 5a is not stable in this
environment; instead, it disproportionates to give 0.5 equivalent each of 4a and [6a]+
(Figure 4.10). Thus, the only way to convert 4a into 5a is to employ an H-atom
abstracting agent like TTBP• that is not an effective one-electron oxidant. Our results also
indicate that deprotonation of the O,N-ligand dramatically lowers its redox potential, thus
favoring ligand-based over metal-based oxidation.
The electrochemical behavior of 10a is straightforward since the DMAPH ligand
cannot easily participate in proton or electron transfers. This complex displays a quasireversible redox event with E1/2 = -15 mV (ΔE = 130 mV) that corresponds to the
Fe3+/Fe2+ couple (Figure 4.9). The 10a potential can serve as an approximate value for
the irreversible 4aox/4a couple. The free tBuAPH2 and DMAPH ligands are irreversibly
oxidized at more positive potentials of +280 and +450 mV, respectively, in CH2Cl2
(Figure 4.11).
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Figure 4.11. Cyclic voltammograms of ligands tBuAPH2 and DMAPH in CH2Cl2 with 100
mM (NBu4)PF6 as the supporting electrolyte. The scan rate was 100 mV/s.

4.D. Geometric and Electronic Structures of DFT-Optimized Models
Since the spectroscopic data presented below are frequently interpreted with the
assistance of DFT calculations, it is necessary to first describe the molecular and
electronic structures of our computational models. We employed truncated versions of
the complexes in which the tert-butyl groups of the O,N-donor were replaced with methyl
groups and the phenyl substituents at the 5-positions of the pyrazole (Ph2Tp) and
imidazole (Ph2TIP) rings were removed. Unless otherwise noted, all calculations
employed the B3LYP functional. The most stable geometry-optimized structure of 5a
was obtained using the broken symmetry (BS) methodology and an overall spin of 3/2;
this model provided metric parameters in excellent agreement with the crystallographic
data (Table 4.4).
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Table 4.4. Selected Bond Distances (Å) and Angles (deg) for Complexes 5a and [8b]+
Obtained by XRD and DFT.
Bond distances

5a (XRD)

5a (DFT)

[8b]+ (DFT)

Fe1-N1

2.108(2)

2.129

2.176

Fe1-N3

2.087(2)

2.136

2.188

Fe1-N5

2.216(2)

2.299

2.335

Fe1-O1

2.095(2)

2.130

2.121

Fe1-N7

1.982(2)

2.029

2.003

O1-C1

1.285(3)

1.276

1.277

N7-C2

1.328(4)

1.335

1.337

C1-C2

1.469(5)

1.461

1.460

C2-C3

1.413(4)

1.420

1.417

C3-C4

1.363(4)

1.372

1.372

C4-C5

1.427(4)

1.427

1.430

C5-C6

1.375(4)

1.372

1.370

C1-C6

1.440(4)

1.432

1.432

Bond angles

5a (XRD)

5a (DFT)

[8b]+ (DFT)

N1-Fe1-N3

93.44(7)

94.6

95.1

N1-Fe1-N5

82.76(7)

83.3

83.9

N3-Fe1-N5

89.80(7)

86.1

86.2

O1-Fe1-N1

94.16(7)

97.2

95.2

O1-Fe1-N3

95.62(7)

97.6

93.8

O1-Fe1-N5

173.93(8)

176.2

179.1

N7-Fe1-N1

138.99(9)

138.5

136.5

N7-Fe1-N3

127.37(9)

126.8

128.0

N7-Fe1-N5

99.36(8)

98.6

102.2

O1-Fe1-N7

79.52(8)

78.5

78.6

τ-value

0.58

0.63

0.71

The Mulliken spin populations, listed in Figure 4.3, support the view that the
electronic structure of 5a should be described as a high-spin Fe2+ center (3.77 α spins)
AF-couple to an ISQ-based π-radical (0.86 β spins). The exchange coupling constant (J)
has a computed value of ─223 cm-1, based on the Yamaguchi approach (H =
─2JSA●SB).156 The AF coupling is mediated by a nonorthogonal pair of singly occupied
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molecular orbitals (SOMOs) with opposite spins, shown in the qualitative MO diagram in
Figure 4.12. The relevant magnetic orbitals for 5a are the α-Fe(dxy)- and β-ISQ(π*)-based
MOs that display 33% spatial overlap, indicative of a ligand-based radical with rather
weak interactions with the Fe2+ center. The structure and bonding scheme of [8b]+, also
computed with the BS approach, are nearly identical to the corresponding 5a model
(Table 4.3 and 4.4), consistent with the spectral similarities between 5a and [8b]+ (vide
supra).

Figure 4.12. Qualitative molecular orbital diagrams for 5a (left) and [6a]+ (right)
obtained from broken-symmetry DFT calculations. Isosurface plots for important MOs
are provided, along with the overlap (s) between corresponding magnetic orbitals.
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While the optimized [6a]+ geometry obtained with the B3LYP functional agrees
reasonably well with the crystallographic data, Fe─N/O and intraligand bond lengths in
the DFT structure of [9b]2+ deviate significantly from the experimental values (Table
4.5). Better agreement was obtained with the BP functional for both [6a]+ and [9b]2+,
and therefore, our analysis of these complexes has employed the BP-derived structures.
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Table 4.5. Experimental and computed bond distances (Å) and bond angles (deg) for complexes [6a]+ and [3b]2+ Obtained by
XRD and DFT.
Bond distances
Fe1-N1
Fe1-N3
Fe1-N5
Fe1-O1
Fe1-N7
O1-C1
N7-C2
C1-C2
C2-C3
C3-C4
C4-C5
C5-C6
C1-C6
RMS dev (all)

[6a]+ (XRD)
2.071(7)
2.038(7)
2.134(6)
2.082(6)
2.017(8)
1.264(11)
1.333(11)
1.473(12)
1.423(12)
1.345(15)
1.433(16)
1.375(14)
1.439(12)

RMD dev (ligand)
Bond angles
N1-Fe1-N3
N1-Fe1-N5
N3-Fe1-N5
O1-Fe1-N1
O1-Fe1-N3
O1-Fe1-N5
N7-Fe1-N1
N7-Fe1-N3
N7-Fe1-N5
O1-Fe1-N7
τ-value

[3a]+ (XRD)
94.5(3)
84.6(3)
92.4(3)
86.6(2)
93.8(3)
169.6(3)
144.6(3)
117.6(3)
106.9(3)
77.4(3)
0.42

[6a]+ (B3LYP)
2.078
2.077
2.137
2.078
2.047
1.256
1.311
1.482
1.425
1.364
1.451
1.361
1.442
0.018

[6a]+ (BP)
2.050
2.043
2.138
2.064
1.999
1.278
1.329
1.473
1.422
1.378
1.444
1.376
1.437
0.014

0.014

0.013

[3a]+ (B3LYP)
95.4
88.5
90.3
93.3
93.3
175.9
137.3
126.0
100.0
76.2
0.64

[3a]+ (BP)
96.9
88.3
91.0
93.6
93.4
175.0
136.3
126.0
98.1
77.4
0.65

[9b]2+ (XRD)
2.077(3)
2.089(4)
2.093(4)
2.037(3)
2.013(4)
1.287(5)
1.314(6)
1.483(6)
1.429(6)
1.340(7)
1.448(7)
1.370(7)
1.427(7)

[3b]2+ (XRD)
98.9(1)
85.5(1)
93.3(2)
91.8(1)
92.3(1)
174.1(1)
140.2(2)
119.5(2)
101.3(2)
77.6(2)
0.57

[9b]2+ (B3LYP)
2.124
2.135
2.193
2.180
2.088
1.235
1.295
1.514
1.428
1.358
1.465
1.353
1.454
0.060

[9b]2+ (BP)
2.095
2.091
2.180
2.057
2.001
1.273
1.326
1.483
1.420
1.378
1.451
1.374
1.440
0.028

0.027

0.016

[3b]2+ (B3LYP)
95.3
89.1
90.7
92.2
92.0
177.0
135.7
126.7
102.4
74.8
0.69

[3b]2+ (BP)
98.5
89.2
91.4
92.0
91.8
176.3
134.4
125.8
99.1
77.6
0.70
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For each complex, DFT calculations converge to the same S = 2 state irrespective
of whether the BS approach is employed. The Mulliken spin populations appear to favor
an Fe2+─tBuIBQ description, as the Fe center carries approximately four unpaired spins
and the ligand-based spin density is reduced relative to 5a/[8b]+ (Table 4.3). The βHOMO of [6a]+ contains significant amounts of both Fe (39%) and O,N-ligand (53%)
character (Figure 4.12), indicative of intermediate Fe2+/3+ and IBQ/ISQ oxidation states
(the corresponding values for [9b]2+ are 53 and 37%). In addition, the spatial overlap
between the pair of magnetic orbitals involved in the spin-coupling interaction is about
80%, which reflects a high degree of spin pairing (as opposed to the “diradical” situation
of 5a). However, these computational results should be viewed with caution, since the
experimental metric parameters for [6a]+/[9b]2+ are not consistent with a pure IBQ
description, as evident in the ligand charges shown in Table 4.3. Spectroscopic studies
are therefore required to properly evaluate the electronic structures of [6a]+ and [9b]2+.
Finally, we generated DFT models of the hypothetical Ga3+ complexes,
[Ga3+(Ph2Tp)(ISQ)]+ (Ga-ISQ) and [Ga3+(Ph2Tp)(IBQ)]2+ (Ga-IBQ). The Ga3+ ion has
been employed in previous computational studies as a closed-shell analog of Fe3+ due to
similarities in charge and ionic radius.70 Since Ga3+ is not redox active, the Ga-ISQ and
Ga-IBQ models allow us to assess the electronic and spectroscopic properties of “pure”
ISQ and IBQ ligands without complications from the paramagnetic Fe center.
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4.E. Mӧssbauer Spectroscopy
Mӧssbauer (MB) spectroscopy has proven capable of providing definitive
assessments of Fe oxidation states in complexes with non-innocent ligands (Figure 4.13).
displays low-temperature (6 K) MB spectra collected in an applied field of 0.04 T for
polycrystalline samples of 4a, 5a, and [6a]SbF6; the corresponding spectra of the Ph2TIPbased “b series” are provided in Figure 4.14. MB parameters are summarized in Tables
4.3 and 4.5. Complex 4a displays a single doublet with an isomer shift (δ) of 1.06 mms-1
and quadrupole splitting (ΔEQ) of 2.52 mm-1, consistent with the presence of a
conventional high-spin Fe2+ center.

Figure 4.13. Mӧssbauer spectra of complexes 4a, 5a, and [6a]SbF6 recorded at 6 K in
an applied field of 0.04 T. The parameters indicated represent the principal species
discussed in the text. The spectrum of sample 5a contains a contribution from 4a,
amounting to 30% of the total Fe in the sample (inner doublet, indicated by the bracket).
The spectrum of [6a]+ shown in this figure was obtained by subtracting 20% of
impurities from the raw data.
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Figure 4.14. Mӧssbauer spectra of complexes [7b]OTf, [8b]OTf, and [9b](OTf)2,
recorded at 6 K, in an applied field of 0.04 T. The solid lines are least-square fits with
parameters in Table 4.6.
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Table 4.6. Experimental Mӧssbauer Parameters
Isomer Shift
a

Quadrupole Splitting

FWHM

ΔEQ (mm/s)

mm/s

Complex

δ (mm/s)

4a

1.06

2.52

0.26

5a

0.97

3.50

0.35, 0.6

0.73 (80%)

2.33

0.4

0.55 (15%)

0.75

0.4

0.10 (5%)

1.0

0.28, 0.35

1.06 (70%)

2.08

0.29

1.14 (30%)

2.93

0.95 (26%)

2.08

0.95 (44%)

1.68

0.99 (30%)

2.5

0.64

1.94

1.27

3.20

1.00

3.44

[6a]SbF6

[7b]OTf

[8b]OTf

[9b](OTf)2

0.33

0.35

a

Isomer shifts are quoted at 6 K. with respect to iron metal spectra at room temperature.

In contrast, the MB spectrum of [7b]OTf features two doublets in a roughly 2:1
ratio; the parameters for both species are typical of high-spin Fe2+ complexes: δ = 1.06
and 1.14 mms-1 and ΔEQ = 2.08 and 2.93 mms-1 for the major and minor components,
respectively. The two observed species likely correspond to conformational isomers of
[7b]+ that lie at different points along the continuum between square-pyramidal and
trigonal-bipyramidal geometries. In support of this conclusion, the X-ray structure of
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[7b]+ (vide supra) features two independent complexes in the unit cell with distinct τ
values of 0.60 and 0.55.
The MB spectrum of 5a exhibits a broad doublet with a large quadrupole splitting
(δ = 0.97, ΔEQ = 3.5 mms-1), although the presence of starting material (ca. 30% of Fe) is
also evident (Figure 4.13). Significantly, the modest decrease of 0.09 mms -1 in isomer
shift upon conversion of 4a to 5a provides unequivocal evidence that the oxidation is
ligand based, in support of the Fe2+─ISQ formulation for 5a. Likewise, the MB spectrum
required three doublets with δ values of (0.97 ± 0.02) mms -1 and ΔEQ values between 1.72.5 mms-1 (Table 4.6). Given the nearly identical isomer shifts, these three species likely
correspond to conformational isomers of [8b]+, similar to the situation discussed above
for [7b]+. The heterogeneity observed in the [8b]+ spectrum is related to the inability to
prepare suitable crystals of this complex, which necessitated the use of powder samples
lacking the intrinsic order of crystalline material. The broadness of the doublets for both
5a and [8b]+ is likely due to spin-spin relaxation effects.
MB spectra of [6a]+ and [9b]2+ each display a single doublet centered at δ = 0.73
and 0.64 mms-1, respectively, with quadrupole splittings of about 2.0 mms -1 (Figure 4.14
and Table 4.6; the [9b]2+ spectrum also contains features arising from ferrous impurities).
The lower δ values suggest that one-electron oxidation of 5a → [6a]+ (or [8b]+ → [9b]2+)
involves significant removal of electron density from the Fe ions. However, the observed
isomer shifts are larger than one would expect for high-spin Fe3+ centers, which typically
display values between 0.4 and 0.6 mms -1.157 A survey of high-spin [Fe3+-(ISQ)n]
complexes (n = 1, 2, or 3) prepared by Wieghardt and co-workers found δ values ranging
from 0.44 to 0.54 mms-1.78,80-82 The MB data are therefore consistent with our DFT
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results that suggest partial IBQ character for the O,N-ligands in [6a]+/[9b]2+. It is also
important to note that the a- and b-series of complexes yield very similar MB parameters,
suggesting that the supporting ligand (Ph2Tp(1─) vs Ph2TIP) has little effect on the Fe/LO,N
unit.
As show in Table 4.3, the isomer shifts derived from DFT calculations are quite
consistent with the experimental data, although DFT generally underestimates δ values
by about 0.05-0.15 mms-1. In particular, DFT nicely reproduces the magnitude of
changes (Δδ) across the 4→5→6 (or 7→8→9) series. The overall agreement is less
satisfactory for quadrupole splittings, but it is well-known that DFT has more difficulty
computing accurate ΔEQ values.158-160 The general agreement between calculated and
experimental MB parameters indicates that our computational models faithfully represent
the electronic structures of these “redox-ambiguous” complexes.

4.F. Electronic Absorption and MCD Spectroscopy
The UV/vis/NIR spectra of 5a and [8b]+ displayed in Figure 4.5 are characterized by
a broad absorption manifold (ε ~ 1.0 mM-1cm-1) centered around 750 nm (13,300 cm-1).
In this region, the 5a/[8b]+ spectra closely resemble those reported for other ISQcontaining complexes with various metal ions (Co 3+, Ni2+, and Cu2+),89,131 as well as the
spectrum measured by Carter et al. for a “free” ISQ radical. 161 These spectral similarities
suggest that the transitions observed for 5a and [8b]+ are primarily ligand based. This
conclusion is supported by literature precedents162,163 and our time-dependent DFT (TDDFT) calculations. The dominant contributor to the 750 nm feature is an intraligand
transition in which the acceptor orbital is the SOMO of the tBuISQ radical. TD-DFT
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calculations predict this transition to appear at 16,100 and 15,200 cm-1 for 5a and [8b]+,
respectively. In general, the TD-DFT methodology nicely replicates the energies and
intensities of the experimental absorption features, as shown in Figure 4.15 for 5a
(electron density difference maps – EDDMs, for key transitions are provided in Figure
4.16).

Figure 4.15. Experimental (dashed line) and TD-DFT computed (solid line) absorption
spectra for 5a (top) and [6a]+ (bottom). The arrows point to features in the computed
spectra arising from the indicated type of electronic transition.
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Figure 4.16. Top: Experimental (dashed line) and TD-DFT computed (solid line)
absorption spectra for 5a. Bottom: Electron density difference maps (EDDMs) for
computed transitions. Blue and grey regions indicate gain and loss of electron density,
respectively.

These calculations indicate that another component of the absorption manifold
involves excitation to the tBuISQ SOMO from an molecular orbital with mixed
tBu

ISQ/Fe(II) character; the computed energy for this transition is 15,000 cm-1 for 5a.

The weak near-infrared (NIR) bands evident for both complexes likely arise from Fe(II)
d-d transitions, while features at higher energies (> 20,000 cm-1) are attributed by TD-
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DFT to tBuISQFe(II) charge transfer (CT). These latter bands are relatively weak due to
poor overlap between the tBuISQ SOMO and half-occupied Fe(II) orbitals (Figure 4.16).

Table 4.7. Comparison of Computed (TD-DFT) and Experimental Energies for Selected
Electronic Transitions of Complexes 5a and [6a]SbF6.
Complex
5a

[6a]SbF6

Transition
assignment
Fe(II) d-d

Transition energy (cm-1)
TD-DFT
experimental
8000
6500
14100

intraligand

15000
16100

13200
15200

ISQ→Fe(II) CT

20700

21400

LO,N→Fe CT

7600

6050

Fe/LO,N π→π*

14600

13050

intraligand

19000

~20000

Analysis of the [6a]/[9b]2+ spectra is more complex due to the large extent of
mixing between Fe and ligand orbitals. For both complexes, the β-HOMO – containing
approximately equal parts metal and ligand character (vide supra) – arises from a πbonding interaction between the parent Fe 3d and LO,N orbitals (Figure 4.17). TD-DFT
calculations, which again faithfully reproduce key features of the experimental spectrum
(Figure 4.18 and Table 4.7), indicate that the intense absorption feature at about 13000
cm-1 involves electron transfer from the β-HOMO to its unoccupied π-antibonding
counterpart; therefore, this excitation is best described as a π→ π* transition centered on
the O1─Fe1─N7 unit. The broad band evident in the NIR region (ε ≈ 1.0 mM -1 cm-1) is
then attributed to β-HOMO→Fe 3d transitions where the acceptor orbitals lack
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significant LO,N character. Given the mixed nature of the β-HOMO, this low-energy
feature possesses both Fe d-d and LMCT character, as revealed in the EDDMs in Figure
4.17.

Figure 4.17. Top: Experimental (dashed line) and TD-DFT computed (solid line)
absorption spectra for [6a]+. Bottom: Electron density difference maps (EDDMs) for
computed transitions. Blue and grey regions indicate gain and loss of electron density,
respectively.
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Interestingly, the intraligand transition that is prominent at about 13300 cm-1 in the
5a/[8b]+ spectra is calculated to appear at 18900 cm-1 for [6a]+, although this transition
now contains some LCMT character. The blueshift reflects the partial IBQ character of
the O,N-coordinated ligands, since previous reports have demonstrated that the lowestenergy IBQ based transition in metal complexes occurs near 20800 cm-1.89,131 This
intraligand transition is largely obscured in the [6a]+ spectrum by intense NTp→Fe CT
transitions. However, because the Ph2TIP-based MOs are greatly stabilized relative to
their Ph2TIP counterparts (on account of the difference in charge), the N TIP→Fe CT
transitions are therefore evident in the 20000-25000 cm-1 region of the [9b]2+ spectrum
with intensities of about 1.5 mM-1 cm-1.
The electronic transitions of [9b](OTf)2 were further probed through the collection of
solid-state MCD spectra at low temperatures (4-30 K). All bands in the visible region
exhibit temperature-dependent intensities characteristic of C-term behavior (Figure 4.18,
top), as expected for a paramagnetic S = 2 species. Based on our analysis of the
absorption spectrum, the most intense MCD feature at 12500 cm-1 corresponds to the
Fe/LO,N π→π* transition, while the bands centered around 20000 cm-1 are ascribed
primarily to intraligand transitions. Since MCD c-term intensity requires spin-orbit
coupling between states, features that involve metal d-orbitals, such as ligand-field (d-d)
and CT transitions, are relatively more intense in MCD than absorption spectra (C/D
ratio).164 Thus, the comparative weakness of the higher-energy features in the [9b]2+
MCD spectrum is further confirmation of the ligand-based nature of these transitions.
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Figure 4.18. Top: Variable-temperature solid-state MCD spectra of [9b](OTf)2. Spectra
were measured at a magnetic field of 7 T and at temperatures of 4, 8, 15 and 30 K.
Bottom: VTVH-MCD data collected at 790 nm for [9b](OTf)2. Data were obtained at the
indicated temperatures with magnetic fields (H) ranging from 0 to 7 T. The best fit (ʘ)
was obtained with the following spin Hamiltonian parameters: S = 2, D = -5 cm-1, E/D =
0.20, giso = 2.0.

Variable-temperature variable-field MCD (VTVH-MCD) data were collected at
790 nm (12660 cm-1) for [9b]2+. In these experiments, the MCD intensity was monitored
at five temperatures (2, 4, 8, 15, and 30 K) as the magnetic field (H) was varied from 0 to
7 T; by convention, the resulting magnetization curves are plotted against βH/2kT (Figure
4.18, bottom). As demonstrated by Solomon and Neese, quantitative analysis of the
VTVH-MCD curves provides valuable information regarding spin-Hamiltonian
parameters and transition polarizations. 165,166 The VTVH-MCD method is particularly
powerful for non-Kramers systems, such as [9b]2+, that are often inaccessible by EPR
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spectroscopy. The magnetization curves obtained at 790 nm saturate rapidly with field
and exhibit very little “nesting” (i.e., spread between curves obtained at different
temperatures). Such behavior is characteristic of S =2 systems with negative zero-field
splitting (ZFS).167,168 Indeed, the best fit of the 790 nm data was obtained with D = ─5.0
cm-1 and E/D = 0.20 (Figure 4.18), although a broad range of negative D values (˂ 4 cm1

) with moderate rhombicities (0.1 ˂ E/D ˂ 0.25) provided acceptable fits. Our analysis

indicates that the corresponding transition is polarized in the xz direction, which requires
the O,N-donor ligand to lie in the xz plane of the D tensor (Figure 4.18).

4.G. Resonance Raman Spectroscopy
Vibrational spectroscopy has proven valuable in the characterization of metalbound phenoxyl and semiquinone radicals.86,169-171 In the case of dioxolenecomplexes,
the C─O stretching frequency is a sensitive indicator of ligand oxidation state, ranging
from 1400-1500 cm-1 for semiquinones and 1620-1640 cm-1 for benzoquinones.172 By
contrast, the vibrational features of iminobenzo(semi)quinones have not been examined
in detail. We therefore collected resonance Raman (rR) spectra on frozen samples of
[6a]SbF6 in CD2Cl2 (Figure 4.19). The experiments utilized 488 nm laser excitation, in
resonance with the intraligand transitions that appear in this region (vide supra). To aid
in peak assignments, we prepared a sample of [6a]+ in which the O,N-ligand was labeled
with the 15N isotope; the difference spectrum revealed several peaks that are sensitive to
15

N substitution (Figure 4.19). Interpretation of the rR data was further aided by DFT

frequency calculations employing the BP functional.
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Figure 4.19. Resonance Raman spectra obtained with 488.0 nm excitation (45 mW) of
frozen CD2Cl2 solutions of (top) natural abundance [6a]SbF6 with incorporation of 15N
isotope in the LO,N ligand. The difference spectrum is shown on the bottom. Frequencies
(in cm-1) are provided for selected peaks, with the corresponding 14N→15N shifts shown
in parenthesis. Peaks marked with an asterisk (*) arise from the frozen solvent, while the
peak marked with a triangle arises from condensed liquid O2.

Based on literature precedents involving metal-semiquinone complexes,170,171 the
two isotopically sensitive peaks at 520 and 577 cm-1 in the [6a]+ spectrum are attributed
to motions of the five-membered chelate ring formed by the Fe center and O,N-ligand. In
support of this assignment, DFT predicts two modes at 532 and 588 cm-1 (with 15N
isotope shifts of 7 and 4 cm-1, respectively) with large degrees of chelate stretching
character. The mode at 520 cm-1 (calculated at 532 cm-1) is best described as a chelate
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breathing mode, whereas the chelate vibrations in the higher-energy mode are strongly
mixed with intraligand C─C bond movements. Graphical depictions of these normal
modes, along with further information concerning the computed vibrational spectrum, are
provided in Figure 4.20.

Figure 4.20. Normal modes, experimental and DFT-calculated frequencies, and
computed isotope shifts for 15N- and 18O-labeled ligand.
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Figure 4.21. Resonance Raman spectra obtained with 488.0 nm excitation (45 mW) of
frozen CD2Cl2 solutions of 4a (red) and [6a]SbF6 (black). Frequencies (in cm-1) are
provided for selected peaks.

The [6a]+ spectrum exhibits numerous peaks in the 1000-1650 cm-1 region. These
features are not present in the rR spectrum of 4a (Figure 4.21); we therefore conclude that
they arise from the oxidized O,N-ligand (an exception is the 1609 cm-1 peak, which
appears in both spectra). Studies of analogous semiquinone complexes170,171 found that
the most intense peaks in this region correspond to modes that couple O─C stretching
and C─C ring motions. Indeed, DFT predicts two ν(O─C)-based modes for [6a]+ at 1342
and 1404 cm-1 that are slightly sensitive to 15N substitution (calculated shifts of ≈ 1 cm-1).
These modes likely corresponding to the prominent peaks at 1308 and 1383 cm-1 in the
experimental spectrum. Modes with significant ν(N─C) character have computed
frequencies of 1319, 1384, and 1495 cm-1, with 15N isotope shifts of about 1-3 cm-1 in
each case. The two lower-energy modes nicely match the experimental peaks at 1279
and 1373 cm-1, while the higher-energy mode is not observed.
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Vibrational frequency calculations were also performed for the Ga-ISQ and GaIBQ possess O,N-ligands with unambiguous oxidation states (vide supra). DFT predicts
two ν(O─C) modes at 1319 and 1424 cm-1 for Ga-ISQ, while the corresponding modes
for Ga-IBQ possess much higher frequencies of 1540 and 1584 cm-1. Since the putative
ν(O─C) modes of [6a]+ have experimental energies of 1308 and 1383 cm-1, the rR data
appear to support an ISQ assignment for the ligand oxidation state.

4.H. Discussion
The results strongly support our earlier conclusion─made on the basis of XRD
and EPR data─that 2a contains a high-spin Fe2+ center antiferromagnetically coupled to
an tBuISQ ligand radical (overall spin of 3/2). Specifically, the presence of a ferrous ion
in 5a was verified by MB spectroscopy (δ = 0.97), and the unique absorption features
were shown to arise from tBuISQ ligand-based transitions. Although we were not able to
obtain a crystal structure of [8b]+, similarities between the spectral properties of 5a and
[8b]+ indicate that the complexes share identical electronic configurations. Analysis of
the more-oxidized [6a]+ and [9b]2+ species is less straightforward, since a preponderance
of the data indicate that actual electronic structures lie between the Fe 3+─ISQ and
Fe2+─IBQ limits. For instance, the O,N-ligand in the [9b]2+ crystal structure exhibits a
more pronounced quinoid distortion than expected for a typical ISQ ligand, and the
isomer shifts measure for [6a]+ and [9b]2+ (δave ≈ 0.68) are considerable outside the range
expected for high-spin ferric ions. However, the ν(O─C) frequencies observed by rR
spectroscopy are more consistent with an ISQ oxidation state.
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The unprecedented example of an Fe2+ center bound to an ISQ radical in
complexes 5a and [8b]+ is made possible by the combination of high-spin states and
trigonal-bipyramidal 5C geometries, which result in Fe centers with enhanced electron
affinities. Concerning the role of spin state, our DFT calculations indicate that isomers of
5a with intermediate- or low-spin centers converge to the alternate
Fe3+─amidophenolate(2─) configuration. The importance of coordination number is
highlighted by comparison to the six-coordinate (6C) [(LN4)Fe3+(ISQ)]2+ complexes
prepared by Wieghardt (where LN4 = cis-cyclam or tren).81,82 These complexes undergo
only ligand-based reductions to give the corresponding Fe3+ species with closed-shell
amidophenolate(2─) ligands, even when the Fe center is high-spin. To the best of our
knowledge, Wieghardt and coworkers have not explored the reduction of their fivecoordinate [Fe3+(ISQ)2X] complexes (X=Cl, Br, I, N3). However, the square pyramidal,
trianionic coordination environment likely lowers the potential of the Fe 3+ center,
favoring ligand-based reduction. These insights have implications for the Fe/O2/substrate
intermediate in the catalytic cycle of APDOs. Like 5a/[8b]+, this species contains a highspin center, yet it also has a 6C geometry due to the presence of the O 2 ligand. Thus,
extrapolation from the synthetic models would seem to favor the closed-shell electronic
structure of intermediate 1 in Figure 4.1. However, unlike Wieghardt’s [LN4)Fe3+(ISQ)]2+
models, the sixth ligand in the enzymatic intermediate (i.e., superoxide) is redox active
and electron withdrawing, and therefore capable of facilitating electron transfer from the
substrate ligand to the Fe center
Finally, it is worthwhile to consider why complexes like 5a/[8b]+ are viable,
whereas the corresponding Fe2+─SQ complexes have not been reported despite extensive
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efforts in modeling catechol dioxygenases. Indeed, a catecholate analogue of 5a has
already been reported and crystallographically characterized by Moro-oka, namely,
[Fe3+(tBuiPrTp)(DBC)] (where DBC = dianion of 3,5-di-tert-butylcatechol).107 Like 5a,
[Fe3+(tBuiPrTp)(DBC)] contains a trigonal bipyramidal Fe/Tp unit bound to a bidentate
“substrate” ligand; however, the catecholate lacks quinoid distortion (C─O bond lengths
of 1.35 and 1.38 Å), and the collective metric and spectroscopic data demand an
Fe3+─catecholate description. The divergent electronic structures of 5a and
[Fe3+(tBuiPrTp)(DBC)] point to the intrinsic difference in redox potentials between
catecholate and amidophenolate dianions. This difference may have mechanistic
implications for APDOs and ECDOs.

4.I. Conclusions
A variety of spectroscopic and computational methods have been employed to
evaluate the electronic structures of mononuclear Fe complexes bound to redox-active
ligands derived from 2-amino-4,6-di-tert-butylphenol (tBuAPH2). Our studies included
the Ph2Tp-supported complexes 5a and [6a]SbF6, as well as a parallel “b-series” of
complexes prepared with the neutral Ph2TIP supporting ligand (Figure 4.2). Utilizing
spectroscopic and DFT methods we have provided definitive evidence that complexes
5a/[8b]+ can best be described as a ferrous center bound to an ISQ radical. The higher
oxidized complexes [6a]+/[9b]+ while not as clear suggest that the oxidation state lies
between an ferric-ISQ and a ferrous-IBQ.
It is assumed the ECDOs and APDOs share a common catalytic mechanism;
however, our synthetic experience indicates that a species like intermediate II in Figure
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4.1 is more feasible for APDOs than ECDOs. Thus, the two catalytic cycles may differ at
this point, with the ECDOs adopting an intermediate I structure (as proposed by Ye and
Neese46) and the APDOs adopting an intermediate II structure with considerable radical
character on the substrate, exemplifying the mechanistic sophistication of the enzymes
catalytic mechanism.

4.J. Experimental
All reagents and solvents were purchased from commercial sources and used as
received, unless otherwise noted. Acetonitrile, dichloromethane, and tetrahydrofuran
were purified and dried using a Vacuum Atmospheres solvent purification system. The
synthesis and handling of air-sensitive materials were performed under inert atmosphere
using a Vacuum Atmospheres Omni-Lab glovebox. The ligands K(Ph2Tp),137 Ph2TIP,173
and tBuAPH2138 were prepared according to literature procedures.

15

N-labeled tBuAPH2

was prepared using 15NH4OH purchased from Cambridge Isotopes. Elemental analyses
were performed at Midwest Microlab, LLC in Indianapolis, IN.
Samples of [8b]OTf for spectroscopic studies were prepared by treating [7b]OTf
with one equivalent of TTBP●139 in CH2Cl2. After stirring for two hours, the green
solution was filtered and the solvent removed under vacuum. The resulting powder
exhibited the following peaks in the IR spectrum: 3342 [ν(N─H)], 3054, 1439, 1259,
1222 cm-1.
UV/Vis absorption spectra were obtained with an Agilent 8453 diode array
spectrometer; NIR absorption spectra were measured using an Agilent Cary 5000
spectrophotometer. Fourier-transform infrared (FTIR) spectra of solid samples were
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measured with a Thermo Scientific Nicolet iS5 FTIR spectrometer equipped with the iD3
attenuated total reflectance accessory. EPR experiments were performed using a Bruker
ELEXSYS E600 equipped with an ER4415DM cavity resonating at 9.63 GHz., an
Oxford Instruments ITC503 temperature controller, and an ESR-900 He flow cryostat.
MCD spectra were obtained using a Jasco J-715 spectropolarimeter in conjunction with
an Oxford Instruments SM-4000 8T magnetocryostat. Solid-state samples of [6a]SbF6
were prepared as uniform mulls in fluorolube. All MCD spectra were obtained by
subtracting the -7 T spectrum from the + 7 T spectrum to eliminate potential artifacts.
Resonance Raman spectra were measured using 488.0 nm excitation from a Spectra
Physics Ar+ laser (model 202505), with 45 mW at the sample point in a 180°
backscattering geometry. The sample was placed in a transparent quartz Dewar cell filled
with liquid nitrogen and spun at 800 rpm. Spectra were collected with the Spec-10
system (Princeton Instruments) installed on the 1269 spectrograph (SPEX Industries)
equipped with a standard 1200 grove/inch grating at 80 mm slit width. Spectra were
calibrated with fenchone and indene standards. Low-field (0.04 T) variable temperature
(5-200 K) Mӧssbauer spectra were recorded on a closed-cycle refrigerator spectrometer,
model CCR4K, equipped with a 0.04 T permanent magnet, maintaining temperatures
between 5 and 300 K. Mӧssbauer spectra were analyzed using the software WMOSS
(Thomas Kent, See Co., Edina, Minnesota). The samples were polycrystalline powders,
suspended in nujol, placed in Delrin 1.00 mL cups and frozen in liquid nitrogen. The
isomer shifts are quoted at 6 K with respect to iron metal spectra recorded at 298 K.
Cyclic voltammetric (CV) measurements were conducted in the glovebox with an
epsilon EC potentiostat (iBAS) at a scan rate of 100 mVs -1 with 100 mM (NBu4)PF6 A
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three-electrode cell containing a Ag/AgCl reference electrode, a platinum auxiliary
electrode, and a glassy carbon working electrode was employed. Under these conditions,
the ferrocene/ferrocenium (Fc+/0) couple has an E1/2 value of +0.52 V in CH2Cl2.
X-ray diffraction (XRD) data were collected with an Oxford Diffraction
SuperNova kappa-diffractometer (Agilent Technologies) equipped with dual microfocus
Cu/Mo X-ray sources, X-ray mirror optics, Atlas CCD detector, and low-temperature
Cryojet device. The data were processed with CrysAlis Pro program package (Agilent
Technologies, 2011) typically using a numerical Gaussian absorption correction (based
on the real shape of the crystal), followed by an empirical multi-scan correction using
SCALE3 ABSPACK routine. The structures were solved using SHELXS program and
refined with SHELXL program147 within Olex2 crystallographic package.148 B- and Cbonded hydrogen atoms were positioned geometrically and refined using appropriate
geometric restrictions on the corresponding bond lengths and bond angles within a
riding/rotating model (torsion angles of methyl hydrogens were optimized to better fit the
residual electron density).
DFT calculations were performed using the ORCA 2.8 software package
developed by Dr. F. Neese.174 Geometry optimizations employed either the Beck-Perdew
(BP86) functional175 or Becke’s three-parameter hybrid functional (B3LYP).142 Ahlrichs’
valence triple-ζ basis set (TZV), in conjunction with the TZV/J auxiliary basis set, 144,145
were used for all calculations. Time-dependent DFT (TD-DFT) calculations176-178
computed absorption energies and intensities within the Tamm-Dancoff
approximation.179 In each case, at least 60 excited states were calculated. Vibrational
frequency calculations were performed with a truncated [6a]+ model with hydrogen
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atoms at the 3- and 5-positions of the Tp ligand. Calculation of the harmonic force fields
proved that the optimized structure is a local minima on the approach described in
Rӧmelt et al.180; in these calculation, the size of the integration grid for Fe, O, and N
atoms was increased. The gOpenMol program146 developed by Laaksonen was used to
generate isosurface plots of molecular orbitals.
Ph2

TIPFe2+( tBuAPH)OTf ([7b]OTf): [Ph2TIPFe2+(CH3CN)3]OTf (1.1194 g,

0.927 mMol) and 4,6-di-t-butyl-aminophenol (205.1 mg, 0.927 mMol) were mixed in 10
mL of CH2Cl2. NEt3 (142 µL, 1.02 mMol) was added and the reaction allowed to stir
over night. The next morning the reaction was filtered and the solvent removed under
vacuum. The brown solid was taken up in mL toluene and the product precipitated with
excess pentane. The yellow solid was collected and was further washed with pentane.
The product was collected and dried to yield a bright yellow powder. % Yield 921.4mg,
86% UV-vis [λmax, nm (ε, M-1 cm-1) in CH2Cl2]: 399 (1163). IR (neat, cm-1): 3348, 3059,
2949, 2901, 2861, 1064, 1462, 1442, 1273, 1255, 1152, 1030.
Ph2

TIPFe2+( tBuAPH)BPh4 ([7b]BPh4): Ph2TIPFe2+( tBuAPH)OTf (125.3 mg, 0.108

mMol) in 4 mL MeOH was combined with NaBPh4 (37.6 mg, 0.110 mMol) in 3 mL
MeOH. Stirred for 15 minutes. The solid was collected as a yellow paste and dried
under vacuum. Crystals suitable for x-ray analysis were obtained by a 1,2-dichloroethane
and MeOH layering. % Yield: 83.1 mg, 58%. Elemental Analysis cald for
C86H81BFeN7OP: C, 77.88; H, 6.16; N, 7.39%; found: C, 76.70; H, 6.13; N, 7.13%. UVvis [λmax, nm (ε, M-1 cm-1) in CH2Cl2]: 815 (8.598). IR (neat, cm-1): 3340, 3050, 2948,
2863, 1578, 1478, 1443, 1379, 1305, 1264, 1142, 1074, 1023.
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Ph2

TIPFe3+(tBuISQ)OTf2 ([9b]OTf2): Ph2TIPFe2+( tBuAPH)OTf (184.1 mg, 0.159

mMol) and AgOTf (83 mg, .323 mMol) were stirred in 6 mL THF for 1 hour to give a
dark green solution. The solution was filtered through celite and the THF removed under
vacuum. The remaining dark green solid was taken up in 1,2-dichloroethane and layered
with hexanes. After several days dark green crystals formed. X-ray analysis confirmed
the correct structure. [λmax, nm (ε, M-1 cm-1) in CH2Cl2]: 798 (2506). IR (neat, cm-1):
3270, 3058, 2959, 1603, 1578, 1469, 1445, 1364, 1257, 1221, 1147, 1073, 1026.
Ph2

TPFe2+(DMAPH) (10a): 2-(N,N-Dimethylamino)-4,6-di-tert-butylphenol was

prepared according to the previously published procedure. 181 The aminophenol (174.8
mg, 0.701 mMol) was taken up in 5 mL of CH3CN while KTpPh2 (496.8 mg, 0.701
mMol) and Fe(OTf)2 (248.2 mg, 0.701 mMol) were taken up in 5 mL of CH2Cl2 and
CH3CN respectively. The aminophenol and KTpPh2 solutions were mixed and NEt 3 (108
µL, 0.774 mMol) was added. The Fe(OTf)2 solution was then added and the resulting
brown solution stirred overnight. The solvents were removed under vacuum the next day
and the solid taken up in 6 mL of CH2Cl2 and filtered. The solution was stored in a
freezer at -30C for several days to yield bright yellow crystals. % Yield: 160 mg, 24%.
Elemental Analysis cald for C61H60BFeN7O: C, 75.23; H, 6.21; N, 10.07%; found: C,
74.97; H, 6.18; N, 10.07%. UV-vis [λmax, nm (ε, M-1 cm-1) in CH2Cl2]: 365 (1955). IR
(neat, cm-1): 3056, 2948, 2855, 2637, 1545, 1462, 1412, 1356, 1302, 1264, 1246, 1167,
1060, 1028, 1007.
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Table 4.8. Summary of X-ray Crystallographic Data Collection and Structure Refinement
[7b]BPh4•1.5DCE

[9b](OTf)2•CH2Cl2

[10a]•4CH2Cl2

C89H87BCl3FeN7O

C65H62Cl2F6FeN7O7P

C65H68BCl8FeN7O

P

S2

formula weight

1474.68

1389.08

1313.56

crystal system

triclinic

monoclinic

monoclinic

space group

Pī

P21/c

P21/c

a, Å

17.32204(4)

20.0160(13)

17.1045(5)

b, Å

20.6267(4)

15.3008(11)

14.4938(5)

c, Å

22.0768(4)

22.2057(18)

26.5165(8)

α, deg

81.955(2)

90

90

β, deg

78.343(2)

94.320(8)

100.482(3)

, deg

87.958(2)

90

90

V, Å3

7649.0(3)

6781.4(9)

6464.0(3)

4

4

4

1.281

1.355

1.317

, Å

1.5418

0.7107

0.7107

µ, mm-1

0.376

4.010

4.987

-range, deg

7 to 59

7 to 148

7 to 146

reflections collected

101066

35453

41153

independent reflections

37578

13347

12682

[Rint = 0.0357]

[Rint = 0.0787]

[Rint = 0.0356]

37578/0/1889

13347/0/887

12682/30/793

GOF (on F2)

1.035

1.033

1.013

R1/wR2 (I>2σ(I))

0.0552/0.1469

0.0723/0.1786

0.0606/0.1488

R1/wR2 (all data)

0.0708/0.1608

0.1153/0.2105

0.0764/0.1588

empirical formula

Z
Dcalc, g/cm

3

data/restraints/paramet
ers
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Chapter 5

Dioxygen Reactivity of Biomimetic Fe(II) Complexes with
Noninnocent Catecholate, o-Aminophenolate, and oPhenylenediamine Ligands

Abstract: In this chapter we describe the O2 reactivity of a series of high-spin mononuclear
Fe(II) complexes each containing the facially coordinating tris(4,5-diphenyl-1methylimidazol-2-yl)phosphine (Ph2TIP) ligand and one of the following bidentate, redoxactive ligands: 4-tert-butylcatecholate (tBuCatH─), 4,6-di-tert-butyl-2-aminophenolate
(tBu2APH─), or 4-tert-butyl-1,2-phenylenediamine (tBuPDA). Each complex is oxidized in
the presence of O2, and the geometric and electronic structures of the resulting complexes
were examined with spectroscopic (absorption, EPR, Mӧssbauer, resonance Raman) and
density functional theory (DFT) methods.
Parts of the following chapter have appeared in the following paper Bittner, M. M.;
Lindeman, S. V.; Popescu, C. V.; Fiedler, A. T. Inorg. Chem. 2014.
All DFT calculations and rR experiments were performed by Dr. Adam Fiedler.
Mӧssbauer experiments were conducted by Codrina V. Popescu of Ursinus College.
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5.A. Introduction
Catechols and their nitrogen-containing analogs (o-aminophenols and ophenylenediamines; see Figure 5.1) are well established members of the “o-phenylene
family” of redox noninnocent ligands. 36-38,88,136,182-194 One-electron oxidation of these
bidentate ligands provides the corresponding (di)(imino)semiquinonate radicals, and twoelectron oxidation yields the closed-shell (di)(imino)benzoquinones. Complexes that
combine the noninnocent ligands in Figure 5.1 with redox-active metal center(s) often
possess ambiguous electronic structures, since multiple assignments of ligand and metal
oxidation states are possible. Thus, careful examination with a variety of experimental
and computational methods is usually required to obtain accurate electronic-structure
descriptions.85-87,89,159

Figure 5.1 Redox active o-Phenylene ligands and their varying electron configurations.
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While the role of o-phenylene ligands in electron-transfer series has been studied
extensively, their ability to facilitate proton-coupled electron transfers (PCETs) in
transition-metal complexes has received less attention. As shown in Figure 5.1, the free
compounds are able to donate a total of two protons (2H+) and two electrons (2e-) in
various combinations. Coordination to a redox-active metal center is expected to perturb
the chemical and electronic properties of these ligands, resulting in complexes with rich
and unpredictable PCET landscapes. Such complexes may find applications in chemical
processes that require multiple proton and electron transfers, including energy-related
reactions like water oxidation, hydrogen production, and nitrogen fixation. 195-200 For
instance, an iron complex with o-phenylenediamine ligands was recently shown to
undergo photochemical H2-evolution via PCET steps.201 Similarly, Heyduk et al. have
found that zirconium(IV) complexes with noninnocent bis(2-phenolato)amide ligands
react with O2 to yield [Zr4+2(µ-OH)2] species-a process that requires donation of 1H+ and
2e- from each ligand.202
Our interest in noninnocent ligands stems from efforts to prepare synthetic
mimics of mononuclear nonheme iron dioxygenases. These enzymes carry out the
oxidative ring cleavage of aromatic substrates (catechols, aminophenols, and
hydroquinones), and the catalytic cycles are thought to involve formation of a ferrous(substrate radical) intermediate.5,23,43,203 Earlier in this manuscript, we reported the
synthesis of two mononuclear Fe(II) complexes (4 and [7]OTf) that model the substratebound form of aminophenol dioxygenases. 173,204 The high-spin ferrous centers of 4 and
[7]+ are bound to the 2-amino-4,6-di-tert-butylphenolate (tBu2APH) “substrate,” and the
enzymatic coordination environment is replicated using a facially coordinating N3
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supporting ligand: hydrotris(3,5-diphenylpyroazol-1-yl)borate (Ph2TP) in the case of 4 and
tris(4,5-diphenyl-1-methylimidazol-2-yl)phosphine (Ph2TIP) in [7]OTf (see Figure 5.2).

Figure 5.2 Complexes discussed in this chapter.

These complexes were shown to engage in ligand-based H-atom transfer (HAT)
reactions to yield novel species containing an Fe(II) center coordinated to an
iminobenzosemiquinonate (tBu2ISQ) radical, thus providing synthetic precedents for the
putative Fe(II)/ISQ intermediate of the enzyme. The Fe(II)/ISQ complexes can be further
oxidized by one electron, although it has proven difficult to determine whether this
process is ligand- or iron-based. Detailed crystallographic, spectroscopic, and
computational analyses suggest that the fully oxidized species have intermediate
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electronic configurations between the Fe3+tBu2ISQ and Fe2+-tBu2IBQ limits,205 where
tBu2

IBQ is iminobenzoquinone with tert-butyl substituents at the 4- and 6- positions.
In this chapter, we expanded upon our previous studies by preparing monoiron(II)

Ph2

TIP-based complexes with ligands derived from catechol and o-phenylenediamine.

Like the o-aminophenolate studies described earlier, we began with the synthesis and Xray structural characterization of mononuclear, high-spin Fe(II) complexes, each
containing a bidentate ligand capable of both proton and electron transfer. The
catecholate complex [11]OTf was prepared using 4-tert-butylcatechol (tBuCatH2) and the
Ph2

TIP supporting ligand (Figure 5.2). The o-phenylenediamine complex [12](OTf)2 has

the overall formulation of [Fe(Ph2TIP)(tBuPDA)(OTf)2, where tBuPDA is 4-tert-butyl-1,2phenylenediamine. Each of the three Fe(II) complexes ([7]+, [11]+, and [12]2+) is airsensitive, and the products of the O2 reactions have been characterized with spectroscopic
(ultraviolet-visible (UV-vis) absorption, electron paramagnetic resonance (EPR),
Mӧssbauer, resonance Raman) and computational (density functional theory (DFT))
methods. These studies revealed that the identity of the ligand controls whether the O 2driven oxidation is an Fe- or ligand based process (or a combination of both). In
addition, O2 reaction rates vary by greater than 5 orders of magnitude across the series,
despite the fact that the overall structures of the Fe(II) complexes are quite similar. Thus,
this unique series of complexes has provided a valuable framework for exploring the
relationship between ligand-based PCET chemistry and the O2 reactivity of Fe
complexes. Implications for ring-cleaving dioxygenases are also discussed.
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5.B. Synthesis, Solid State Structures, and Spectroscopic Features
Reactions of [Fe( Ph2TIP)(MeCN)3](OTf)2 with tBuCatH2 or tBuPDA in THF
generated the Ph2TIP-based complexes [11]OTf and [12](OTf)2, respectively; the
synthesis of [11]+ also required 1 equiv. of NEt 3. Yellow crystals of [11]OTf were grown
by layering a 1,2-dichloroethane (DCE) solution with hexane. Recrystallization of
[12](OTf)2 by slow diffusion of Et 2O into a DCE solution provided colorless and
analytically pure material that was used in subsequent reactivity and spectroscopic
studies. Crystals for X-ray diffraction (XRD) analysis were obtained by either (i) slow
diffusion of Et2O into a concentrated MeCN solution of [12](OTf)2 or (ii) pentane
layering of a DCE solution, we were able to grow well-diffracting crystals with an overall
composition of [12](OTf)(BPh4). As shown in Figure 5.3, the X-ray structure of [11]OTf
features a five-coordinate (5C) Fe(II) complex with bidentate monoanionic catecholate
and facially coordinating Ph2TIP ligands. The [3]OTf unit cell contains two
symmetrically independent complexes, and metric parameters for both are provided in
Table 5.1 The Fe(II) coordination geometry is trigonal-bypyramidal for one cation (τ =
0.70)155 and distorted square-pyramidal (τ = 0.24) for the other.
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Figure 5.3. Thermal ellipsoid plot (50% probability) derived from the X-ray structure of
[11]OTf•2DCE. Counteranions, noncoordinating solvent molecules, and most hydrogen
atoms have been omitted for clarity.

The crystallographic data provide solid evidence that the catecholate ligand is
monoanionic. First, there is a significant difference in the lengths of the O1-C49 and O2C50 bonds (1.39 and 1.33 Å, respectively). Second, the tBuCatH ligand binds
asymmetrically with Fe1-O1 bond distances that are ~0.30 Å longer than the
corresponding Fe1─O2 distance of 2.23 ± 0.01 Å, while the anionic donor exhibits a
shorter Fe1─O2 distance of 1.92 ± 0.01 Å (Table 5.1). Such bond distances are generally
similar to those observed in the four previously reported Fe(II) complexes with
monoanionic catecholate ligands.206-209 The triflate counteranion forms a hydrogen bond
with the hydroxyl group of the tBuCatH ligand, consistent with the O1…O3(OTf) distance
of ~2.67 Å. The average Fe─N bond distance is 2.150 Å, similar to the corresponding
distances measured for the tBu2APH-based complex ([7]+) and indicative of a high-spin,
pentacoordinate Fe(II) complex.173 Consistent with this fact, the 1H NMR spectrum
displays paramagnetically shifted peaks ranging from 65 to -30 ppm (Figure 5.4).
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Figure 5.4. 1H NMR spectra of [11]OTf (top) and [12](OTf)2 (bottom) in CD2Cl2. Peak
intensities in the insets were enlarged (× 20) for the sake of clarity.
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Figure 5.5. Thermal ellipsoid plots (50% probability) derived from
[12](OTf)(BPh4)•DCE•C5H12 (top) and [12(MeCN)](OTf)•MeCN•Et2O (bottom).
Counteranions, noncoordinating solvent molecules, and most hydrogen atoms have been
omitted for clarity. The phenyl rings of the Ph2TIP ligands have also been removed to
provide a clearer view of the first coordination sphere.
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Table 5.1. Selected Bond Distances (Å) and Bond Angles (deg) for [11]+, [12]2+, and [13]+ Measured with X-ray Diffraction.
[11]OTf•2DCEa

[12](OTf)(BPh4) •DCE•C5H12

[12(MeCN)](OTf)•MeCN•Et2O

[13](OTf)•1.5CH2Cl2b

(A)

(B)

Fe1-N1

2.118(3)

2.121(3)

2.089(4)

2.174(2)

2.124(2)

Fe1-N3

2.124(3)

2.155(3)

2.115(3)

2.162(2)

2.120(2)

Fe1-N5

2.192(3)

2.192(3)

2.181(3)

2.227(2)

2.142(2)

Fe1-O1/N7

2.226(3)

2.241(3)

2.224(3)

2.237(2)

2.229(2)

Fe1-O2/N8

1.922(3)

1.938(3)

2.131(4)

2.246(2)

1.919(2)

Fe1-N9

2.214(2)

O1/N7-C49

1.390(5)

1.395(5)

1.445(5)

1.444(2)

1.390(3)

O2/N8-C50

1.323(5)

1.327(5)

1.458(5)

1.454(2)

1.336(3)

N1-Fe1-N3

93.5(1)

94.2(1)

95.3(1)

86.07(6)

94.03(7)

N1-Fe1-N5

91.3(1)

91.9(1)

84.5(1)

91.74(6)

89.20(7)

N3-Fe1-N5

85.4(1)

85.9(1)

91.1(1)

88.90(6)

85.81(7)

N1-Fe1-O1/N7

90.5(1)

102.3(1)

94.7(1)

167.47(6)

90.75(6)

N3-Fe1-O1/N7

90.7(1)

89.6(1)

96.9(1)

99.93(6)

90.21(6)

N5-Fe1-O1/N7

175.7(1)

165.4(1)

172.0(1)

89.59(6)

176.01(6)

N1-Fe1-O2/N8

130.7(1)

114.5(1)

145.3(1)

93.45(6)

124.35(7)

N3-Fe1-O2/N8

133.8(1)

1503(1)

119.2(1)

172.48(6)

139.32(7)

N5-Fe1-O2/N8

103.7(1)

100.0(1)

92.2(1)

96.87(6)

105.70(7)

O1/N7-Fe1-O2/N8

77.9(1)

77.4(1)

77.8(1)

75.38(6)

77.58(6)

τ-valuec

0.70

0.24

0.45

a

0.61

The [11]OTf•2DCE structure contains two symmetry-independent complexes per unit cell. Parameters are provided for both structures. bThe
[13]OTf•1.5CH2Cl2 structure contains two symmetry-independent complexes per unit cell. Since the structures are nearly identical, parameters
are only provided for one complex. cSee reference 39 for definition of the τ value.
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The two X-ray structures of complex [12]2+ shown in Figure 5.5 reflect the
different conditions under which the crystals were generated (vide supra). Crystals
grown in a DCE/pentane mixture contain a 5C dicationic Fe complex associated with one
OTf and one BPh4 counteranion, in addition to DCE and pentane solvent molecules
(Table 5.1). The coordination environment of the Fe(II) center is intermediate between
square-planer and trigonal-bipyramidal (τ = 0.45; Table 5.1). In contrast, the structure
arising from crystals grown in MeCN/Et 2O features a six-coordinate (6C) Fe(II) center
bound to a solvent-derived MeCN ligand in addition to Ph2TIP and tBuPDA (Figure 5.5).

Figure 5.6. Thermal ellipsoid plot (50% probability) derived from the X-ray structure of
[13]OTf•1.5CH2Cl2. Counteranions, noncoordinating solvent molecules, and hydrogen
atoms have been omitted for clarity.

The increase in coordination number lengthens the average Fe-NTIP bond distance
from 2.13 Å in [12]2+ to 2.19 Å in [12(MeCN)]2+. The tBuPDA ligand binds
symmetrically in the 6C structure (Fe-NPDA distance of 2.24(1) Å), while the Fe1-N7/N8
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distances differ by 0.093 Å in the 5C structure. The observed Fe-N bond lengths indicate
that the Fe(II) centers are high-spin in both structures. This conclusion is supported by
the corresponding 1H NMR spectrum (Figure 5.4) and the measured magnetic moment of
5.48 µB in CH2Cl2. The neutral charge of the tBuPDA ligands is confirmed by the
presence of N-C bond lengths of 1.45(1) Å, typical of aryl amines (anilide anions, in
contrast, exhibit N-C bond distances of ~1.39 Å). In both structures, the tBuPDA ring tilts
out of the plane formed by the N7-Fe1-N8 chelate by ~23°, and each triflate is hydrogenbonded to an amino group of tBuPDA.
As described below, the noninnocent nature of the o-phenylene ligands play an
important role in the reactions of the corresponding Fe(II) complexes with O 2. To
highlight this phenomenon, we prepared a “control” Ph2TIP-based Fe(II) complex with a
completely innocent ligand (i.e., one incapable of transferring either protons or
electrons). For this purpose we selected 2-methoxy-5-methylphenolate (Me2MP); this
ligand is structurally similar to tBuCatH, yet the second O-donor is methylated instead of
protonated. Complex [Fe2+(Ph2TIP)( Me2MP)]OTf, was prepared in a manner similar to
[11]OTf, and light green crystals were obtained by layering a CH 2Cl2 solution with
hexanes. The resulting structure reveals a 5C, high-spin Fe(II) center bound to Ph2TIP
and Me2MP in a distorted trigonal-bypyramidal geometry Figure 5.6. Importantly, the FeO/N bond distances measured for [13]+ are very similar to those found for [11]+ Table
5.1; like tBuCat, the Me2MP ligand binds in an asymmetric manner, with Fe-O distances of
1.92 and 2.23 Å. Thus, the overall structure of [13]+ closely resembles those in the ophenylene series. However, methylation of the –OH donor eliminates the possibility of
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ligand-based electron transfer (ET) and proton transfer (PT), and this change causes the
O2 reactivities of [11]+ and [13]+ to diverge in dramatic fashion (vide infra).
Voltammetric studies of the Fe(II) complexes were conducted in CH 2Cl2 at scan
rate of 100 mV/s with 0.1 M (NBu4)PF6 as the supporting electrolyte; redox potentials
were referenced to ferrocenium/ferrocene (Fc+/0). The CV of the catecholate complex
[11]+ displays an irreversible anodic wave at +740 mV (Figure 5.7) and a quasi-reversible
couple with E1/2 = -30 mV (peak-to-peak separation, ΔE, of 120 mV). Complex [13]+
exhibits a quasi-reversible event at nearly the same potential (-10 mV, ΔE = 145 mV),
consistent with the structural similarity between [11]+ and [13]+ noted above. In our
previous electrochemical studies of high-spin 5C Fe(II) complexes with Tp or TIP
ligands, the Fe2+/Fe3+ couple generally appears within 300 mV of the Fc+/0
reference.126,173,205,210 Thus, it is reasonable to assign the first oxidations of [3]+ and [5]2+
to the Fe2+/Fe3+ couple.
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Figure 5.7. Cyclic voltammograms for [11]OTf (top, black), [13]OTf (middle, red) and
[12](OTf)2 (bottom, grey) collected in CH2Cl2 with 0.1 M (NBu4)PF6 as the supporting
electrolyte and scan rate of 100 mV/s. The corresponding square-wave voltammogram
(dashed line) is also shown for [12](OTf)2. In all cases the voltammogram was initiated by
the anodic sweep.

By comparison, the cyclic voltammogram of the phenylenediamine complex
[12](OTf)2 is less well-defined, but two events are clearly evident at +70 and 560 mV in
the corresponding square-wave voltammogram (dashed line in Figure 5.7). We attribute
the low-potential peak to the Fe2+/Fe3+ couple, which appears ~100 mV higher than the
corresponding potentials for [11]+ and [13]+. This anodic shift is likely due to the neutral
charge of tBuPDA compared to the monoanionic tBu CatH and Me2MP ligands. The highpotential redox events for [11]+ and [12]2+ arise from oxidation of the catecholate or
phenylenediamine ligand, respectively. This assignment is consistent with a previous
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study by Lever et al., which found that the PDA ligand is oxidized at +500 mV (vs
saturated calomel electrode) when bound to a Ru(II) center.211 Both redox events are
irreversible for [12]2+; indeed, the electrochemical behavior of [12]2+ resembles that
reported previously for the o-aminophenolate complex 4, which likewise exhibits an
irreversible anodic wave near 0 mV, likely due to an ET-PT process.205 For reasons that
are not clear to us, complex [7]OTf failed to exhibit well-defined electrochemical
features; however, on the basis or prior results, 126 the Fe2+/Fe3+ potential of [7]OTf is
likely ~150 mV more positive than the corresponding potential of 4.

5.C. Reaction With Dioxygen
Pale yellow solutions of [11]OTf in CH2Cl2 undergo rapid color change upon
exposure to air, yielding the blue-green chromophore 11ox. The corresponding electronic
absorption spectrum, shown in Figure 5.8, consists of two broad bands at 700 and 905 nm
with ε-values of ~1100 M-1 cm-1. These spectral features are characteristic of ferriccatecholate(2-) complexes and arise from tBuCat → Fe(III) ligand-to-metal charge transfer
(LMCT) transitions.206,208,209 The EPR pectrum of 11ox displays two S = 5/2 signals with
E/D values of 0.14 and 0.25 (Figure 5.9), consistent with the presence of a high-spin
Fe(III) center. In addition, the Mössbauer (MB) spectrum of 11ox reveals two quadrupole
doublets with isomer shifts (δ) near 0.5 mm/s, typical of high-spin ferric ions (Table 5.2
and Figure 5.10). The doublets have different splittings (ΔE Q) of 0.82 and 1.24 mm/s.
The heterogeneity in E/D and ΔEQ values likely arises from different orientations of the
tBu

Cat ligand in the oxidized complex, similar to the situation observed in the solid state
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for [11]OTf. Collectively, the spectroscopic data indicate that 11ox has the formula of
[Fe3+(Ph2TIP)(tBuCat)OTf.

Figure 5.8. Time-resolved absorption spectra for the reaction of [11]OTf (top), [7]OTf
(middle), and [12](OTf)2 (bottom) with O2; spectra were collected at intervals of 1, 20,
and 14400 s, respectively. Each reaction was performed at room-temperature in O2saturated CH2Cl2 ([O2] = 5.8 mM). The path length of the cuvette was 1.0 cm.
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Figure 5.9. (a) Experimental X-band EPR spectrum of 11ox in CH2Cl2 collected at 10 K.
(b) Simulated spectrum generated with the program EasySpin4. Adequate simulation
required the presence of two S = 5/2 signals in a 2:1 ratio. The major and minor species
have E/D−values of 0.14 and 0.25, respectively.

Table 5.2. Experimental Mӧssbauer Parameters
complex isomer shift (δ) mm/s quadrupole splitting (ΔEQ) mm/s

reference

4

1.06

2.52

32

[7]OTf
7ox

1.06 (70%)/1.14(30%)
0.64

2.08/2.93
1.94

32
32

[11]OTf
11ox

1.08
0.53/0.50

2.05
0.82/1.24

this work
this work

[12](OTf)2
12ox

1.04 (75%)/1.05 (25%)
1.03 (40%)/1.18 (35%)a

3.13/2.53
1.98/3.24

this work
this work

a

The remaining intensity (25%) arises from the starting material, [12](OTf)2.
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Figure 5.10. Mössbauer spectra of complexes 11 and 11ox recorded at 5 K and 77 K,
respectively, in an applied field of 0.04 T. The solid lines represent spectral simulations
of the most important species in the spectra. The resulting parameters are provided in
Table 5.2. The lowest figure is a superposition of the 11 and 11ox spectra showing the
clear conversion of the Fe(II) complex into a species with an Fe(III) center.

In the presence of air, the distinctive absorption bands of 11ox exhibit first-order
decay with a half-life (t1/2) of 6300 s, eventually yielding a nearly featureless spectrum.
Previous studies of related complexes indicate that this decomposition corresponds to
oxidation of the catecholate ligand via one (or more) of the pathways shown in Figure
5.11.111,208,212
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Figure 5.11. Possible decomposition pathways of Fe(III)-catecholates.

To determine reaction products, the final mixture was analyzed after treatment
with acid and extraction into organic solvent (MeCN/Et2O). The extradiol cleavage
products, 4-tert-butyl-2-pyrone and 5-tert-butyl-2-pyrone, are generated in a 40:60 ratio
with an overall yield of ~30%, as determined by 1H NMR. These compounds were also
observed using GC-MS, although the isomers are indistinguishable by this technique.
When the reaction was performed with 18O2, the ion signal arising from the extradiol
products shifted upward by two mass units, providing conclusive evidence for
incorporation of one O atom from O2 (Figure 5.12). The 11ox reactivity conforms to the
previously established pattern that iron(III)-catecholate complexes with facial, tridentate
supporting ligands yield primarily extradiol products, while those with tetradentate
ligands provide intradiol products.107,206,213,214
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Figure 5.12. GC-MS data of the solution obtained from the reaction of [11]OTf with
16
O2 (top) and 18O2 (bottom).

Interestingly, while [11]+ converts to 11ox in a matter of seconds upon exposure to
O2, complex [13]+ is relatively stable in the presence of air. As shown in Figure 5.13, the
1

H NMR spectrum of [13]+ in CD2Cl2 features paramagnetically shifted peaks at 58 and -

10 ppm that arise from the Me2MP ligand. These peaks display only modest decreases in
intensity (relative to an internal standard) after exposure to O 2 for several days, indicating
that the geometric and electronic structures of [13]+ remain essentially intact in aerobic
solution.
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Figure 5.13. 1H NMR spectra of [13]OTf in CD2 Cl2. The insets display peak intensities
at 58 and -10 ppm measured at t = 0, 16, and 88 hours.
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Figure 5.14. Top: Absorption spectrum of [13]OTf measured in anaerobic CH2Cl2
(dashed red line). The black spectrum (solid line) was collected after exposure of the
same sample to O2 for 24 hrs. The grey spectrum (dashed) was obtained after treating
[13]+ with one equivalent of [acetyl-Fc+]BF4, where acetyl-Fc+ = acetylferrocenium. The
concentration of [13]+ was 0.40 mM in each case. Bottom: Plot of absorption intensity at
610 nm as a function of time for the reaction of [13]OTf with O2. The reaction was
performed in O2 saturated CH2Cl2 at room temperature ([Fe] = 0.40 mM). The solid line
is a linear fit of the kinetic trace. The pathlength of the cuvettes was always 1.0 cm.

UV-vis absorption spectra of [13]+ in O2 saturated CH2Cl2 were collected over a
span of 24 hours (Figure 5.14). These data revealed a gradual increase of absorption
intensity in the 500-900 nm region, which corresponds to formation of the ferric
complex, [Fe3+(Ph2TIP)(Me2MP)]2+ (13ox). The absorption spectrum of 13ox was measured
independently by treating [13]+ with 1 equiv. of an acetylferrocenium salt (Figure 5.14).
On the basis of these results, the conversion of [13]+ → 13ox is only 20% complete after
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24 hours. The stark contrast in O2 reactivities between [11]+ and [13]+ is remarkable
given that the two complexes possess very similar geometric structures and Fe 3+/Fe2+
redox potentials.
As shown in Figure 5.8, reaction of the o-aminophenolate complex [7]OTf with
O2 at room temperature generates a green chromophore (7ox) with absorption peaks at
790 and 420 nm. This spectrum is essentially identical to the one previously obtained by
treating [7]OTf with 2 equiv. of a one-electron oxidant (e.g., AgOTf).205 Thus, it is
reasonable to assume that 7ox corresponds to [Fe(Ph2TIP)(LO,N)]2+, where the electronic
structure can be described as either Fe3+-tBu2ISQ or Fe2+-tBu2IBQ (vide supra). These
results indicate that O2 is capable of extracting two electrons from [7]+, whereas initial
exposure of [11]+ to O2 involves only one-electron oxidation of the complex. In both
reactions, the ET process is associated with loss of a proton from the bidentate ligand.
Similar to 11ox, complex 7ox undergoes decomposition in the presence of O2, albeit at a
much slower rate (t 1/2 ≈ 18 hours).
The o-phenylenediamine complex [12](OTf)2 is comparatively less reactive
toward O2, requiring days (instead of minutes or hours) for complete oxidation. The
resulting complex, 12ox, displays an intense absorption band with λmax = 715 nm (ε =
4300 M-1 cm-1) and a weaker feature at ~500 nm (Figure 5.8). This deep-green species is
air-stable at room temperature, allowing for crystallization from a MeCN/Et 2O mixture.
Unfortunately, extensive disorder within the crystal has prevented the collection of a
high-resolution structure. The crude crystallographic data indicate that 12ox carries a +2
charge, based on the number of counteranions present. The complex is 5C with the
tBu

PDA-derived ligand bound in a bidentate manner, although sizable uncertainties in
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metric parameters preclude reliable evaluation of Fe or ligand oxidation states. Solutions
of 12ox are EPR silent with room-temperature magnetic moments of 5.14 μB indicative of
a S = 2 paramagnet. Since it was not possible to obtain a suitable X-ray crystal structure
of 12ox, we employed spectroscopic and computational techniques to gain insight into its
geometric and electronic structures, as described in the following section.

5.D. Spectroscopic and Computational Studies of 4 ox
Low-temperature (5 K) MB spectra of [12](OTf)2 collected before and after
exposure to O2 are shown in Figure 5.14. The parameters obtained from fitting the data
are provided in Table 5.2. The major component (75%) of the [12](OTf)2 spectrum is a
quadrupole doublet with an isomer shift (δ) of 1.04 mm/s and large splitting (ΔE Q) of 3.1
mm/s. A minor feature (25%) is also evident with δ- and ΔEQ-values of 1.05 and 2.5
mm/s, respectively. Both signals are characteristic of nonheme high-spin Fe(II) centers
with N/O coordination.
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Figure 5.15. Mӧssbauer spectra collected before and after exposure of [12](OTf)2 to O2
(top and bottom spectra, respectively). Both spectra were recorded at 5 K in an applied
field of 0.04 T. The solid red lines are least-squares fits to the experimental data using
the parameters in Table 5.2. Both spectra were fitted assuming nested doublets.
Approximately 25% of the area in the spectrum of the O2-exposed sample (bottom) was
ascribed to [12](OTf)2 starting material.

Given the nearly identical isomer shifts, the two doublets likely correspond to
conformational isomers of [12]2+ that adopt different geometries along the squarepyramidal to trigonal-bipyramidal continuum; indeed, similar “τ-strain” was observed in
our previous MB studies of [7]OTF.205 Upon exposure to O2 for 20 hours, new features
arising from 12ox become clearly evident (Figure 5.14), although starting material
remains. Adequate fitting of the new signal required two equally intense doublets with δ
= 1.03 and 1.18 mm/s and ΔEQ = 2.0 and 3.2 mm/s (Table 5.2). As with [12](OTf)2, the
observed heterogeneity is likely due to minor changes in coordination geometries.
Significantly, the MB data provide conclusive proof that the conversion of [12]2+ to 12ox
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by O2 does not involve oxidation of the Fe center, as the isomer shifts remain above 1.0
mm/s in the final complex.
With the MB data in hand, it is now possible to determine the oxidation state of
the tBuPDA-derived ligand in 12ox. Since the overall complex has a +2 charge, the ligand
itself must be neutral; thus, two possibilities exist: (diimino)benzosemiquinone radical or
(diimino)benzoquinone (tBuDIBQ). The former possibility is inconsistent with the EPRsilent nature of 12ox and its magnetic moment of 5.14 μB. Therefore, 12ox is best
formulated as [Fe2+(Ph2TIP)(tBuDIBQ)]2+ - a conclusion further supported by the DFT and
rR results described below. Similar to [7]+, complex [12]2+ is oxidized by two electrons
upon exposure to O2, although in the PDA system the electrons are derived exclusively
from the ligand, and two protons are removed.
Table 5.2 summarizes the MB parameters reported here (and previously) for
complexes 4-[12]2+ and their Xox counterparts. The electronic structures of the Fe(II)
precursors are quite similar, with isomer shifts of δ = 1.09 ± 0.05 mm/s and ΔE Q values
between 2.05 and 3.13 mm/s. In contrast, there is considerable variation in the Xox
parameters. Isomer shifts for 11ox and 12ox are characteristic of high-spin ferric and
ferrous ions, respectively, whereas the δ value of 7ox (0.64 mm/s) precludes an
unambiguous assignment of oxidation state, as noted above. Significantly, the MB
results reveal that the redox chemistry of these complexes spans the entire gamut from
iron-based to ligand-based oxidations.
Following the experimental data, the geometry optimization of 12ox assumed a 5C
geometry, S = 2 ground state, and overall charge of +2. Metric parameters for the
resulting model (12ox-DFT) are provided in Figure 5.16. The short N-C bond distances
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of 1.29 Å and “four long/two short” pattern of C-C bonds in the N,N-ligand are wellestablished characteristics of DIBQ units. 184,201,215-218 Mulliken populations revealed that
spin-density is found almost exclusively on the Fe center (3.88 α spins), while the
bidentate ligand is largely devoid of unpaired spin. The most relevant molecular orbital
(MO) for evaluating the 12ox-DFT electronic configuration is the highest-occupied (HO)
spin-down (β) MO, shown in Figure 5.15. The character of this MO is 74% Fe and 14%
N,N-ligand, with electron density from the Fe(II) center to the tBuDIBQ ligand, in
agreement with the MB data presented above.

Figure 5.16. (a) Bond distances (in Å) of the [Fe(DIBQ)] 2+ unit in the 12ox-DFT model.
(b) Isosurface plot of the spin-down (β) HOMO of 12ox-DFT.
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Figure 5.17. Left: Experimental (solid line) and TD-DFT computed (dashed line)
absorption spectra for 12ox. Right: Electron density difference maps (EDDMs) for
computed transitions. Blue and grey regions indicate gain and loss of electron density,
respectively.

To aid in band assignments, the absorption spectrum of 12ox-DFT was calculated
using TD-DFT. As shown in Figure 5.17, the computed spectrum exhibits two bands at
635 and 460 nm (ε = 5.4 and 2.2 M-1 cm-1, respectively) that correspond to features in the
experimental spectrum. The higher-energy band arises primarily from a tBuDIBQ-based
π-π* transition, as revealed in the electron density difference map (EDDM; Figure 5.17).
In contrast, the intense near-IR (NIR) band corresponds to an Fe(II) → tBuDIBQ MLCT
transition localized on the N7-Fe1-N8 unit.
The electronic structure of the tBuPDA-derived ligand in 12ox was further
examined using resonance Raman (rR) spectroscopy. Since the complex exhibits a pair
of prominent absorption bands, data were collected with two wavelengths of excitation
(λex): 647.1 nm light from a Kr+ laser was used to probe the NIR feature that arises from a
MLCT transition, while 488.0 nm light from an Ar + laser was selected to resonate with
the tBuDIBQ-based π-π* transition. The composite spectrum shown in Figure 5.18, was
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obtained by irradiating frozen samples of 12ox in CD2Cl2. In some samples, the bidentate
N,N-ligand was labeled with the 15N isotope at the 2-position to aid in peak assignments.

Figure 5.18. Resonance Raman spectra of 12ox in frozen CD2Cl2 solutions ([Fe] = 7.8
mM) collected with 647.1 nm (left) and 488.0 nm (right) laser excitation. The black
(solid) spectra were obtained using natural abundance (NA) complex, while the gray
(dashed) spectra were obtained using 15N-substituted complex (the 15N isotope was
incorporated at the 2-position of the PDA ligand). Frequencies (in cm−1) are provided for
select peaks in the NA spectra, and the corresponding 14N→15N shifts are shown in
parentheses. Peaks marked with an asterisk (*) arise from frozen solvent.

The low-frequency region of the 12ox spectrum features two intense peaks at 557
and 601 cm-1 with 15N isotope shifts of 2 and 8 cm-1, respectively (Figure 5.18). The 601
cm-1 peak is attributed to the breathing mode of the five-membered FeN2C2 chelate ring,
based on its intensity and sizable isotope shift. This assignment is supported by literature
precedents170,171,219 and DFT frequency calculations performed with the 12ox-DFT model
(computed frequencies and normal mode compositions are provided in Figure 5.19). The
smaller isotope shift of the 557 cm-1 peak suggests that the corresponding normal mode
involves substantial mixing of Fe-N stretching motions with internal C-N/C-C vibrations
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of the bidentate ligand. Both modes are strongly enhanced by excitation into the NIR
band at 715 nm, consistent with its assignment as an Fe(II) → tBuDIBQ MLCT transition.

Figure 5.19. Normal mode compositions, experimental and DFT-calculated frequencies,
and computed isotope shifts for the 15N-substituted ligand.

Compared to the metallocycle-based features, peaks arising from ligand-based
modes (ν ≅ 1200-1600 cm-1) are quite weak in the 12ox spectrum obtained with λex =
647.1 nm. However, the higher-energy peaks gain in relative intensity when λ ex is
changed to 488.0 nm, providing further confirmation that the absorption manifold near
500 nm arises from tBuDIBQ-based transitions. Three isotopically sensitive peaks are
apparent at 1384, 1413, and 1453 cm-1 (Figure 5.19). Prior rR studies of metal-dioxolene
complexes indicate that these peaks correspond to modes that couple ν(N-C) and ν(C-C)
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motions within the bidentate N,N-ligand.170,171,219 On the basis of its large 15N isotope
shift (8 cm-1), the experimental peak at 1384 cm-1 matches the DFT-computed mode at
1372 cm-1, which has primarily ν(N-C) character (calculated 15N isotope shift of 7 cm-1;
Figure 5.19). The peaks at 1413 and 1453 cm-1 then correspond to ν(C-C) motions of the
tBu

DIBQ ring with only minor amounts of ν(N-C) character. Similarly, Lever and co-

workers recently published the crystal structure and rR spectrum of
[Ru3+Cl2(NH3)2(DIBQ)]+, where DIBQ is unsubstituted (diimino)benzoquinone. 219 This
complex displays three peaks between 1400 and 1500 cm-1 that the authors attribute to
stretching modes of the DIBQ ligand. The presence of resonance enhanced peaks at
similar frequencies in the 12ox spectrum provides further evidence that his complex
contains a tBuDIBQ ligand.

5.E. Kinetic Analysis of O2 Reactivity
Kinetic studies were generally conducted in O2-saturated CH2Cl2 solutions ([O2]
= 5.8 mM at 20 °C140,220), and rates were measured by monitoring the growth of
absorption features associated with Xox species. To ensure a large excess of O2,
concentrations of the Fe(II) complexes never exceeded 1.0 mM. For the reactions of [7]+
and [11]+ with O2, initial rates increased linearly with Fe and O2 concentrations, indicating
that the reactions are first-order in both reactants (Figure 5.20 and 5.21). Interestingly,
while the [12]2+ + O2 reaction is also first-order in Fe concentration, the reaction rate
displays only minor variations as [O2] increases from 0.2 to 5.4 mM (Figure 5.21). This
zero-order [O2] dependence indicates that O2 binding is not the rate-limiting step in the
conversion of [12]2+ → 12ox.
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Figure 5.20. Plots of initial rates versus Fe concentration for the reactions of [11]OTf
(top), [7]OTf (middle), and [12](OTf)2 (bottom) with O2. All reactions were performed at
room temperature in O2-saturated CH2Cl2. Each data point represents one reaction.
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Figure 5.21. Plots of initial rates versus O2 concentration for the reactions of [11]OTf (top),
[7]OTf (middle), and [12](OTf)2 (bottom) with O2 . All reactions were performed at room
temperature in CH2Cl2. For reactions involving [7]OTf and [11]OTf, the Fe concentration
was fixed at 0.36 mM; for [12](OTf)2, the observed initial rate was divided by the Fe
concentration. Each data point represents one reaction.
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As shown in Figure 5.22, the reaction of [11]OTf with O2 at ambient temperature
proceeds via pseudo-first-order kinetics with a rate constant (k1) of 0.67(5) s-1. The
formation of 7ox and 12ox under the same conditions is more complex, however, as
indicated by the “S-shaped” kinetic traces (Figure 5.22). This behavior suggests that
these species are generated via multistep mechanisms involving both ET and PT-a
common occurrence for reactions that require net hydride (7ox) or H2 transfer (12ox).221,222
Because of this mechanistic complexity, k1 values for the reactions of O2 with [7]+ and
[12]2+ were measured using the initial rates approach. Interestingly, the rates of
formation span more than 5 orders of magnitude, with k 1 values of 0.67(5) (11ox), 1.3(2)
× 10-3 (7ox), and 4(2) × 10-6 s-1 (12ox) in O2-saturated CH2Cl2 at room temperature. We
also measured an initial rate of 5 × 10-6 s-1 for the one-electron oxidation of [13]+ to 13ox
(Figure 5.14). Thus, despite similar structures, the complexes examined here differ
dramatically in their O2 reactivities.
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Figure 5.22. Plots of absorption intensity as a function of time for the reactions of [11]OTf
(top), [7]OTf (middle), and [12](OTf)2 (bottom) with O2. All reactions were performed in
O2-saturated CH2Cl2 at room temperature ([Fe] ≈ 0.50 mM).
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Activation parameters for the [7]OTf + O2 reaction were determined by
measuring rates at temperatures between 22 and -30 °C. The linear Eyring plot (Figure
5.23) indicates an activation enthalpy (ΔH‡) of 12(2) kcalmol-1 and a large negative
activation entropy (ΔS‡) of -22(5) kcalmol-1. Such values are similar to parameters
obtained for similar Fe/O2 adducts223 (Because of its fast nature, it was not possible to
measure accurate activation parameters for the reaction of [11]+ with O2 using
conventional methods) and are consistent with an associative reaction involving O 2
binding to the Fe center as the rate-determining step.

Figure 5.23. Eyring plot for the reaction of [7]OTf with O2 in O2-saturated CH2Cl2 over a
temperature range of 22 °C to -30 °C. Second-order rate constants (k2) were obtained by
dividing the pseudo-first order constant by [O2] at the specified temperature. Each data
point represents one reaction.
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In previous sections, we demonstrated that formation of the oxidized species 7ox,
11ox, 12ox under aerobic conditions requires both electron and proton transfers from the
parent complexes, although the rates of O2 reaction vary by a factor of 105 across the
series. Thus, it is plausible that the O2 activation mechanisms involve a combination of
electron and proton transfer from the complexes to either dioxygen or superoxide. We
therefore examined the reactivity of the title complexes with two well-established H-atom
acceptors: TEMPO and 2,4,6-tri-tert-butylphenoxyl radical (TTBP). Both reagents
exhibit a strong propensity to react via PCET mechanisms, but TTBP  is a much more
effective H-atom abstractor than TEMPO, as indicated by the bond dissociation free
energies (BDFE) of the resulting H-O bonds (BDFE = 77.1 and 66.5 kcal/mol,
respectively, in MeCN).224
Treatment of [11]+ with either TEMPO or TTBP yields a blue-green species
with absorption features identical to those observed for 11ox (Figure 5.24). Given the
formulation of 11ox as [Fe3+(Cat)(Ph2TIP)]+, this reaction is classified as “separated
PCET” because the electron and proton originate from different units of the [11]+
complex, namely, the Fe(II) center and CatH ligand. While complexes [7]+ and [12]2+ are
inert toward TEMPO, both react rapidly with TTBP. As described in Chapter 4 TTBP
removes a hydrogen atom from the tBu2APH ligand of [7]+ to generate the corresponding
Fe(II)-tBu2ISQ complex. Complex [12]2+ reacts with 2 equiv. of TTBP to provide a
species with spectral features that are similar to those of 12ox, although not identical
(Figure 5.25). This chromophore is evident by UV-vis spectroscopy even when a single
equivalent of TTBP is added; this result suggests that the species generated by removal
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of one H-atom from [12]2+ undergoes disproportionation to yield the starting complex
and a 12ox-like species.

Figure 5.24. Absorption spectra obtained by treating [11]OTf with TEMPO• (solid line)
or O2 (dashed line) in CH2Cl2 at room temperature.
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Figure 5.25. Absorption spectra of [12](OTf)2 (solid red line) and 12ox (dashed black line)
compared to the one obtained by treating [12](OTf)2 with two equivalents of TTBP• (solid
black-line). All spectra were collected in CH2Cl2 at room temperature ([Fe] = 0.50 mM in
each case). The pathlength of the cuvette was 1.0 cm.

It is noteworthy that [11]+ is the only complex in the series capable of donating a
H-atom to TEMPO, indicating that the [11ox-H] bond is very weak (BDFE < 66
kcal/mol). Bordwell and Mayer have demonstrated that the BDFE of the X-H bond
formed in a 1H+/1e- PCET reaction (i.e., X + H+ + e- → X-H) is given by the following
equation:
BDFE(X-H) = 1.37pKa + 23.06E° + CG,solv

where CG,solv is a solvent-dependent constant.224,225 In our case, the relevant parameters
are the E° values of the starting Fe(II) complexes and the pKa values of the one-electron
oxidized species. The complexes examined here exhibit greater variability in ligand
acidities than in redox potentials. As described above, initial redox potentials differ by
~100 mV across the series, accounting for a modest shift of ~2.5 kcal/mol in BDFE. In
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contrast, the pKa values of aromatic amines are generally ~12 units higher than the
corresponding phenols−a shift of 14 kcal/mol in BDFE. 224,226,227 Thus, while the
differences in redox potential cannot be ignored, the weaker H-atom donating ability of
complexes [7]+ and [12]2+ compared to [3]+ is largely due to the greater acidity of the
tBu

CatH ligand relative to tBu2APH and tBuPDA.
These results have mechanistic implications for the O2 reactivity of the complexes

examined here. The strength of the [3ox−H] bond is comparable to that of perhydroxyl
radical (HO2), which is the product of HAT and O2 (BDFE of HO2− ≅ 60 kcal/mol).224
Therefore, complex [3]+ may be able to react directly with O2 via 1H+/1e− PCET without
prior formation of a ferric-superoxo intermediate. By contrast, complexes [7]+ and
[12]2+ cannot participate in HAT reactions with O2 due to the greater strength of their
N−H bonds. For these complexes, O2 activation likely requires initial ET from Fe(II) →
O2, followed by oxidation of the ligand via concerted (or stepwise) electron and proton
transfers. These mechanistic scenarios are considered further in the discussion section.

5.F. Computational Studies of O2 Reactivity
The thermodynamics of O2 binding were examined with DFT calculations. A
previous study by Schenk et al. found that hybrid functionals with a reduced amount
(~10%) of Hartree-Fock (HF) exchange are most reliable for evaluating energetics of O 2
(or NO) binding to nonheme Fe(II) centers.228 We therefore employed the PBE
functional229 with 10% HF exchange to calculate geometries and thermodynamic
parameters for O2, the Fe(II) precursors, and the 6C [Fe/O2] adducts. Since exchange
interactions between the unpaired electrons of Fe and O2 give rise to three possible spin
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states (Stot = 1, 2, 3), it was necessary to optimize three models for each [Fe/O 2] species.
The resulting S = 2 [Fe/O2] structures are shown in Figure 5.26. (Tables 5.3−5.5 provide
metric parameters for each model.) The [12/O2]2+ adduct is dissociative on the S = 3
surface, with calculations invariably converging to structures with very long Fe …O
distances (>3.75 Å).

Figure 5.26. DFT-calculated structures of the Fe/O2 adducts. Selected bond distances (Å)
and angles are provided (see Tables 5.3−5.5 for additional metric parameters).
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Table 5.3. Selected Bond Distances (Å) and Angles (deg) for Complex [7]+ and the
corresponding [Fe/O2]+ Species (Stot = 3,2, and 1) Obtained by DFT Calculations.

Bond Lengths

Angles

[7]+

[7/O2]+

[7/O2]+

[7/O2]+

Spin

S=2

S=3

S=2

S=1

Fe1-N1(TIP)

2.148

2.158

2.181

2.187

Fe1-N3(TIP)

2.173

2.301

2.281

2.279

Fe1-N5(TIP)

2.206

2.243

2.264

2.193

Fe1-O(APH)

1.903

1.915

1.895

1.937

Fe1-N(APH)

2.282

2.254

2.260

2.262

Fe1-O(O2)

2.182

1.946

2.095

O─O

1.263

1.268

1.246

Fe1-N(TIP) ave

2.176

2.234

2.242

2.220

Fe1-L(all) ave

2.142

2.176

2.138

2.159

132.8

128.5

120.1

Fe─O─O

Table 5.4. Selected Bond Distances (Å) and Angles (deg) for Complex [11]+ and the
corresponding [Fe/O2]+ Species (Stot = 3,2, and 1) Obtained by DFT Calculations.

Bond Lengths

Angles

[11]+

[11/O2]+

[11/O2]+

[11/O2]+

Spin

S=2

S=3

S=2

S=1

Fe1-N1(TIP)

2.122

2.131

2.151

2.156

Fe1-N3(TIP)

2.138

2.214

2.223

2.177

Fe1-N5(TIP)

2.156

2.181

2.203

2.158

Fe1-O(CatH)

1.871

1.895

1.879

1.873

Fe1-N(CatH)

2.482

2.606

2.435

2.727

Fe1-O(O2)

2.133

1.960

2.126

O─O

1.250

1.266

1.247

Fe1-N(TIP) ave

2.139

2.175

2.192

2.164

Fe1-L(all) ave

2.154

2.193

2.142

2.203

139.6

125.5

121.5

Fe─O─O
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Table 5.5. Selected Bond Distances (Å) and Angles (deg) for Complex [12]2+ and the
corresponding [Fe/O2]+ Species (Stot = 2, and 1) Obtained by DFT Calculations.

Bond Lengths

[12]+

[12/O2]2+

[12/O2]2+

Spin

S=2

S=2

S=1

Fe1-N1(TIP)

2.175

2.173

2.181

Fe1-N3(TIP)

2.168

2.166

2.168

Fe1-N5(TIP)

2.126

2.209

2.155

Fe1-O(CatH)

2.209

2.205

2.201

Fe1-N(CatH)

2.212

2.205

2.201

Fe1-O(O2)

1.994

2.128

O─O

1.249

1.228

2.156

2.183

2.168

2.178

2.159

2.172

126.9

122.1

Fe1-N(TIP)
ave
Fe1-L(all) ave
Angles

Fe─O─O

In all other cases, O2 coordinates in a bent conformation with Fe−O−O angles
between 120 and 140° and Fe−O distances ranging from 1.95 to 2.18 Å. The O2 ligand
can adopt two possible orientations depending on whether the O−O vector is pointed
toward (T) or away (A) from the bidentate ligand. The two orientations are
approximately isoenergetic with differences less than the estimated error of the
calculations (±2 kcal/mol). In the remainder of this chapter, only the T isomers of the
[Fe/O2] adducts are discussed, since these models are more relevant from a mechanistic
standpoint.
Table 5.6 summarizes the computed thermodynamic parameters for the eight
Fe(II) + O2 → [Fe/O2] reactions considered here. While the enthalpic contributions
(ΔHgas + ΔSolv) are slightly favorable in most instances, all of the reactions are
endergonic (ΔG = +7.0−13.0 kcal/mol) due to large and unfavorable entropic effects. A
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similar pattern has been observed in DFT studies of O2 binding to nonheme Fe(II)
enzymes, where the calculated ΔG values range between +8 and 12 kcal/mol. 46,230-232 To
understand why the O2 binding reactions are decidedly “uphill”, it is instructive to
examine the computed properties of the O−O bonds in the [Fe/O 2] intermediates.
Superoxide ligands typically exhibit O−O bond distances near 1.3 Å and ν(O−O)
frequencies between 1050 and 1200 cm-1.233 In contrast, our DFT-generated [Fe/O2]
models have short O−O distances of 1.25 ± 0.02 Å and ν(O−O) frequencies greater than
1250 cm-1 (Table 5.3), indicating that there is only partial charge transfer from Fe(II) to
the O2 ligand. The weakness of the Fe−O2 interactions is also reflected in the low
ν(Fe−O) frequencies, which range between 230 to 370 cm-1.

Table 5.6. Energetics of O2 Binding to Complexes [7]+, [11]+, [12]2+, and Comparison of
O─O Bond Distances and Stretching Frequencies in the Resulting Fe/O 2 Adductsa
reactants

spin (Stot)

ΔHgas

TΔS

ΔSolvb

ΔGc

r(O─O)(Å)

ν(O─O)(cm-1)

[11]+ + O2

S =3

-0.5

-11.9

-0.1

+11.3

1.25

1287

S=2

-0.2

-12.2

-1.1

+10.9

1.27

1260

S=1

-1.6

-11.7

+0.2

+10.3

1.25

1287

S=3

-2.0

-10.0

-1.1

+6.9

1.26

1254

S=2

-1.4

-10.9

-1.7

+7.8

1.27

1251

S=1

-2.9

-11.4

-0.2

+8.3

1.25

1303

S=2

+4.0

-11.3

-2.3

+13.0

1.25

1328

-1.8

-12.2

+0.4

+10.8

1.23

1406

[7]+ + O2

[12]2+ + O2

S=1
a
c

b

All energies in kcal/mol. Enthalpies of solvation were calculated using COSMO.
ΔG = ΔHgas + ΔSolv ─ TΔS

On the basis of the DFT calculations, complex [7]+ has the greatest affinity for O2,
followed in the series by [11]+ and [12]2+ (Table 5.6). This trend correlates with the
relative donor strengths of the bidentate ligands (APH− > CatH− > PDA) because
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formation of the Fe−O2 bond requires transfer of electron density from an Fe d orbital to
an empty O2 π* orbital. However, our DFT results appear to contradict the kinetic studies
reported above, which found that [11]+ is significantly more reactive than [7]+ toward O2.
Possible explanations for this discrepancy are provided in the following section.

5.G. Discussion
In this chapter, we described the O2 reactivity of monoiron(II) complexes bound
to three types of o-phenylene ligands (Figures 5.1 and 5.2). The complexes resemble the
substrate-bound intermediates of nonheme Fe(II) dioxygenases that catalyze the oxidative
ring-cleavage of aromatic substrates.5,23,203 The Ph2TIP supporting ligand mimics the
facial triad of protein ligands in the active site and the substrate ligands each coordinate
in a bidentate manner, resulting in 5C Fe(II) complexes capable of O 2 binding. In chapter
4, we demonstrated that one- and two-electron oxidation of the tBu2APH-based complex
[7]OTf yields species containing (imino)benzosemiquinone ligands. Like
aminophenolates, catecholates and phenylenediamines can serve as redox-active ligands,
although the ease of oxidation of the free ligands increases across the series CatH 2 <
APH2 < PDA. We therefore synthesized and structurally characterized the homologous
complexes [11]OTf and [12](OTf)2 to better understand the role of redox-active ligands
in modulating the O2 reactivity of Fe complexes. The ligands are capable of donating
protons as well as electrons, but the acidities run counter to the redox potentials. In other
words, the most acidic ligand (tBuCatH2) is the hardest to oxidize, while the most reducing
ligand (tBuPDA) is the least acidic. This interplay between ET and PT capabilities
influences the rates of the O2 reactions as well as the identities of the oxidized products.
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Despite similar overall structures, the three Fe(II) complexes in this study display
remarkable diversity in their O2 reactivities, as summarized in Figure 5.27. The
differences concern both the total number of electrons transferred in the reaction (1e − or
2e−) and the source of these electrons (iron and/or ligand). The resulting Xox species have
been characterized by various spectroscopic (UV−vis, EPR, MB, rR) and computational
(DFT) methods. These results indicate that the [11]+ → 11ox conversion is an Fe-based
1e− process, while the [12]2+ → 12ox reaction involves 2e− oxidation of the ligand only.
The [7]+ → 7ox reaction occupies an intermediate position, since substantial electron
density is lost from both the Fe center and tBu2AP ligand. This continuum in electronic
structures is evident in the isomer shifts (δ) of the Xox species (Table 5.2), which range
from 0.50 (11ox, Fe3+) to 0.64 (7ox, Fe2.5+) to ~1.1 (12ox, Fe2+) mm/s. In addition, each of
the three possible o-phenylene oxidation states (aromatic, semiquinone, benzoquinone;
Figure 5.1) is represented in the Xox series. Thus, the [Fe2+(Ph2TIP)(o-phenylene)]
framework supports a wide spectrum of redox and O2 chemistry.
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Figure 5.27. Summary of diverse O2 reactivity displayed by our complexes.

Our kinetic analysis revealed that O2 reaction rates vary by a factor of 105 across
the series, following the order [11]+ ˃ [7]+ ˃ [12]2+. It is somewhat counterintuitive that
this order is inversely related to the electron-donating abilities of the free ligands.
Moreover, these rates fail to correlate adequately with Fe2+/3+ redox potentials, all of
which fall within a 100 mV range near 0 mV (vs Fc+/0). Finally, if one assumes that
formation of the Fe/O2 adduct is the rate-determining step, then our DFT calculations of
O2-binding affinities indicate that [7]+ should be more reactive than [11]+, even though
the kinetic data indicate that the reverse is true.
We believe these conflicting results can be reconciled by considering the role of
PT in the O2 reaction. The fact that [11]+ undergoes HAT with TEMPO─a very weak Hatom acceptor suggests that ET and PT processes are tightly coupled in the [11]+ + O2
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reaction. A likely mechanism involves concerted transfer of 1e ─ and 1H+ to O2 as it
approaches the Fe center. In contrast, the intrinsically lower acidity of aromatic amines
(relative to phenols) prevents PT in the initial interaction of O 2 with [7]+ and [12]2+.
Deprotonation of these ligands in the course of the O2 reaction likely requires complete
oxidation of the Fe center to lower the pKa of the amino group(s). Thus, these complexes
cannot avoid the thermodynamically uphill ET from Fe(II) to O 2; yet once the ferric
complex is generated, proton loss to superoxide or bulk solvent would be feasible, as
indicated by the CV data (vide supra). Importantly, deprotonation destabilizes the redoxactive MOs of the ligand, making it possible for O2 to extract a second electron, thus
generating the final 7ox and 12ox products. Thus, we propose that the [7]+ → 7ox
conversion proceeds via a stepwise ET─PT─ET mechanism, although PT may be
coupled with the second ET in a HAT reaction. This mechanism follows the one
established by Paine et al. for the oxidation of [Fe2+(L)(tBu2APH)] to [Fe3+(L)(tBu2ISQ)]+
in the presence of O2 (where L is the tris(2-pyridylthio)methanido anion).234
The enormous contrast between the O2 reactivites of [11]+ and [13]+ provides the
clearest evidence for the decisive role of PT in determining reaction rates of the ophenylene complexes. These two complexes have nearly identical coordination
geometries and Fe3+/2+ redox potentials; however, replacing the ─OH group of tBuCatH
with the ─OCH3 donor of Me2MP decreases the O2 reaction rate by 5 orders of
magnitude. Indeed, complex [13]+ is quite stable in the presence of air, even though slow
oxidation to the ferric analog (13ox) is observed over the course of days. These results
provide further confirmation that the one-electron oxidation of high-spin Fe(II) centers by
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O2 is an unfavorable process, but the overall reaction barrier can be lowered substantially
if the ET is coupled with PT (in either a stepwise or concerted manner).
The 11ox intermediate reacts further with O2 to yield products arising from
extradiol ring cleavage. Previous studies have proposed a mechanism that involves direct
reaction of the [Fe3+(Cat)]+ unit with O2 to form a ferric-alkylperoxo species, followed by
rearrangement to the corresponding lactone (Figure 5.28a).111,212 In contrast, 7ox and 12ox
are relatively air-stable, since they lack the two reducing equivalents necessary to
generate the critical alkylperoxo intermediate. Interestingly, Paine and co-workers
recently reported a 6C complex, [Fe2+(6-Me3-TPA)(tBuAPH)]+, that (unlike [7]+) reacts
with O2 to yield the ring-cleaved product (6-Me3-TPA = tris(6-methyl-2pyridylmethyl)amine).235 The proposed mechanism is analogous to the one employed by
ferric-catecholate complexes. Paine’s system differs from the one described here in that
the initial product of the O2 reaction is an [Fe3+(AP)]+ species, whereas our studies
indicate that [7]+ likely converts to a [Fe2+(ISQ)] intermediate. This difference in
electronic structure apparently controls subsequent reactivity, with the latter species
undergoing simple 1e─ oxidation and the former direct addition of O2.
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Figure 5.28. (a) Proposed mechanism for the formation of a ferric-alkylperoxo
intermediate leading to ring-cleavage products. (b) Condensed mechanism utilized by
ring-cleaving dioxygenases.
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5.H. Conclusions
The results presented here highlight the mechanistic sophistication of the ringcleaving dioxygenases. Figure 5.28b provides a condensed version of the canonical
enzymatic mechanism. A recent DFT study by Christian et al. of extradiol catechol
dioxygenases has emphasized the role of the conserved second-sphere histidine residue in
the PT steps that occur after O2 binding.236 This residue first deprotonates the substrate
ligand, resulting in an imidazolium group that stabilizes the superoxide ligand through Hbonding interactions. The proton is eventually returned to the O 2 unit after formation of
the bridging alkylperoxo intermediate (Figure 5.28b). Thus, the enzyme carefully
“manages” the PT events to promote O2 activation and discourage the autoxidation
processes observed in our models. Indeed, studies of homoprotocatechuate 2,3dioyxgenase (HPCD) have demonstrated that if the His200 residue is mutated to Ala, the
enzyme generates quinone and H2O2 instead of the ring-cleaved products.44 Therefore,
the critical difference between the ring-cleaving dioxygenases and the synthetic models
reported here (and elsewhere) is the ability to coordinate PT with O 2 activation.
It is noteworthy that none of the synthetic dioxygenase models prepared to date
follow the enzymatic mechanism in proceeding through an Fe/O 2 adduct. Even for those
complexes that carry out ligand cleavage, like [11]OTf, the first step always involves 1e─
oxidation to the ferric complex followed by direct reaction of the ligand with O 2. The
enzyme not only stabilizes the [FeO2] adduct through H-bonding interactions, it also
prevents formation of the dead-end intermediate that arises when the substrate proton is
transferred to O2●─ instead of H200.44,45 In this study, we have shown that PCET is an
effective strategy for bypassing the unfavorable ET from Fe(II) to O 2; however, in the
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case of [11]OTf, the PCET reaction does not lead to formation of the Fe(II)-alkyperoxo
intermediate (as in the enzyme) because the resulting superoxide moiety has been
deactivated through protonation, By coupling O2 binding with PT to a second-sphere His
residue, the dioxygenases reap the energetic benefits of PCET while avoiding the pitfall
that has plagued synthetic models. Future modeling efforts should therefore be directed
toward the generation of complexes capable of mimicking the enzyme’s exquisite control
of PT reactions.

5.I. Experimental
Reagents and solvents were purchased from commercial sources and were used as
received, unless otherwise noted. Air-sensitive materials were synthesized and handled
under inert atmosphere using a Vacuum Atmospheres Omni-Lab glovebox. The Ph2TIP173
and tBuAPH2138 ligands and the 2,4,6-tri-tert-butylphenoxyl radical139 (TTBP) were
prepared according to literature procedures. Synthetic procedures for complexes
[Fe(Ph2TIP)(MeCN)3](OTf)2,173 4,204 and [7]OTf205 were reported earlier in this
manuscript.
Elemental analyses were performed at Midwest Microlab, LLC in Indianapolis,
IN. UV─absorption spectra were measured with an Agilent 8453 diode array
spectrometer equipped with a cryostat from Unisuko Scientific Instruments (Osaka,
Japan). Fourier-transform infrared (FTIR) spectra of solid samples were obtained with a
Thermo Scientific Nicolet iS5 FTIR spectrometer equipped with the iD3 attenuated total
reflectance accessory. 1H and 19F NMR spectra were recorded at room temperature with
a Varian 400 MHz spectrometer.

19

F NMR spectra were referenced to the
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benzotrifluoride peak at ─63.7 ppm. Mass spectra were collected using an Agilent 6850
gas chromatography─mass spectrometer (GC-MS) with a HP-5 (5%
phenylmethylpolysiloxane) column. Cyclic voltammetric (CV) measurements were
conducted in the glovebox with an epsilon EC potentiostat (iBAS) at a scan rate of 100
mV/s with 100 mM (NBu4)PF6 as the supporting electrolyte. The three electrode cell
contained a Ag/AgCl reference electrode, a platinum auxiliary electrode, and a glassy
carbon working electrode. Potentials were referenced to the ferrocene/ferrocenium
(Fc+/0) couple, which has E1/2 values of +0.52 V in CH2Cl2 under these conditions.
EPR experiments were performed using a Bruker ELEXSYS E600 featuring an
ER4415DM cavity that resonates at 9.63 GHz, an Oxford Instruments ITC503
temperature controller, and an ESR-900 He flow cryostat. The program EasySpin302C
was used to simulate and fit experimental spectra. Resonance Raman (rR) spectra were
measured with excitation from either a Coherent I-305 Ar+ laser (488.0 nm) or I-302C
Kr+ laser (647.1 nm) with ~50 mW of power at the sample. The scattered light was
collected using a 135° backscattering arrangement, dispersed by an Action Research
triple monochromator equipped with a 1200 grooves/mm grating and detected with a
Princeton Instruments Spec X 100BR CCD camera. Spectra were accumulated at 77 K,
and rR frequencies were referenced to the 983 cm-1 peak of K2SO4.220 Low-field (0.04 T)
variable temperature (5─200 K) Mӧssbauer spectra were recorded on a closed-cycle
refrigerator spectrometer, model CCR4K, equipped with a 0.04 T permanent magnet,
maintaining temperatures between 5 and 300 K. Mӧssbauer spectra were analyzed using
the software WMOSS (Thomas Kent, SeeCo.us, Edina, Minnesota). The samples
consisted of solid powders (or crystalline material) suspended in nujol, placed in Delrin
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1.00 mL cups, and then frozen in liquid nitrogen. The [12](OTf)2 sample was prepared
from material crystallized from a mixture of 1,2-dichloroethane (DCE) and Et2O. The
air-oxidized sample 4ox was prepared by exposing a solution of [12](OTf)2 in CH2Cl2 to
air for 20 h, followed by removal of solvent to give a dark green powder. The isomer
shifts are quoted at 5 K with respect to iron metal spectra recorded at 298 K.
X-ray diffraction (XRD) data were collected with an Oxford Diffraction
SuperNova κ-diffractometer (Agilent Technologies) equipped with dual microfocus
Cu/Mo X-ray sources, X-ray mirror optics, Atlas CCD detector, and low-temperature
Cryojet device. The data were processed with CrysAlis Pro program package (Agilent
Technologies, 2011), followed by an empirical multiscan correction using SCALE3
ABSPACK routine. Structures were solved using SHELXS program and refined with
SHELXL program.147 X-ray crystallographic parameters are provided in Table 6.4, and
experimental details are available in the CIFs.
[Fe(Ph2TIP)(tBuCatH)(OTf) [11]OTf: Equimolar amounts of
[Fe(Ph2TIP)(MeCN)3](OTf)2 (456 mg, 0.38 mmol) and tBuCatH2 (63 mg, 0.38 mmol) were
dissolved in tetrahydrofuran (THF) (10 mL), followed by addition of NEt 3 (58 µL, 0.42
mmol). The dark yellow solution was stirred for 30 min, and the solvent was removed
under vacuum. The crude material was taken up in DCE (5 ml) and filtered. Layering of
this solution with hexane provided bright yellow crystals suitable for X-ray diffraction.
Crystals were washed with hexanes and dried under vacuum (yield = 83 mg, 20%). µ eff =
4.7 µB (Evans method). UV-vis [λmax, nm (ε, M-1 cm-1) in CH2Cl2]: 397 (940). IR (neat,
cm-1): 3058 (w), 2955 (w), 1603 (w), 1505 (m), 1460 (m), 1443 (m), 1443 (m), 1369 (m),
1241 (s), 1154 (s), 1028 (s). 1H NMR (400 MHz, CD2Cl2): δ = -27.52, -10.44, 2.22, 4.51,
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5.98, 6.94, 9.53, 10.06, 11.47, 23.88, 29.58, 61.67, 65.98.

19

F NMR (376 MHz, CD2Cl2):

δ = -80.3 (OTf) ppm. Elemental analysis calcd (%) for C59H52F3FeN6O5PS●2DCE: C,
58.26; H, 4.66; N, 6.47. Found: C, 58.00; H, 4.98; N, 6.46.
[Fe(Ph2TIP)(tBuPDA)(OTf)2 [12](OTf)2: Equimolar amounts of
[Fe(Ph2TIP)(MeCN)3](OTf)2 (304 mg, 0.25 mmol) and tBuPDA (42 mg, 0.25 mmol) were
dissolved in tetrahydrofuran (THF) (10 mL), and the reaction was stirred for 18 h.
Removal of the solvent under vacuum yielded a white solid that was dissolved in DCE (3
mL) and filtered. Vapor diffusion of ET 2O into this solution afforded the product as a
colorless solid (yield = 123 mg, 39%) suitable for use in spectroscopic and kinetic
studies. The complex does not exhibit absorption features in the visible region. µeff =
5.48 µB (Evans method). IR (neat, cm-1): 3306 (w, ν(NH)), 3254 (w, ν(NH)), 3057 (w),
2960 (w), 1572 (w), 1443 (w), 1261 (s), 1147 (m), 1029 (w). 1H NMR (400 MHz,
CD2Cl2): δ = -28.8 (1H), 0.62 (9H), 4.98 (6H), 7.00 (3H), 7.32 (3H), 7.68 (6H), 8.53
(6H), 11.81 (1H), 12.89 (9H), 15.33 (6H), 19.01 (2H), 24.33 (2H), 31.36 (1H).

19

F NMR

(376 MHz, CD2Cl2): δ = -79.3 (OTf) ppm. Elemental analysis revealed that a small
amount of DCE solvent (0.5 equiv/Fe) remains after drying. Elemental analysis calcd
(%) for C60H55F6FeN8O6PS2●2DCE: C, 56.42; H, 4.42; N, 8.63; F, 8.78. Found: C,
56.56; H, 4.51; N, 8.54; F, 8.32. X-ray quality crystals were obtained by either slow
diffusion of Et2O into a concentrated MeCN solution or pentane layering of a DCE
solution containing 1 equiv. of NaBPh4.
[Fe(Ph2TIP)(Me2MP)]OTf [13]OTf. Equimolar amounts of
[Fe(Ph2TIP)(MeCN)3](OTf)2 (143 mg, 0.12 mmol) and 2-methoxy-5-methylphenolate
(Me2MPH, 16.3 mg, 0.12 mmol) were dissolved in THF (10 mL), followed by addition of
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NEt3 (20 µL, 0.15 mmol). The mixture was stirred for 3 h, and the solvent was removed
under vacuum. The crude solid was taken up in CH2Cl2 (5 mL) and layered with
hexanes. After several days, light green crystals suitable for X-ray crystallography were
collected (yield = 101 mg, 80%). UV-vis [λmax, nm (ε, M-1 cm-1) in CH2Cl2]: 390 (1400),
610 (500). IR (neat, cm-1), 3048 (w), 1499 (w), 1444 (m), 1396 (w), 1260 (s), 1220 (s),
1146 (s), 1073 (w), 1028 (s), 982 (m), 790 (s), 771 (s). The crystals used for elemental
analysis were prepared from a mixture of DCE/hexanes. The results suggest that some
DCE solvent (~1 equiv/Fe) remains after drying consistent with the X-ray structures that
found 1.5 equiv. of uncoordinated CH2Cl2 in the unit cell. Elemental analysis calcd (%)
for C57H48F3FeN6O5PS●DCE: C, 60.47; H, 4.47; N 7.17. Found: C 59.00; H, 4.63; N,
7.55.
Synthesis of tBuPDA with 15N at 2-Position. Using a published procedure,237
acetic anhydride (2.64 g, 22.4 mmol) was added dropwise to a solution of 4-tertbutylaniline (3.34 g, 22.4 mmol) in CH2Cl2 (30 mL) at O°C. A white precipitate formed
as the mixture was stirred for 30 min. After addition of 30 mL of hexanes, the solution
was filtered to give 4-tert-butylacetanilide as a white solid. Without further purification,
680 mg (3.55 mmol) of the product was dissolved in CHCl3 (15 mL). To this solution,
H2SO4 (0.3 mL) and 15N-labeled HNO3 (1.0 g, 7.04 mmol, Aldrich, 98% 15N) were added
dropwise. The resulting dark orange solution was stirred for 1 h and was then washed
successively with H2O, saturated NaHCO3, and brine. After drying the organic layer with
MgSO4 the solvent was removed to yield 4-tert-butyl-2-nitroacetanilide. The protecting
group was then removed by refluxing in EtOH with KOH (143 mg, 2.6 mmol). The
mixture was poured into ice-water, yielding a precipitate that was isolated by filtration,
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washed with cold H2O, and dried in vacuo. The resulting 15N-labeld 4-tert-butyl-2nitroaniline (300 mg, 1.54 mmol) was dissolved in MeOH (20 mL), and 5% Pd/C catalyst
(90 mg) was added. The mixture was stirred under H2 (46 psi) for 5 h and filtered
through Celite, and the solvent was removed under vacuum to yield a dark purple solid
(yield = 201 mg, 79%). 1H and 13C NMR spectra of the product were identical to those
obtained with commercially available tBuPDA.
Oxygenation studies were performed by injecting anaerobic solutions of the Fe(II)
complex into O2-saturated solutions of CH2Cl2 at the desired temperature. Formation of
the oxidized species was monitored using UV-vis spectroscopy. The concentration of O2
in CH2Cl2 solutions at various temperatures (T) was estimated using the formula: S =
(LPO2)/TR), where L is the Ostwald coefficient (0.257 for CH 2Cl2), PO2 is the partial
pressure of O2, and R is the gas constant.223,238 The determination of PO2 accounted for
the vapor pressure of CH2Cl2 (Psolv) as a function of T: PO2 = 1 atm ─ Psolv. Following
established procedures,135,206,213,234 the decomposition products of the 3ox + O2 reaction
were isolated by removing the CH2Cl2 solvent under vacuum, taking the residue up in
MeCN, and treating the solution with ~3 mL of HCl (2 M). After extraction of the
aqueous layer with Et2O, the solvent was removed to give a residue that was analyzed
with GC-MS and/or 1H NMR spectroscopy. The 1H data was interpreted with the aid of
published spectra.239
DFT calculations were performed using the ORCA 2.9 software package
developed by Dr. F. Neese (MPI for Chemical Energy Conversion). Calculations
involving 4ox employed Becke’s three-parameter hybrid functional for exchange along
with the Lee-Yang-Parr correlations functional (B3LYP). 142,143 These calculations
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utilized Ahlrichs’ valance triple-ζ basis set (TZV) and TZV/J auxiliary basis set, in
conjunction with a polarization functions on all atoms. 144,145,240 In the geometry
optimized model, the Ph2TIP ligand was modified by replacing the Ph-groups at the 5position of the imidazolyl rings with H-atom. In addition, the tert-butyl substituent of the
tBu

PDA ligand was replaced with a Me group. To avoid spurious transitions, time-

dependant DFT (TD-DFT) calculations used a truncated version of the optimized 12ox
model with Me groups (instead of Ph groups) at the 4-position of the imidazolyl rings.
TD-DFT calculations176-178 calculated absorption energies and intensities for 50 excited
states with the Tamm-Dancoff approximation.179,241 Isosurface plots of molecular
orbitals and electron-density difference maps (EDDMs) were prepared with Laaksonen’s
gOpenMolprogram.146
Energetic parameters for the biding of O2 to the Fe(II) complexes were computed
using the Perdew-Burke-Ernzerhof (PBE) functional229 with 10% Hartree-Fock
exchange. These calculations employed modified

Ph2

TIP ligands containing three N-

methylimidazole rings attached at the 2-position to a central P atom, and the tert-butyl
substituents of the bidentate ligand were replaced with Me groups. Geometry
optimizations were performed for the Fe(II) precursors, [Fe/O2] adducts, and O2 under
tight convergence criteria, and the resulting models were used to obtain gas-phase
vibrational and thermodynamic data. Solvent effects were calculated using the
conductor-like screening model (COSMO)242 with a dielectric constant (ε) of 9.08 for
CH2Cl2. The “spin-flip” feature of ORCA was employed to generate [Fe/O2] wave
functions for Stot = 2 and 1 states.
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Table 5.7. Summary of X-ray Crystallographic Data Collection and Structure Refinement
[11]OTf•2DCE

[12](OTf)(BPh4)•DCE•C5H12a

[12(MeCN)](OTf)2•MeCN•Et2O

[13](OTf)•1.5CH2Cl2

empirical formula

C63H60Cl4F3FeN6O5PS

C90H91BCl2F3FeN8O3PS

C68H71F6FeN10O7PS2

C58.5H51Cl3F3FeN6O5PS

formula weight

1298.85

1590.34

1388.96

1200.28

crystal system

monoclinic

monoclinic

triclinic

triclinic

space group

P21

P21/n

Pī

P

a, Å

16.0859(2)

19.6939(4)

15.3998(3)

15.5548(2)

b, Å

21.4779(2)

18.3202(4)

15.6626(3)

17.2278(3)

c, Å

17.8488(2)

22.2057(4)

17.9588(3)

23.4768(4)

α, deg

90

90

88.191(2)

97.790(1)

β, deg

90.1428(9)

92.009(2)

64.934(2)

91.828(1)

, deg

90

90

61.081(2)

115.875(2)

6166.6(1)

8006.8(3)

3351.4(1)

5578.9(2)

4

4

2

4

1.399

1.293

1.376

1.429

1.5418

0.7107

0.7107

1.5418

µ, mm-

4.642

0.350

0.388

4.654

-range, deg

6 to 148

6 to 58

6 to 58

6 to 147

reflections collected

60871

77363

74982

71466

independent reflections

23500

19234

16362

21895

[Rint = 0.0372]

[Rint = 0.0418]

[Rint = 0.0363]

[Rint = 0.0345]

23500/7/1532

19234/67/1058

16362/7/898

21895/129/1607

3

V, Å
Z

Dcalc, g/cm

3

, Å
1

data/restraints/parameters
2

GOF (on F )

1.041

1.051

1.050

1.074

b

0.0390/0.1022

0.0962/0.2182

0.0470/0.1170

0.0425/0.1169

R1/wR2 (all data)

0.0395/0.1028

0.1280/0.2375

0.0589/0.1253

0.0478/0.1215

R1/wR2 (I>2σ(I))
a

b

The DCE solvate is only partially (80%) populated. The ethereal solvate is only partially (78%) populated.
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Chapter 6

O2 Reactivity of Fe(II) Complexes that Mimic the Active-Site
Structure of Acetylacetone Dioxygenase

Abstract: Two complexes that exhibit Dke1 like activity have been synthesized and
characterized by X-ray crystallography. Exposure of each [(Ph2TpFe2+(acacX)] (where
acacX is the anion of dialkyl malonate) to O2 at room temperature in toluene results in the
oxidative cleave of the substrate concomitant with degradation of the initial iron species.
The reaction was monitored by 1H NMR and GC-MS.
Parts of the following chapter have appeared in the following paper Park, H.; Bittner, M.
M.; Baus, J. S.; Lindeman, S. V.; Fiedler, A. T. Inorg. Chem. 2012, 51, 10279-10289.
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6.A. Introduction
The oxidative cleavage of carbon−carbon bonds by mononuclear nonheme iron
dioxygenases is a crucial step in the microbial degradation of many organic
pollutants.2,3,203 Well studied examples include the intradiol and extradiol catechol
dioxygenases,92 (homo)gentisate dioxygenases,243 and (chloro)-hydroquinone
dioxygenases.8,96,244 In 2003, Straganz and co-workers demonstrated that a strain of
Acinetobacter johnsonii is able to use acetylacetone ─ a toxic pollutant ─ as its sole
source of carbon.52 The initial step of this process is performed by the enzyme
acetylacetone dioxygenase (also known as β-diketone dioxygenase, Dke1), which uses O2
to convert acetylacetone to acetic acid and 2-oxopropanal.52 Biochemical and
crystallographic studies revealed that the Dke1 active site contains a monoiron(II) center
facially ligated by three histidine (3His) residues, a deviation from the 2-His-1carboxylate facial triad normally employed by nonheme iron dioxygenases. 49,54,245 Dke1
is capable of oxidizing β-diketones and β-ketoesters with a variety of substituents at the
1-, 3-, and 5-positions; in each case, the substrate coordinates to Fe as the deprotonated
acac-type anion.53 Initial mechanistic studies suggested that O2 reacts with the bound
acac ligand in a concerted two-electron process, resulting in a peroxidate intermediate
without direct involvement of the Fe center.56 However, in a subsequent computational
study, Solomon and Straganz have set forth an alternative mechanism that involves
formation of an Fe/O2 adduct prior to substrate oxidation.230
Dke1 has attracted the interest of synthetic inorganic chemists because of the
presence of the unusual 3His triad in the active site, as well as the enzyme’s ability to
catalyze aliphatic C−C bond cleavage. Interestingly, the first relevant model system was
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reported a decade before the discovery of Dke1. In 1993, Kitajima and co-workers
generated the complex [Fe2+(iPr2Tp)(acac)(MeCN)] (where R2Tp = hydrotris- (pyrazol-1yl)borate with R-groups at the 3- and 5-positions of the pyrazole rings).246 Exposure to O2
in MeCN at room temperature eventually produced crystals of the triiron(III) complex
[Fe3+(μ-O)(μ-OH)(μ-OAc)4(iPr2Tp)2], where the bridging acetate ligands derive from the
acac group of the ferrous precursor. Thus, this synthetic model exhibits Dke1-type
reactivity, although generation of the acetate ligands may proceed via a different
mechanism than the one employed by the enzyme. In 2008, Limberg and Siewer
demonstrated that the related complex, [Fe2+(Me2Tp)(acacPhmal)] (acacPhmal = anion of
diethyl phenylmalonate), reacts with O2 to give Dke1- type products with incorporation
of oxygen atoms from O2.72 The activated diethyl malonate anion was used because the
corresponding acac complex failed to exhibit oxidative cleavage. Significantly, the
[Fe2+(Me2Tp)(acacPhmal)] system is catalytic in the presence of excess Li(acac Phmal) and O2
with a turnover frequency of 55 h−1.
In our group, Dr. Heaweon Park and Jacob Baus generated three series of Dke1
models featuring Fe(II)/acacX units (acacX = substituted -diketonates) bound to faciallycoordinating N3 supporting ligands (LN3).247 These complexes incorporated acacX
ligands with a range of steric and electronic properties. Following the labeling scheme
employed in that paper (Figure 6.1), the 1-acacX and 2-acacX complexes contain anionic
Me2

Tp and Ph2Tp donors, respectively. The [3-acacX]OTf series utilizes the neutral tris(2-

phenylimidazoly-4-yl)phosphine (PhTIP) ligand, which was shown by spectroscopic and
computational analysis to faithfully reproduce the 3His coordination environment of the
Dke1 active site. In this chapter, we describe the synthesis and O 2 reactivity of three
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additional complexes that incorporate -diester anions (i.e., acacOMe and acacPhmal in
Figure 6.1). These complexes were prepared in order to compare our results with those
previously published by Siewert and Limberg. 17 Thus, we seek to expand upon previous
discoveries that have demonstrated that synthetic Fe/acacX complexes are capable of
performing Dke1-type chemistry.

Figure 6.1. Naming scheme of compounds in this chapter.

6.B. Synthesis, Solid State Structures, and Spectroscopic Features
Following earlier procedures,72,126 the iron(II) complexes, 2-acacOMe (14), and 2acacPhmal (15) were prepared by reacting equimolar amounts of K(R2Tp), FeCl2, LDA,
and dimethyl malonate or diethyl phenylmalonate. The resulting X-ray crystal structures
are shown in Figure 6.1 and selected metric parameters are provided in Table 6.1. The
Ph2

Tp complexes 14 and 15 exhibit distorted 5C square-pyramidal geometries (τ =0.03

and 0.39, respectively124) with a pyrazole ligand in the axial position. The lack of bound
solvent shortens the Fe−NTp and Fe−Oacac distances in 14 and 15 (Table 6.1). Because of
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steric interactions with the 3-Ph group of the axial pyrazole, the acacOMe ligand is tilted
out of the N1−Fe1−N3 plane by ∼30°.
Most Fe(R2Tp)(acacX) complexes are brightly colored because of the presence of
Fe2+→acacX (C=O*) metal-to-ligand charge-transfer (MLCT) transitions in the visible
region.126 The acacOMe and acacPhmal complexes are colorless, however, as the
corresponding MLCT bands appear in the UV region, reflecting the electron-rich nature
of the dialkyl malonate anions. The 1H NMR spectra of these complexes exhibit broad,
paramagnetically shifted peaks consistent with the presence of a high-spin Fe(II) center.
For complex 14, resonances arising from the methyl groups of the acacOMe moieties
appear near 8 ppm in CD2Cl2. The remaining R2Tp-derived peaks largely follow the
patterns previously described for previously published complexes.126

Figure 6.2. Thermal ellipsoid plots (50% probability) derived from 14 • 1.5 CH2Cl2 (A),
and 15 • MeCN (B). Hydrogen atoms and noncoordinating solvent molecules have been
omitted for clarity. Selected metric parameters are provided in Table 6.1.
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Table 6.1. Selected Bond Distances (Å) and Bond Angles (deg) for 14 • 1.5 CH2Cl2, and
15 • MeCN
14•1.5 CH2Cl2

15 • MeCNa

Fe-O1

2.042(1)

1.982(2)

Fe-O2

2.046(1)

2.065(2)

Fe-N1

2.151(1)

2.214(2)

Fe-N3

2.154(1)

2.105(2)

Fe-N5

2.129(1)

2.076(2)

Fe-Oacac (ave)

2.044

2.024

Fe-NTp (ave)

2.144

2.132

O1-Fe-O2

87.50(4)

86.34(6)

O1-Fe-N1

92.16(4)

97.02(7)

O1-Fe-N3

159.16(4)

147.45(7)

O1-Fe-N5

108.31(4)

120.57(7)

O2-Fe-N1

157.09(4)

170.87(7)

O2-Fe-N3

88.54(4)

90.05(7)

O2-Fe-N5

109.58(4)

95.66(7)

N1-Fe-N3

83.68(4)

82.54(7)

N1-Fe-N5

92.28(4)

89.95(7)

N3-Fe-N5

92.29(4)

91.98(7)

τ-value

0.03

0.39

a

The unit cell of 15 • MeCN contains two symmetrically independent complexes with
nearly identical geometries. Only parameters for the first complex are shown.

6.C. Oxygenation of Fe(II) Complexes
Treatment of Fe(II) complexes in the 2-acacX and series with O2 failed to
generate the corresponding green intermediates or triiron complexes under any
conditions. These complexes react slowly, or not at all, with O 2 in both coordinating and
noncoordinating solvents. For instance, the UV−vis absorption and 19F NMR spectra of
2-acacF3, and 2-acacPhF3 in O2-saturated toluene solutions exhibit no significant changes
over the course of several days at room temperature. Only the β-diester complexes 14 and
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15 exhibit perceptible reactivity toward O2. Exposure of these complexes to O2
eventually yields colorless crystals that were shown by XRD to consist of Fe( Ph2Tp)2
suggesting that the acac ligands are degraded in the process.72 Monitoring the O2 reaction
with 1H NMR spectroscopy in toluene-d8 revealed that the paramagnetically shifted peaks
of 14 and 15 slowly disappear, concomitant with the growth of peaks arising from methyl
2-oxoacetate and ethyl benzoylformate, respectively. The formation of ethyl
benzoylformate was also verified by GC-MS. When the reaction with 15 was performed
with 18O-enriched dioxygen, GC-MS analysis indicated that one O-atom of ethyl
benzoylformate is derived from O2, proving that the observed products are due to
dioxygenolytic cleavage of the ligand (the alkyl carbonate products that are also
generated quickly decompose to CO2 and the corresponding alkoxide). Thus, our Ph2Tpbased complexes are capable of performing Dke1-type chemistry on a reasonable time
scale provided that the substrate ligand is sufficiently activated. The rates of the O2
reactions in toluene were measured using UV−vis absorption spectroscopy. 15 decays
relatively quickly in the presence of O2 (kO2 = 3.4 × 10−4 s−1; Figure 6.2), whereas 14
requires more than a day for complete reaction (k O2 ∼4 × 10−5 s−1).
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Figure 6.3. Time-dependent absorption spectra of the reaction of 15 (0.36 mM) with O2
at room temperature in toluene. Inset: Absorption intensity at 350 nm as a function of
time.

Figure 6.4. Proposed mechanistic path for the oxidative cleavage of acac X ligands
utilized by our synthetic models.

Based on the work with 2-acacX and Dr. Parks previous work with acac-based
compounds we have proposed the mechanistic framework shown in Figure 6.4 for our
[Fe2+(Ph2Tp)(acacX)] complexes.248 Fe(II)-acacX complexes with Ph2Tp exhibit
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dramatically diminished reactivity toward O2. Complexes with β-diketonato ligands are
stable in oxygenated solutions at room temperature for several hours or days, regardless
of solvent. We initially assumed that this inert behavior was due to the steric bulk of the
phenyl substituents, which might be expected to block O2 coordination the Fe center. Yet
this hypothesis is not consistent with the facile formation of FeNO 53 adducts upon
exposure of the 2-acacX complexes to NO, proving that formation of an Fe/O2 species is
sterically feasible for the Ph2Tp-based complexes. However, the size of the Ph groups
likely prevents the formation a diiron intermediate via reaction with a second Fe(II)
complex. The scenario illustrated in Figure 6.4 requires the reaction equilibrium of the
first step (i.e., O2 binding) to lie far to the side of Fe(II) + O2, since the putative iron(III)superoxo adduct is never observed. Indeed, a number of computational studies have
indicated that the reversible transfer of one electron from a mononuclear nonheme Fe(II)
center to O2 is endergonic by approximately 5−10 kcal/mol.42,230,249 In Dr.Parks Me2Tp
systems, the uphill nature of this initial step is overcome by the thermodynamicly
favorable second step; formation of a di- [Fe3+(Me2 Tp)(acacX)]+ intermediate, which
“pulls” the entire process forward (where Me2Tp is hydrotris(3,5-diphenylpyrazol-1-yl)
borate(1−) ligand. However, when this second step is hindered because of steric reasons,
the ferrous complexes are rendered much less reactive toward O2, as observed for the 2acacX series. Obviously, the protein environment surrounding the Fe center in Dke1
prevents formation of a diiron-peroxo intermediate. Instead, the enzymatic mechanism
likely involves formation of a peroxy bridge between Fe and acac following initial
formation of an iron(III)-superoxo species. One would therefore expect the Ph2Tp and
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TIP supporting ligands, which prevent dimerization, to be ideal scaffolds for

reproducing the catalytic activity of Dke1.

6.D. Conclusions
We have demonstrated that complexes in the 2-acacX series with activated anions
of dialkyl malonate are able to cleave the acac anion in a manner similar to the enzymatic
system. Key differences a found in the rate and mechanism of oxidative cleavage.
Namely, our complexes react slower and through a separate mechanism than the enzyme
catalytic mechanism. We also showed that nonacctivated acacX complexes do not exhibit
any activity when exposed to O2, these complexes being stable for days in air, even
though ligands such as acacF3 are viable substrates for Dke1. The differences between
our complexes and Dke1 serve to highlight the importance of second-sphere residues in
the protein environment, and some of the challenges that Dke1 must overcome.

6.E. Experimental
Unless otherwise noted, all reagents and solvents were purchased from
commercial sources and used as received. Acetonitrile, dichloromethane, and
tetrahydrofuran were purified and dried using a Vacuum Atmospheres solvent
purification system. The synthesis and handling of air-sensitive materials were performed
under inert atmosphere using a Vacuum Atmospheres Omni-Lab glovebox equipped with
a freezer set to −30 °C. Nitric Oxide was purified by passage through an ascarite II
column followed by a cold trap at -78 °C to remove higher nitrogen impurities.
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K(Ph2Tp)137 was prepared according to literature procedures. Elemental analyses were
performed at Midwest Microlab, LLC in Indianapolis, IN. UV−vis absorption spectra
were obtained with an Agilent 8453 diode array spectrometer equipped with a cryostat
from Unisoku Scientific Instruments (Osaka, Japan) for low temperature experiments.
Infrared (IR) spectra were measured in solution using a Nicolet Magna-IR 560
spectrometer. Mass spectra were recorded using an Agilent 6850 gas chromatography −
mass spectrometer (GC-MS) with a HP-5 (5% phenylmethylpolysiloxane) column.
(Ph2Tp)Fe(acacOMe) (2-acacOMe) (14): Li(acacOMe) was generated by treating
dimethyl malonate (0.92 mmol) with LDA (1.0 mmol) in tetrahydrofuran (THF),
followed by removal of the solvent to yield the salt as a white powder. FeCl2 (0.92 mmol)
and K(Ph2Tp) (0.92 mmol) were then combined with Li(acacOMe) in 15 mL of 1:3
CH2Cl2/CH3CN. The solution was stirred for 24 h, and the solvents were removed under
vacuum. The white product was taken up in 5 mL of CH2Cl2 and filtered to remove
insoluble salts. The resulting solution was layered with CH3CN to yield colorless crystals
suitable for XRD studies. Anal. Calcd for C50H41BFeN6O4: C, 70.11; H, 4.82; N, 9.81.
Found: C, 70.02; H, 4.82; N, 9.85. UV−vis [λmax, nm (ε, M−1 cm−1) in toluene]: 330
(400). IR (KBr, cm−1): 3061, 2950, 2616 [ν(BH)], 1632 [ν(CO)], 1503, 1460, 1304.
(Ph2Tp)Fe(acacPhmal) (2-acacPhmal) (15): Diethyl phenylmalonate (Phmal) (0.712
mmol) was stirred with LDA (0.790 mmol) for 30 min in 5 mL of THF. Removal of the
solvent yielded a white salt that was dissolved in a 3:2 mixture of MeCN/CH 2Cl2.
Addition of FeCl2 (0.713 mmol) and K(Ph2Tp) (0.712 mmol) resulted in a cloudy gray
solution that was stirred overnight. The solvents were removed under vacuum to yield a
pale green solid that was taken up in 5 mL of CH2 Cl2 and layered with CH3CN. After one
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day, light green crystals suitable for XRD were obtained. Anal. Calcd for
C58H49BFeN6O4: C, 72.51; H, 5.14; N, 8.75. Found: C, 72.39; H, 5.11; N, 8.74. UV−vis
[λmax, nm (ε, M−1 cm−1) in toluene]: 350 (1806). IR (neat, cm−1): 3024, 2974, 2614
[ν(BH)], 1615 [v(CO)], 1594, 1544, 1478, 1463, 1448, 1433, 1405, 1375, 1337, 1303.
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Table 6.2. Summary of X-ray Crystallographic Data Collection and Structure Refinement

a

2-acacOMe•CH2Cl2

2-acacPhmal•MeCN

empirical formula

C51.5H44BCl3FeN6O4

C60H52BFeN7O4

formula weight

983.94

1001.75

crystal system

triclinic

monoclinic

space group

P1─

P21/c

a [Å]

12.2090(3)

38.1369(8)

b [Å]

13.0283(4)

13.5597(3)

c [Å]

17.0877(5)

20.5303(4)

α [°]

95.921(3)

90

β [°]

103.201(3)

104.121(2)

γ [°]

117.095(3)

90

V [Å3]

2287.5(1)

10295.9(4)

Z

2

8

Dcalcd. [g/cm3]

1.429

1.293

λ [Å]

0.7107

1.5418

μ [mm–1]

0.559

2.789

θ range [°]

3 to 62

7 to 148

Reflections collected

49672

72082

Independent reflections

13415 [Rint = 0.0278]

20374 [Rint = 0.0351]

Data/restraints/parameters

13415/24/609

20374/0/1321

GOF (on F2)

1.031

1.040

R1/wR2 (I > 2σ(I))a

0.0364/0.0861

0.0525/0.1393

R1/wR2 (all data)a

0.0463/0.0925

0.0570/0.1430

R1 = Σ||Fo| − |Fc||/Σ|Fo|; wR2 = [Σw(Fo2 − Fc2)2/Σw(Fo2)2]1/2.
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